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Abstract 
Sox2 is one of the earliest known transcription factors to be expressed during 
development of the nervous system (Rex et al., 1997; Silvia Brunelli, 2003; 
Wang et al., 2006b; Dee et al., 2008). Ectodermal cells expressing Sox2 have 
the potential to differentiate into nerve cells. Cells expressing Sox2 are 
specified to a neural fate during neural induction. Sox2 belongs to the SoxB1 
family, comprising Sox1, Sox2 and Sox3, which are generally considered to 
activate specific target genes, whereas, the SoxB2 group, Sox14 and Sox21, act 
as transcriptional repressors (Uchikawa, Kamachi, & Kondoh, 1999). However, 
Sox2 has also been demonstrated to act as a repressor (Kopp et al., 2008) 
which implies that Sox2 could have a dual-function in vivo. Previous studies 
indicated that the HMG box-containing protein, Tcf/Lef, interacts with the 
transcriptional co-repressor, Groucho (Helen Brantjes, 2001). We therefore set 
out to determine if interaction with the Groucho co-repressor could also 
explain the repressor ability of Sox2.  
In this study, we have examined the interaction between Sox2 and Groucho 
using nuclear translocation, yeast-two-hybrid and co-immunoprecipitation 
assays. The data suggest that Sox2 interacts with Groucho through a C-terminal, 
engrailed-like motif. The effect of Groucho on Sox2 function was measured 
using a luciferase reporter assay. The transcriptional activation activity of Sox2 
was repressed after co-expressing with Groucho. To address the biological 
function of Sox2-Groucho interaction, a loss-of-repressor-function mutant of 
Sox2 was created by point mutating the essential engrailed-like motif. Analysis 
in Zebrafish embryos indicated that the of loss-of-repressor-function mutant of 
Sox2 (Sox2LQY/AAA) lost the ability to repress the expression of chordin. In 
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human neural stem cells, Affymetrix arrays revealed that 676 genes were 
activated and 786 genes were repressed by Sox2 overexpression. Within the 
genes that were repressed by Sox2, approximatly 7% were less repressed by 
Sox2LQY/AAA. Together, these data suggest that Sox2 functions not only as a 
transcriptional activator but also as a repressor through interacting with the co-
repressor Groucho. However, because only 7% of the repressed genes were 
affected by the Sox2LQY/AAA mutant, this suggests that there are other 
mechanisms involved in Sox2 transcriptional repressor function. 
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Chapter 1 Introduction 
1.1 SoxB1 in early neural development 
1.1.1 Neural induction 
During embryonic development, neural induction is one of the earliest events. 
After fertilization is completed, a series of cell divisions occurs, this process is 
called cleavage. Later, a fluid-filled cavity is formed and the embryo is now 
called a blastula (Figure 1.1.1 A). Gastrulation is the stage of embryonic 
development which initiates the establishment of the three germ layers – 
ectoderm, endoderm and mesoderm (Figure 1.1.1 B, C). The nerve system is 
derived from the dorsal ectoderm called the “neuroectoderm”, whereas the 
ventral ectoderm will generate epidermis. This decision to become neural or 
epidermal is through the process of neural induction - formation of the neural 
plate, and neurulation (establishment of the neural tube) (Figure 1.1.2). Signals 
that originate from the midline mesoderm cause thickening of adjacent 
ectoderm to form the neural plate. The lateral edges keep rolling to form neural 
folds that fuse dorsally to form the neural tube (Figure 1.1.2). During the 
formation of the neural tube, neural crest cells migrate between the epidermis 
and the neural tube. The rostral region of the neural tube progresses to become 
the brain whereas the caudal region gives rise to the spinal cord. The 
proliferation rate is not uniform along the neural tube, resulting in the 
formation of three brain vesicles: the forebrain (prosencephalon), the midbrain 
(mesencephalon), and the hindbrain (rhombencephalon).  
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Figure 1.1.1 Gastrulation of Xenopus embryo 
(A) Blastula. (B) Gastrulation start from the dorsal lip of the blastopore. Cell movements 
are indicated with arrows. (C) The formation of the three germ layers (From Gilbert, 
2000). 
 
Figure 1.1.2 Illustration of neural tube formation. 
 (a) Neural plate can be distinguished in the midline of the dorsal ectoderm. (b)  When the 
neural ectoderm starts folding, the medial neural hinge point (MHP) cells associate with the 
notochord whilst the adjacent ectoderm rolls up. (c) The epidermis keep moving toward the 
dorsal midline causing elevation of the neural fold. (d) The forming of wedge-shaped 
dorsolateral hinge point (DLHP) cells results in the convergence of the neural fold. (e) The 
neural tube is formed after closure of neural fold. (From Gilbert, 2000) 
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Neural induction has been studied for many decades, and a number of 
molecules have been identified that play central roles in neural fate 
specification and commitment. Bone morphogenetic proteins (BMPs), which 
belong to the TGFβ superfamily, are the most thoroughly studied of these 
signalling molecules (Figure 1.1.3). The ventral expression of BMPs induces 
epidermal (non-neural) fate, whereas the expression of BMP antagonists, such 
as noggin (Smith and Harland, 1992), chordin (Sasai et al., 1994) and follistatin 
(Hemmati-Brivanlou et al., 1994), has been shown to be involved in the 
initiation of neural induction. The mechanism behind the contrary functions of 
these molecules is that the antagonists of BMPs interfere with BMP signalling 
by directly binding to BMPs or blocking the phosphorylation of the Smad 
complex (Massague and Chen, 2000; Onichtchouk et al., 1999). Hence, these 
BMP antagonists are defined as neural inducers. 
There are two types of BMP receptors (Type I and Type II), both are 
transmembrane proteins. When BMP/typeI and typeII receptors form a ternary 
complex, signal transduction occurs via the serine/threonine kinase activity of 
the receptors (Figure 1.1.3) (Munoz-Sanjuan and Brivanlou, 2002). BMP 
signalling result in phosphorylation of the intracellular signal transducer, Smad 
complex, which translocates into the nucleus after activation and triggers the 
transcription of downstream genes by cooperating with other transcription 
factors (Bubnoff and Cho, 2001; Massague and Chen, 2000). BMP4 inhibits 
neural differentiation and induces epidermis (Wilson and Hemmati-Brivanlou, 
1995). The inhibition of BMP signalling triggers the expression of a specific 
set of transcription factors, including Sox family proteins, and subsequently 
induces neural fate. 
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Following neural induction, the cells of the neural ectoderm form neural 
progenitors later giving rise to oligodendrocytes and astrocytes through 
gliogenesis or neurons through neurogenesis.  
 
 
Figure 1.1.3 BMP signalling 
Binding of the ligand (BMP2, 4, 7) with the typeI (RI) and typeII (RII) receptors leads to a 
series of phosphorylation events on the type I receptor and appropriate R-Smads (Smad1, 5, 
8). This results in the formation of a Smad complex with co-Smad (Smad4) and causes the 
complex to relocate the nucleus. This allows the Smad complex to activate or repress target 
genes (From Bubnoff and Cho, 2001). 
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1.1.2 Transcription factors  
The genome contains the complete information of all genes, but not all of 
genes are expressed in all cells. Different genes are expressed in different 
tissues and different development stages. Transcription factors play a key role 
ensuring the right genes are expressed at the right time. 
The term “transcription factor” broadly refers to any protein that has the ability 
to regulate gene transcription in cells. Generally, transcription factors regulate 
gene transcription by directly binding to specific DNA regions called 
“regulatory elements” through their DNA-binding domains, affecting 
chromatin structure or recruiting cofactors to the target genes (Lee and Young, 
2000). Generally, according to their different DNA-binding domains, 
transcription factors have been categorized into five classes: basic domains, 
zinc-coordinating DNA-binding domains, helix-turn-helix, beta-scaffold 
factors with minor groove contacts, and other transcription factors (Matys et al., 
2006).  
Transcription factors can also be divided into two classes according to their 
function on target genes: transcriptional activators and repressors. The 
transcriptional activators assemble enhanceosomes that contain appropriate 
regulators through protein-protein interaction. Chromatin-modifying 
complexes such as Swi/Snf can be recruited by transcriptional activators, 
which loosen the structure of the chromatin. On the other hand, the 
transcription initiation apparatus that contains RNA polymerase II, can also be 
recruited by transcriptional activators. The mechanisms of transcriptional 
repression are less well understood. To date, two possible hypotheses of 
transcriptional repression have been proposed. One is that a repressor interacts 
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with an activator and interferes with the binding of the activator on target 
promoters. The other is that repressors bind specific DNA sites and recruit 
other factors to block transcription (Hanna-Rose and Hansen, 1996; Johnson, 
1995). The balance between transcriptional activation and repression is 
important to regulate gene expression in vivo (Lee and Young, 2000). During 
neural induction, transcription factors play an important role in responding to 
the differential signals such as BMPs and turn on/off the transcription of 
appropriate genes for neural fate commitment.  
1.1.3 Sox family 
Sox family members are highly conserved transcription factors in both 
vertebrates and invertebrates. Almost 20 years ago, the Sox (Sry-related high-
mobility-group box) gene family was first identified. To date, the large family 
of Sox factors has more than 30 members, which share a similar DNA-binding 
domain – the HMG (high-mobility-group) domain. The large Sox family has 
been categorized into 10 subgroups according to similarity both within and 
outside of the HMG box domain (Figure 1.1.4). The HMG domain is 
composed of 79 amino acids and exhibits a preference for binding to the 
variant linear DNA sequence (A/T A/T CAAA/TG) in the minor groove (Laudet et 
al., 1993). The binding of the L-shaped HMG domain forces the DNA to bend 
significantly (Lefebvre et al., 2007). The Sox family proteins contain a non-
canonical HMG domain, which evolved from the canonical HMG domain 
found in SRY (the sex determining gene on the Y chromosome). Although the 
identity of the HMG domain of the Sox family and SRY  can be as low as 50%, 
the ability to alter DNA conformation is conserved (Murphy et al., 1999). 
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Within the Sox family proteins, sequences are quite variable except within the 
HMG domain.  
Sox proteins have been found to function in many tissues and developmental 
processes. For example during embryonic development, Sox9 is expressed in 
the embryonic gonad and has a role in sex determination (Kent et al., 1996). In 
addition, Sox2, together with Oct4, was demonstrated to regulate FGF4 and 
osteopontin which play roles in early embryogenesis (Botquin et al., 1998; 
Yuan et al., 1995). As for neural development, Sox2 has been defined as one of 
the earliest pan-neural markers and is known to maintain the multipotency of 
neural stem cell (Bylund et al., 2003; Uwanogho et al., 1995). On the other 
hand, Sox10 is expressed in the neural crest and contributes to peripheral 
nervous system development (Kuhlbrodt et al., 1998). In lens development, all 
of the SoxB1 subgroup members (Sox1-3) were shown to stimulate δ1-
crystallin through binding to the DC5 enhancer (Kamachi et al., 1995). The 
differentiation of optic cup progenitors is also regulated by Sox2 and Pax6 
(Matsushima et al., 2011). In other tissues, Sox9 mutations also cause defects 
of skeletal structure in human (Südbeck et al., 1996). Finally, the B-cells of 
Sox4 knockout mice are blocked in a pro-B-cell stage (Urbánek et al., 1994). 
The correct function of Sox2 is critical in early embryonic development. 
Mutations in the Sox2 gene cause anophthalmia, microphthalmia and 
anomalies in brain, pituitary, genitourinary and gastresophageal (Reis et al., 
2010). Recently, Sox2 has been found to be related to several cancers as an 
oncogene, such as lung squamous cell carcinomas, glioblastoma, gastric 
carcinomas and breast cancer (Gangemi et al., 2008; Lengerke et al., 2011; Lu 
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et al., 2010; Zhang et al., 2010a). These examples show the importance and 
broad functions of Sox family proteins in vertebrates.  
 
Figure 1.1.4 Phylogenical categorisation of Sox genes.  
The Sox HMG domains were analysed by distance method FITCH (GCG). Abbreviations: 
ce, nematode, Caenorhabditis elegans; ch, chicken, Gallus gallus; dr, fruit-fly, Drosophila 
melanogaster; hu, human, Homo sapiens; mo, mouse, Mus musculus; pi, pig, Sus scrofa; tw, 
tammar wallaby (marsupial), Macropus eugenii; tr, rainbow trout, Oncorhynchus mykiss; se, 
sea urchin, Strongylocentrotus purpuratus; xe, frog, Xenopus laevis; zf, zebrafish, Danio 
rerio.  (From Bowles et al., 2000) 
 
1.1.4 SoxB1 subgroup 
The expression and function of the SoxB subgroup proteins in neural 
progenitors are critical during neural induction. Research on the SoxB1 
subgroup (Sox1, Sox2 and Sox3) has focused on transcriptional activation, 
whereas the SoxB2 subgroup factors (Sox14 and Sox 21) have been shown to 
exhibit transcriptional repression (Uchikawa et al., 1999). Within SoxB1 
subgroup, high sequence conservation can be seen not only in the HMG 
domain but also in the C-terminus (Figure 1.1.5).  
In addition to DNA-binding ability, the HMG domains of all Sox proteins have 
nuclear localization signals (NLS) that allows Sox proteins to be imported into 
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the nucleus to perform as transcription factors. The NLS sequences of Sox 
proteins have been identified in various parts of the HMG domain (Poulat et al., 
1995; Sudbeck and Scherer, 1997). Importin β has been shown to be 
responsible for nuclear import of SRY through the NLS that is present in the 
carboxy-terminus of the HMG domain (Forwood et al., 2001). According to the 
conservation of the NLS of Sox proteins, nuclear transportation via importin β 
might be common to all Sox proteins. 
The transcriptional activation domain of SoxB1 subgroup members has been 
localized broadly to the C-terminus of the protein, while the N-terminal DNA-
binding domain appears to mainly function to recognize a specific binding site 
on the promoter of target genes (Uchikawa et al., 1999). It has been suggested 
that the HMG domain DNA-binding ability might not be strong enough to 
maintain binding. Therefore, the HMG box containing proteins are often found 
to act with partner factors (Kamachi et al., 2000). For example, Sox2 was 
demonstrated to function together with Oct4 (containing the DNA-binding 
domain POU) and a bipartite consensus binding sequence of HMG/POU factor 
has been identified (Figure 1.1.6) (Rizzino, 2009).  
Transcriptional activators trigger the transcription machinery to initiate 
expression of their target genes. Many factors such as chromatin remodelers 
and co-activators are recruited to their appropriate locations by transcriptional 
activators. The transcriptional activation function of SoxB1 proteins might be 
mediated by the recruitment of such co-activators. The co-activator p300 was 
shown to be recruited by Sox2 to activate the transcription of FGF4 (Nowling 
et al., 2003). It is known that p300 activates transcription through the basal 
transcription machinery and chromatin remodelling (Ogryzko et al., 1996).  
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Figure 1.1.5 Conserved domains of SoxB1 subgroup factors. 
The percentage of identity within the HMG domain of the chicken SoxB1 subgroup is 
shown in comparison with the Sox2 HMG domain. Group B homology: SoxB1 and SoxB2 
conserved region. SOX 1/2/3 homology: the conserved domain among SoxB1 genes. 
Polyalanine, three amino acids (PRD) repeats, nuclear localization signal and SUMOylation 
site are also indicated (from Uchikawa et al., 1999). 
 
Figure 1.1.6 Consensus DNA binding sequence of HMG/POU cassette. 
ChIP-chip and ChIP-PET studies has identified a consensus sequence, the HMG/POU 
cassette, which provides the binding sites for Sox2 and Oct4 (Rizzino, 2009). The interval 
between the two binding sites can be from 0 to 3 nucleotides (from Rizzino, 2009). 
1.1.5 Sox B1 genes in neural development 
The expression of SoxB1 genes is almost ubiquitous in neural progenitors. 
They function as the earliest transcriptional activators and play a central role in 
the determination of neural fate. However, the timing of appearance of SoxB1 
group members is different in various species. In mouse embryos, Sox2 and 
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Sox3 are expressed pan-ectodermally initially, subsequently Sox1 expression 
and neural induction occur when Sox2 and Sox3 also become restricted to the 
neural ectoderm (Collignon et al., 1996; Wood and Episkopou, 1999) (Figure 
1.1.6). In contrast, in chick embryos it is Sox3 that is expressed throughout the 
ectoderm at first, followed by a dramatic increase of Sox2 expression in the 
neural ectoderm (Okuda et al., 2006) (Figure 1.1.7). The same scenario has 
also been observed in zebrafish embryos (Okuda et al., 2006).  
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Figure 1.1.7 SoxB1 family expression in early mouse embryo. 
Whole mount in situ hybridization of Sox1, Sox2 and Sox3 on 6.5 dpc (E6.5) and 9 dpc (E9) 
mouse embryos is shown. At E6.5, Sox1 was not detectable whereas Sox2 and Sox3 were 
expressed pan-ectodermally. At E9, all three members of SoxB1 subgroup were expressed 
in neural ectorderm. Key: d,dorsal; h, heart; v, ventral; fg, foregut; se, surface ectoderm 
(from Wood and Episkopou, 1999). 
 
 
Figure 1.1.8 SoxB1 family expression in early chicken embryo. 
Whole mount in situ hybridization of Sox1, Sox2 and Sox3 on Hamburger and Hamilton 
stage 5, 8, 11 and 14 (HH st.5, 8, 11 and 14) chicken embryos is shown. At HH st. 5, Sox1 
was not detectable (data not shown).  Sox2 is only expressed in anterial ectoderm whereas 
Sox3 expressed pan-ectodermally. At HH st.8, Sox1 was still not detectable whereas the 
expression of both Sox2 and Sox3 was detected in neural ectoderm. From HH st.11 onward, 
all three members of SoxB1 subgroup were expressed in neural ectorderm and CNS (from 
Okuda et al., 2006). 
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Many reports have demonstrated that SoxB1 genes play an important role in 
neural determination. The expression of Sox2 and FGF initiates neural 
differentiation of the ectoderm in Xenopus (Mizuseki et al., 1998). Conversely, 
expression of dominant negative forms of Sox2 significantly inhibits neural 
differentiation by affecting BMP signals (Kishi et al., 2000). Intriguingly, 
dominant negative forms of Sox2 also block cells from being committed to 
epidermal cell fate, suggesting that Sox2 might generally prevent cells from 
differentiation (Mizuseki et al., 1998). Overexpression of Sox1 has the 
opposite effects, inducing mouse embryonic carcinoma cells (P19) to undergo 
neuronal differentiation programme (Pevny et al., 1998). Similarly, mouse 
embryonic stem cells (ES) differentiate into neuroectoderm when 
overexpressing Sox1 or Sox2 (Zhao et al., 2004).  
After neural induction, the expression of Sox B1 genes is restricted to neural 
precursors located in the CNS. Here, Sox B1 genes maintain neural progenitor 
identity and prevent further differentiation (Pevny and Placzek, 2005). 
Overexpression of Sox2/3 inhibits neural progenitor differentiation in chick 
embryos whilst, in contrast, expression of dominant negative forms of Sox2/3 
results in the premature onset of neuron formation (Bylund et al., 2003; 
Graham et al., 2003). The exact mechanism by which SoxB1 genes keep cells 
from differentiation remains unclear.  
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1.2 Sox2 in stem cells 
1.2.1 Stem cells 
From the mid 1800’s, people knew that some cells could generate other cells. 
However, not until 1963, did Canadian scientists, McCulloch and Till, identify 
the self-renewal ability of transplated mouse bone marrow cells (McCulloch 
and Till, 1960). Later, embryonic stem cells (ES) were derived from the inner 
cell mass (ICM) of blastocysts (Thomson et al., 1998). Also, germ cells were 
derived from fetal gonad tissue in the same year (Shamblott et al., 1998). 
Broadly defined, stem cells have the ability to self-renew and potency to 
differentiate into several cell types. According to the ability to differentiate, 
stem cells could be classified into totipotent, pluripotent and multipotent stem 
cells (Figure 1.2.1). Totipotent stem cells (zygote) can form all living cells and 
generate whole individuals whereas the pluripotent stem cells (ES cells) could 
differentiate into any of the three germ layers (endoderm, mesoderm and 
ectoderm) but not a whole individual because they lack the ability to form 
extraembryonic tissues. Multipotent stem cells (fetal tissue; e.g., cord blood) 
have limited ability to differentiate and could develop only into a closely 
related family of cells.  
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Figure 1.2.1 Different potency of stem cells. 
Zygote (totipotent stem cell) divided into blastocyst. The inner cell mass could be isolated 
and cultured as pluripotent stem cells. The multipotent stem cells have limited ability to 
differentiate (From Anderson et al., 2001). 
 
In differentiated tissues, not all cells are lineage restricted. Adult stem cells 
were found to have plasticity, able to give rise to many cell types within one 
particular lineage (Ferrari et al. 1998). The physical functions of adult stem 
cells include regeneration of injured tissues or replacement of cells lost in 
organs with a high turnover rate. There are, hence, limitations to adult stem cell 
differentiation which allowed them to be defined as multipotent stem cells. To 
date, adult stem cells had been found in many organs such as blood, skin, gut, 
testis, the respiratory tract, brain, skeleton and muscle (Martin Raff, 2003).  
1.2.2 Sox factors in neural stem cells 
Neural stem cells (NSCs) or the later neural progenitor cells (NPCs) with more 
restricted potency can be isolated from the CNS and cultured as primary cells 
using mitogens such as epidermal growth factor (EGF) and basic fibroblast 
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growth factor (bFGF) (Reynolds and Weiss, 1992; Richards et al., 1992). 
Musashi 1 (Kaneko et al., 2000), Nestin (Lendahl et al., 1990), and Sox1 
(Peveny et al., 1998) have been used as markers of NSCs. NSCs are present in 
the developing embryonic neuroectoderm and adult brain subventricular zone 
of the lateral ventricles and the subgranular layer of hippocampal dentate gyrus 
(Figure 1.2.2). The process by while NSCs differentiate into neurons is called 
neurogenesis.  
 
Figure 1.2.2 Illustration of the origins of NSCs 
Embryonic NSCs were isolated from neuroectoderm. (A) shows the position of 
neuroectoderm in mouse embryo.  (B) shows the origin of adult NSCs in rat brain. Adult 
NSCs were isolated from subventricular zone (SVZ) of the lateral ventricles (LV) and the 
subgranular layer of hippocampal dentate gyrus (DG). Hippocampus (Hipp); olfactory bulb 
(OB); rostral migratory stream (RMS). (From Lledo et al., 2006) 
 
During neurogenesis, cells begin to express differentiation markers instead of 
progenitor markers and migrate from the ventricular zone to the marginal zone. 
On the other hand, proneural basic helix-loop-helix (bHLH) transcription 
factors, such as Ngn1, Ngn2 and Mash1, trigger cell cycle exit and the 
differentiation processes that lead to the expression of pan-neuronal markers 
(Kiefer, 2005). 
Many experiments provide evidence that SoxB1 genes play key roles in 
maintaining the stem cell-like state of NSCs. Firstly, NSCs were inhibited from 
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differentiation due to the overexpression of Sox1-3 (Bylund et al., 2003; 
Graham et al., 2003). The expression of Sox1 and Sox2 does not affect the 
propagation of undifferentiated ES cells but promotes ES cell differentiation 
into neuroectoderm after release from self-renewal (Zhao, et al., 2004). 
Furthermore, the overexpression of the HMG domain of Sox2 or Sox3 fused 
with the repression domain of the Drosophila protein Engrailed (EnR) 
(regarded as a dominant negative form of Sox2), resulted in premature exit 
from the cell cycle and expression of differentiation markers. In addition, the 
other Sox family member, Sox10, maintains neural crest stem cells as 
multipotent cells in the peripheral nervous system (Kim et al., 2003) (Figure 
1.2.3). In adult neural stem cells, Sox genes are also expressed and are critical 
for neurogenesis (Ferr et al., 2004). 
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Figure 1.2.3 Sox factors in neurogenesis. 
Sox2 is necessary for maintaining the proliferation and self-renewal in NSCs. Sox10, a 
member of SoxE subgroup, maintains the multipotency of neural crest stem cells. (From 
Shi et al., 2008) 
 
The balance of SoxB1 and SoxB2 proteins is critical in maintaining the 
character of stem cells in the CNS. The expression of Sox1, Sox2 or Sox3 
keeps stem cells from differentiating whereas inhibition of their activity leads 
to premature neuronal differentiation (Avilion et al., 2003). On the other hand, 
SoxB2 subgroup proteins (Sox14 and Sox21) are coexpressed with SoxB1 
subgroup proteins throughout the CNS (Pevny et al., 1998). Due to the high 
similarity of HMG domains in SoxB1 and SoxB2 proteins, they have similar 
DNA-binding specificity and can target the same genes. Therefore, SoxB2 
subgroup proteins could antagonise SoxB1 subgroup proteins through 
competing for the DNA-binding sites on target genes and thus blocking SoxB1 
subgroup protein function (Wegner and Stolt, 2005).  
1.2.3 Sox2 in the core transcriptional network of the ES 
cell 
The homeodoman transcription factors, OCT4 and NANOG, have been 
reported to be essential for ES cells pluripotency maintenance (Mitsui et al., 
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2003; Nichols et al., 1998). Later, Sox2 was found to couple with Oct4 as a 
heterodimer and upregulate the expression of Oct4, Sox2 and Nanog (Chew et 
al., 2005; Kuroda et al., 2005; Rodda et al., 2005). According to genome-wide 
binding site analysis, these three factors co-occupy the regulatory regions of 
several genes that function in the self-renewal and pluripotency of ES cells 
(Boyer et al., 2005; Loh et al., 2006). Therefore, they have been called the 
“master regulators” of ES cells (Zhou et al., 2007). Intriguingly, these three 
master regulators not only regulate a set of target genes but also autoregulate 
themselves by binding at their own promoters (Loh et al., 2006). This feedback 
circuit allows them to be kept in balance and stabilize the pluripotent state of 
ES cells (Jaenisch and Young, 2008) (Figure 1.2.4). In addition to the three 
master regulators, many other factors have been reported to be crucial in 
maintaining pluripotency, such as Sal1, Esrrb, Dax1 and Rif1 (Loh et al., 2006; 
Wang et al., 2006a) (Figure 1.2.4).  
Although the three master regulators were defined as transcriptional activators, 
array data suggest that they repress almost half of their target genes in ES cells 
(Boyer et al., 2005; Loh et al., 2006); implying that this finding as 
transcriptional repressor is important to their biological roles. Moreover, they 
could also regulate gene expression indirectly through affecting chromatin 
structure, DNA methylation, microRNA expression and X chromosome 
inactivation. Our understanding of the whole regulation network is getting 
more and more complicated as much research effort is put into this area. 
However, only a few transcription factors represent central nodes of the 
complicated network. This finding should make it possible to manipulate the 
pluripotency in the future. 
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Figure 1.2.4 A pluripotency regulatory network in mouse ES cells. 
The interactions between factors are showed in lines and the regulatory interaction are 
showed in arrows (From Zhou et al., 2007). The interaction among the core regulators 
(Pink), core regulators’ protein-interaction partners (yellow), regulatory interactions 
inferred by anchor sites and by sites of coregulators within 150 bp of the anchor sites (Blue 
and Pink arrows), protein interactions (Orange).  
1.2.4 Sox2 in induced pluripotent stem (ips) cells 
During development, the totipotent zygote undergoes epigenetic changes and 
loss of differentiation capacity to form various cell lineages. Recent research 
has provided evidence of the reversibility of differentiation. Many strategies 
have been used to drive unipotent somatic cells to pluripotent cells. Nuclear 
transplantation reprogrammes somatic nuclei by transfer into enucleated 
oocytes (Wilmut et al., 1997). Fusion of somatic cells and embryonic stem 
cells can also confer pluripotency on somatic cells (Cowan et al., 2005; Tada et 
al., 2001). Under the culture conditions of germline stem cells, some unipotent 
cells were reprogrammed and became ES-like cells (Kanatsu-Shinohara et al., 
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2004). On the other hand, expression of permeabilized somatic Xenopus cells 
to egg extracts results in chromatin remodelling that reverted the cells to a 
dedifferentiated status (Kikyo et al., 2000). 
More recently, Takahashi and Yamanaka successfully reprogrammed somatic 
mouse cells to pluripotent cells by viral-mediated overexpression of four 
transcription factors; Oct4, Klf4, c-Myc and Sox2 and named these ES-like 
cells, “induced pluripotent stem” (iPS) cell (Takahashi and Yamanaka, 2006). 
Later, Thomson and colleagues reprogrammed human somatic cells to 
pluripotent stem cells with OCT4, SOX2, NANOG and LIN28 (Yu et al., 
2007). In mouse neural stem cells, which express endogenous Sox2 and c-Myc, 
only Oct4 and Klf4 or Oct4 alone was enough to trigger reprogramming 
(Eminli et al., 2008; Kim et al., 2009a; Kim et al., 2008b). These results 
indicate that Sox2 is one of the key transcription factors regulating stem cell 
pluripotency.  
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1.3 Sox2 as a transcription factor 
1.3.1 The transcriptional activation activity domain of the 
SoxB1 subgroup 
 Sox proteins function as transcription factors through the binding of the HMG 
domain to a specific DNA sequence and subsequent activation of the 
transcription of target genes (Wilson and Koopman, 2002). Several studies 
have attempted to map the transcriptional regulation domains of the SoxB1 
family. Kamachi et. al. showed that transcriptional activation activity locates to 
the C-terminus in chicken Sox2 (Kamachi et al., 1999). They inserted the Sox2 
endogenous target sequence, DC5, in front of a luciferase reporter and a 
luciferase assay was carried out, co-expressing a series of C-terminal truncated 
versions of Sox2. The removal of 41 amino acids from the C-terminus had a 
dramatic effect on Sox2 transcriptional activation activity (Figure 1.3.1 a). In 
contrast, the deletion of the Sox2 N-terminus was dispensable for Sox2 
transcriptional activation activity (Figure 1.3.1 a).  In another study, several 
deletions of the Sox2 C-terminus were fused with the Gal4 DNA-binding 
domain to determine the key domains of Sox2 transcriptional activation 
activity. A significant change was observed between GAL4-SOX2 (116-280) 
and GAL4-SOX2 (116-274) which differ in length has only six amino acids 
difference. These results imply the importance of these six amino acids in 
transcriptional activation activity (Figure 1.3.1 b). Likewise, Nowling et. al. 
(2000) also identified the transcriptional activation activity domain of mouse 
Sox2 using C-terminal deletions in the GAL4 luciferase assay system (Figure 
1.3.1 c). The results suggested that the transcriptional activation activity 
domain of Sox2 is located in the C-terminus and contains a serine-rich region 
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(Figure 1.3.1 c). However, the key amino acids or small motifs in the C-
terminus of Sox2 that are required for Sox2 transcriptional function remain 
unclear.  
As for Sox1, significant reduction in transcriptional activation activity was 
found when 51 amino acids were removed from the C-terminus of Sox1 
(C323) (Figure 1.3.1 d) (Kamachi et al., 1999). Therefore, the transcriptional 
activation activity domain of Sox1 might also locate to its C-terminus.  
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Figure 1.3.1 Transcriptional activation activity domain mapping within SoxB1 
subgroup. 
(a) Sox2 C-terminal and N-terminal deletion schema on the left. Chicken lens cells were 
co-transfected with various amounts of pcDNAI/Amp-based SOX2 expression vectors 
(0,0.2,1 and 5 ng) and luciferase reporter plasmid containing the octamerized DC5 
fragment (illustrated at top). The relative luciferase activity of all the deletions is shown on 
the right. (Kamachi et. al., 1998) (b) The activation potential of Gal4 DNA-binding domain 
and Sox2 C-terminus deletion fusion proteins. The luciferase reporter plasmid contains 
tetramerized Gal4 binding sequences and the δ1- crystallin minimal promoter (-51 to +57; 
δ-Cry pro). Varying amounts (0, 1 and 5 ng) of deletion Gal4-Sox2 fusion construct were 
co-transfected with reporter plasmid into the chicken lens cells. The relative luciferase 
activity of all the deletions is shown on the right (Kamachi et al., 1998). (c) Mouse Sox2 
transactivation domain mapping. Various mouse Sox2 C-terminal deletions fused with Gal4 
DNA-binding domain as illustrated on the left. The luciferase activity was measured after 
co-transfection of various deletions of Gal4-Sox2 (1g) with the pG5EC (2g) reporter 
plasmid into HeLa cells (Nowling et al., 2000). (d) Mapping of Sox1 transactivation 
domain. Various  C-terminal deletion of Sox1 were expressed with reporter plasmid as 
described in (b) (From Kamachi et al., 1999). 
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1.3.2 Partners of SoxB1 transcriptional activation activity 
The DNA binding dissociation constant of the Sox family HMG domain is 
10-8-10-9 M in vitro, which is not alone sufficiently stable to activate 
transcriptional regulation (10-11 M is the standard DNA binding affinity for a 
transcription factor) (Mertin et al., 1999). Sox proteins therefore need partners 
to enhance their transcriptional activation ability (Kamachi et al., 2000). This is 
an important characteristic of Sox proteins that allows them to distinguish the 
correct regulatory target (Figure 1.3.2). A good example is cooperation of Sox2 
with the POU domain factor Oct3/4 to enhance the expression of fibroblast 
growth factor 4 (Fgf4) in embryonic stem cells and embryonal carcinoma cells 
(Yuan et al., 1995). The effects of Sox2 and Oct3/4 as a heterodimer are 
synergistic, affecting the expression of many genes in embryos, such as 
undifferentiated embryonic cell transcription factor 1 (UTF1), osteopontin, and 
the Sox2 gene itself (Botquin et al., 1998; Nishimoto et al., 1999). Also, PAX6 
and/or δEF3 form a complex with Sox2 to activate lens-specific δ–crystallin 
expression through the DC5 enhancer (Kamachi et al., 2001) and the 
interaction of Sox2 and Oct1 increases the transcriptional activity of the 
Hox/Pbx1 complex (Di Rocco et al., 2001). All the interactions of Sox proteins 
and their partners so far analysed are through the HMG domain (Kamachi et al., 
1999; Kamachi et al., 1998). The Sox2 target genes were activated through the 
activation domain close to Sox2 C-terminus. A GAL4 DNA-binding domain 
fused with the Sox2 C-terminal activation domain alone trigger target gene 
expression just as well as full-length Sox2 gene (Kamachi et al., 1999). On the 
other hand, when the Sox2 C-terminus was replaced by the highly potent viral 
activation domain VP16, the chimera still required a partner protein to activate 
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down-stream gene expression (Kamachi et al., 1999). In summary, Sox 
proteins function as transcription factors by cooperating with specific partners 
which restrict Sox proteins to particular targets.  
 
Figure 1.3.2 Sox and partner interaction model and binding sites.  
(a) Diagram illustrating the three major functional domains of Sox proteins. (b). When a 
partner factor binds to a DNA site near a Sox protein, a ternary interaction will be stabilized 
and transcription activation/repression of the down stream gene achieved. The binding sites 
of Sox2 are showed on the right. Fgf4: fibroblast growth factor 4; UTF1: undifferentiated 
embryonic cell transcription factor 1 (From Kamachi et al., 2000) 
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1.3.3 Sox B1 genes as transcriptional repressors 
In addition to a transcriptional activation function, recent studies have shown 
that SoxB1 proteins can also function as transcriptional repressors. Kan et al. 
(2004) carried out a luciferase reporter assay in HEK293T cells and P19 cells 
using the Hes1-luc reporter construct, which has the Hes1 (helix-loop-helix 
transcription factor) promoter in front of a luciferase coding sequence. The 
results showed that transcription of the reporter gene was suppressed when 
Sox1 was overexpressed. As for Sox2, it has been reported that a decrease in 
Sox2 expression is closely related to the increasing expression of the L1 
elements in rat neuronal stem cells (Muotri et al., 2005). This implies the 
negative regulation of the LINE1(L1) element by Sox2, although the effect 
could be indirect. On the other hand, the non-coding RNA Xist was reported to 
be bound by Sox2 in intron 1 and was down regulated by Sox2 in 
undifferentiated embryonic stem cells (Navarro et al., 2008). This result 
suggests the direct down-regulation of a target gene by Sox2. In addition, 
overexpression of Sox2 can repress the expression of a glial fibrillary acidic 
protein (GFAP) luciferase reporter (Figure 1.3.3 A). Chromatin-
immunoprecipitaion (Chip) and electrophoretic mobility shift assays (EMSA) 
were used to test the direct binding of Sox2 on the GFAP promoter region 
(Figure 1.3.3 B, C). These results indicate that Sox2 directly represses GFAP 
expression in mouse neural stem cells (Cavallaro et al., 2008). As for Sox3, in 
Xenopus, Zhang et al. (2003) found that XSox3 can bind to the promoter region 
of Xnr5 which is a Nodal-related gene. After knockdown of the endogenous 
XSox3 by morpholino injection in embryos, the RNA level of Xnr5 increased 
significantly (Zhang et al., 2003a).  
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The mechanism of SoxB1 transcriptional repression remains unclear. One 
possible hypothesis is that Sox proteins interact with co-repressors to suppress 
the transcription of target gene. For example, Groucho, a co-repressor (Courey 
and Jia, 2001), has been shown to interact with the transcription factor, TCF, 
which also contains an HMG domain (Brantjes et al., 2001; Cavallo et al., 
1998). Since Sox proteins also have an HMG domain, they might interact with 
co-repressors in similar way.  
 
 
Figure 1.3.3 Sox2 directly represses GFAP expression. 
Sox2 transcriptional activation activity was measured by luciferase assay (A). When Sox2 
expression was absent, the luciferase activity of the GFAP reporter was increased. (B) 
Electrophoretic mobility shift assay (EMSA) showed that Sox2 could directly bind on 
GFAP promoter probes. (C) ChIP showed Sox2 could directly bind on GFAP promoter 
endogenously in p19 cells. (From Cavallaro et al., 2008) 
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1.4 Co-repressors of transcription 
 
Correct gene expression is controlled by the dynamics of co-activator and co-
repressor transcriptional complexes (Figure 1.4.1) (Perissi et al., 2010). 
However, the mode of transcriptional repression is less well understood than 
activation. According to their abilities, repressors are categorized into two 
classes, long-range and short-range repressors (Courey and Jia, 2001). Most 
transcriptional repressors are long-range; they inhibit all of a gene’s enhancers 
which regulate gene expression, even if those enhancers are far distant from the 
repressor binding site. Long-range repression could cause chromosomal locus 
inactivation through post-translational modifications of the lysine in histone 
tails or bring the locus close to regions of heterochromatin to silence gene 
expression. As for short-range repressors, they only block the function of 
neighbouring activators (Gray and Levine, 1996).  One mechanism of 
transcriptional repression is that the transcriptional repressor binds to the 
promoter region of a target gene and represses its expression by recruiting a 
“co-repressor”. For example, a co-repressor could interact with histone 
deacetylase (HDAC) and alter the chromatin structure through post-
translationally modifying the N-terminal tails of core histones (H2A, H2B, H3, 
H4).  
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Figure 1.4.1 Model of transcription regulation. 
The ligand signal-dependent switch of co-repressors and co-activators is illustrated. A co-
repressor binds to on the promoter region of target gene. When the ligand transmits the 
signal into the nucleus, the co-repressor is replaced by a co-activator to trigger the 
transcription of down-stream gene (From Perissi et al., 2010). 
1.4.1 Groucho 
One well-studied co-repressor in long-range repression is Groucho (Fisher and 
Caudy, 1998). Groucho was first identified in Drosophila (Lindsley and Grell, 
1968). It was named according to the dense bristles above the eyes of Groucho 
mutant fly, reminiscent of the eyebrows of the Groucho Marx (Figure 1.4.2).  
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Figure 1.4.2 Groucho mutant Drosophila. 
Picture of the wild type (A) and the Groucho mutant Drosophila (B) are shown. Mutant has 
clumps of extra bristles above eyes and extra bristles on humerus. The pictures were 
generated by UCL cancer institute (http://www.ucl.ac.uk/cancer/research-
groups/transcriptional-regulation/index.htm). (C) Picture of Groucho Marx 
(http://www.quotecollection.com/image-view.php?img=groucho-marx-3.jpg). 
 
Groucho family members share two highly conserved domains; the Q domain 
and the WD-repeat (Figure 1.4.3). There are also a loose conserved CcN motif, 
containing a nuclear localization sequence (NLS) and two phosphorylation 
sites (cdc2 kinase and casein kinase II phosphorylation sites (Stifani et al., 
1992)). The CcN motif is flanked by glycine/proline rich (GP) and 
serine/proline rich (SP) domains. The WD-repeat consists of four to eight 
repeats, however, only a few residues are well conserved (X6-94---[GH---X23-41-
-WD]). Groucho proteins have been found to form homotetramers. The Q 
domain, which contains two putative amphipathic α-helical motifs (AH1, AH2), 
might contribute to the oligomerization of Grouchos. The transcriptional 
repression function of Groucho has been shown to require its 
homotetramerization (Song et al., 2004). The WD-repeat domain in Groucho is 
involved in interacting with DNA-bound transcriptional repressors.  
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Figure 1.4.3 Illustration of Groucho structure. 
The highly conserved Q domain and WD-repreat are shaded. The repression activity has 
been reported to be localized in either N-terminal or C-terminal. Oligomerization is 
believed to be dependent on the Q domain which has two putative amphipathic α-helical 
motifs (AH1, AH2). Protein interaction occurs through the WD-repeats. The nuclear 
localization sequence was identified within the CcN domain. The relative locations are 
labelled beneath. (From Chen and Courey, 2000) 
 
Groucho proteins are abundant and broadly expressed across species. 19 Gro-
homologous proteins have been identified to date (Chen and Courey, 2000). 
Both vertebrates and invertebrates have Gro-like proteins, but, no Gro-like 
proteins are found in plants, fungi, or protozoans. According to sequence 
conservation, there are two subgroups of the Groucho family (Figure 1.4.4). 
The GRO subgroup includes Drosophila Groucho and human Groucho 
orthologs, also called transducin-like enhancer-of-split 1-3 (TLE1-3). GRO 
subgroup members have the structure described above. Members of the other 
subgroup, mouse amino Enhancer of split (AES), only have the domains 
equivalent to the N-terminal Q, GP and partial CcN domain of the long form 
Groucho. Groucho homologues in human include TLE1-4 and the truncated 
version hAES, whereas in mouse they are named Grg1-4 and the truncated 
version AES (Fisher and Caudy, 1998). 
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Figure 1.4.4 Sequence conservation of Gro/TLE family. 
The highly conserved Q domain and WD-repreat are shaded and the similarity is marked 
above the box. d: Drosophila; x: Xenopus; h: Human; m: mouse; z: zebrafish (From Beagle 
and Johnson, 2010; Chen and Courey, 2000) 
 
1.4.2 Groucho interaction motifs in transcription factors 
Grouchos have been reported to interact with a number of transcription factors. 
Some are transcriptional repressors and their repression function depends on 
the interaction with Groucho. There include Hairy (Fisher et al., 1996), HES 
(Grbavec and Stifani, 1996), and Blimp-1 (Ren et al., 1999). On the other hand, 
some transcriptional activators could be converted into repressors when 
interacting with Groucho-related proteins. These include Tcf (Roose et al., 
1998), Runt (Aronson et al., 1997) and Dorsal (Dubnicoff et al., 1997).  
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The specific Groucho interaction sequence of some transcription factors has 
been identified as a short peptide motif. Based on loose similarity of the 
Groucho interaction motifs, they can be classified into two motifs, WRPW/Y 
and eh-like. The tetrapeptide motifs WRPW and WRPY are conserved and 
necessary for the interaction between Groucho and Hairy-related and Runt 
domain proteins, respectively (Aronson et al., 1997; Paroush et al., 1994). 
However, many other similar motifs were found to interact with Groucho. 
Huckebein proteins were reported to interact with Groucho through an FRPW 
motif (Goldstein et al., 1999) whereas Brinker proteins interact with Groucho 
through an FKPY motif (Zhang et al., 2001). Moreover, eyeless proteins 
interact with Groucho via another variant, the YSPW motif (Choi et al., 2005). 
Taken together, in many variants, the third residue of the Groucho interaction 
motif, proline, is never changed. Also, the first and fourth position are occupied 
by the aromatic amino acids, Phenylalanine (F), Tyrosine (Y) and Tryptophan 
(W). These could be considered as the principle amino acids of WRPW/Y 
motif (Figure 1.4.5 A). 
The eh-like motif was originally found in the Engrailed protein, which is a 
transcriptional repressor. Engrailed has two Groucho interaction motifs named 
eh1 and eh2 (engrailed homology 1 and 2) respectively. The amino acid 
sequence of the eh-like motifs can be summarized as FxIxxI/L (Figure 1.4.5 B) 
(Goldstein et al., 2005). However, many variants have been found that have 
loose similarity to the eh-like motif. Pax proteins contain an eh-like motif in 
which the phenylalanine is replaced by tyrosine (YSISGILG) (Eberhard et al., 
2000). Otx2 has tryptophan replacing the phenylalanine (WSPASISP) 
(Heimbucher et al., 2007). Previous studies in our lab also identified a Groucho 
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interaction motif on Sox3 which has loose similarity with eh-like motif 
(YDMPGL) (PhD thesis, Zulfiqar Laghari, 2010). These data indicate that the 
sequence of the eh-like motif is quite flexible except for a few key residues 
such as the first aromatic amino acid, the second serine or proline and the final 
leucine or isoleucine.  
 
Figure 1.4.5 Similarity of Groucho interaction motifs. 
WRPW/Y motifs of various genes are showed in (A). The conserved proline is shadowed in 
gray box whereas the aromatic amino acids are underlined. The FxIxxI/L motifs of various 
genes are showed in (B). The conserved phenylalanine and isoleucine are shadowed in gray 
boxes (From Goldstein et al., 2005). 
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1.4.3 Long form and short form of Groucho 
Groucho proteins can be classified into long forms (GRO subgroup) and short 
forms (AES subgroup) according to the length of amino acid sequence (Figure 
1.4.3). The short form Grouchos have only Q and GP domains which are 
conserved with the long form Grouchos (Figure 1.4.4) (Beagle and Johnson, 
2010). However, the short forms of Groucho lose potential protein interactions 
through the WD-repeat, such as the interaction with HDACs (Zhang et al., 
2008). It has been considered that the short form Grouchos, which retain the Q 
domain, therefore might replace the long form Grouchos in the Groucho 
tetrameric repressor complex or compete for recruitment on promoters with the 
long form Groucho (Gasperowicz and Otto, 2005; Sekiya and Zaret, 2007). 
Therefore, short form Grouchos have been considered as dominant-negative 
family members (Bajoghli et al., 2007). For example, Runx2 interacts with the 
both long form and short form Grouchos, but, the short form Groucho (Grg5) 
enhances Runx2 transcriptional activation activity whereas the long form 
Groucho (Grg3) inhibits it (Wang et al., 2004).  
Recently, more and more exceptions were found which indicate that the short 
forms Groucho are not always antagonists of long forms Groucho. For example, 
both long form and short form Groucho can interact with and repress NF-κB 
mediated transcriptional activity (Tetsuka et al., 2000). Also, the short form 
Groucho functions as a co-repressor of the androgen receptor (AR) (Zhang et 
al., 2010b). Although the short form Groucho does not interact with HDACs, it 
has been reported that it could interact with TFIIE and so negatively regulate 
basal transcription (Yu et al., 2001). These data suggest that the short form 
Grouchos are capable of directly modulating transcription. 
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1.4.5 Functions of Groucho in development 
Groucho proteins are involved in many developmental processes. Human Grg2 
(TLE2) was reported to down regulate the transcriptional activation ability of 
Runx2, which is an important factor in the process of skeletal development 
(Thirunavukkarasu et al., 1998). Pax5 is a bifunctional transcription factor and 
plays a critical role in B-cell lineage commitment (Nutt et al., 1999; Rolink et 
al., 1999). Mouse Grg4 was demonstrated to interact with Pax5 and mediate its 
transcriptional repression function (Eberhard et al., 2000). Grouchos are also 
involved in myogenesis; TLE1 can interact with HES6 which mediated 
repression and promotes myoblast differentiation (Gao et al., 2001; Sasai et al., 
1992). Both long form and short form Grouchos interact with Six3 and Six6, 
which induce eye development (Bernier et al., 2000; Lagutin et al., 2001).  
Moreover, Groucho proteins have been studied in most detail in neurogenesis. 
HES1 (Hairy/Enhancer of split), a basic helix-loop-helix (bHLH) family 
transcription repressor, negatively regulates neuronal differentiation (Knust et 
al., 1992). This negative regulation of Notch signalling, which triggers 
neurogenic gene expression, requires both Groucho and HES in Drosophila 
(Paroush et al., 1994). Similarly, human Grg1 (TLE1) forms a repressor 
complex with HES1 and PARP1 to regulate neuronal differentiation through 
control of MASH1 expression (Ju et al., 2004).  
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1.4.6 Groucho and HMG transcription factors 
A well-studied Groucho co-repressor function is in the canonical Wnt 
signalling pathway (Kormish et al., 2010) (Figure 1.4.7). In the absence of Wnt 
signalling, gene targets are silenced by TCF/Lef via the Groucho co-repressors 
(Brantjes et al., 2001).  
Similar to TCF/Lef, Sox proteins also have HMG DNA-binding domains. 
Therefore, the machinery of switching from transcriptional activator to 
repressor might be shared. Previous studies in our lab have demonstrated the 
interaction of Sox3 with a Groucho co-repressor (PhD theses, Caroline Hirst, 
2009; Zulfiqar Laghari, 2010). Given the high similarity of Sox2 and Sox3, the 
same scenario might also be true for Sox2.  
 
1.4 Research objectives 
 
The early expression in embryos and the ability to reprogram fully 
differentiated cells, suggest an essential role of Sox2 in both embryo 
development and pluripotency. Previous studies have focused on the 
transcriptional activation activity of Sox2 in embryonic stem cells. However, 
genome-wide analysis showed almost the same number of genes were 
repressed as were activated by Sox2 (Boyer et al., 2005). Although this 
repression has been interpreted as an indirect effect of Sox2, there are a number 
of lines of evidence suggesting that Sox2 acts directly as a transcriptional 
repressor.  
The main aims of this thesis are to demonstrate the transcription repressor 
function of Sox2 and identify the possible mechanism of it. Also, I aimed to 
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map the functional domain on Sox2 in order to investigate the biological role 
of Sox2 transcriptional repression. 
Data in this thesis show that Sox2 indeed acts as a transcriptional repressor 
through interaction with Groucho co-repressor. The key domain on Sox2 which 
relates to the repressor function was dissected and a loss of repressor form of 
Sox2 was generated. In order to identify the possible target genes of Sox2 
repressor function, genome-wide analysis was carried out to compare the gene 
expression profile when either wild-type Sox2 or the loss of repressor function 
form of Sox2 was overexpressed in human neural stem cells. Wild-type and 
mutant Sox2 were also overexpressed in early zebrafish embryos in 
consideration of the effect on organizer genes that were demonstrated to be 
repressed by Sox3 previously (Shih et al., 2010). 
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Chapter 2 Materials and methods 
2.1 Construction of Sox2 mutants expression 
plasmid 
 
A single bacterial colony of DH5α E. coli carrying the required plasmid was 
inoculated into 5 ml of LB broth containing appropriate antibiotic. Incubation 
at 37 ºC for at least 16 hours, with shaking at 230rpm was carried out. High 
quality plasmid DNA was then purified using a QIAprep Spin Miniprep Kit 
(Qiagen, UK) following the manufacturer’s instructions. At the final spin, the 
purified DNA was eluted in 50 l of sterile distilled water (SDW).  
2.1.2 Measuring DNA concentrations 
The concentration of purified DNA was measured by a NanoDrop 1000 
Spectrophotometer (Thermo Scientific) by applying 1 l of DNA sample onto 
the lower measurement pedestal after calibrating the blank curve using pure 
water. The software calculates the concentration and the purity (the ratio of the 
reading under 260/280 wave length) of nucleic acid. 
2.1.3 Nucleic acid restriction digests 
In this study, restriction enzymes were purchased from Invitrogen or New 
England Biolabs. Restriction digests were carried out following the 
manufacturer’s instructions. The total reaction volume ranged from 10-50 l 
and with incubations at 37 ºC for 1-3 hours. Digested DNA was then checked 
by gel electrophoresis. 
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2.1.4 Agarose gel electrophoresis 
Gel electorophoresis was carried out using 1-1.5% agarose gels, made with 
electrophoresis grade agarose (Invitrogen). 1x TAE buffer (0.04 M Tris, 0.02 
M Acetic acid, 0.001M EDTA at pH 8.0) and ethidium bromide (0.1 g/ml). 
DNA samples were loaded with 1x DNA loading buffer (New England 
Biolabs). 1Kb or 100bp DNA ladders (New England Biolabs) were loaded 
alongside the samples. Electrophoresis was carried out at 5-10 Volt/cm for 15-
20 minutes. The gels were imaged using the AlphaImager 1220 Documentation 
& Analysis System (Alpha Innotech Corporation). 
2.1.5 DNA purification from agarose gel 
After gel electrophoresis, clearly separated DNA fragments were cut out with a 
scalpel blade under UV light. The extraction of DNA from each gel slice was 
carried out using a GeneCleanII kit (QBIOgene) according to the 
manufacturer’s instructions. 
2.1.6 DNA ligation and bacterial transformation 
Desired DNA inserts were ligated into mammalian expression vectors, eg. 
pcDNA3 (Invitrogen), using T4 DNA ligase (NEB), 1x ligase buffer in 10 µl 
reactions. 5 µl of ligation reaction was then added to DH5α competent cells 
(One Shot® TOP 10F Invitrogen) incubated on ice for 30 minutes. The samples 
were incubated at 42 ºC for 30 seconds then placed on ice immediately for 5 
minutes. Recovery of cells was carried out by adding in 50 l of SOC medium 
and incubation at 37 ºC for 1 hour with shaking. The cells were then plated on 
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LB agar plates which contained the appropriate antibiotic and incubated at 37 
ºC for 16 - 20 hours.  
2.1.7 Glycerol stock of bacteria 
Bacteria were cultured in appropriate selective medium for at least 8 hours. 
The cultures were then mixed with 80% glycerol in 1:1 ratio. The stock 
solution was vortexed before storage at -80 ºC. 
2.1.8 Polymerase chain reaction (PCR) 
Primer sequences are listed in Table 2.1.1. Oligonucleotide primers were 
synthesized by MWG (MWG-Biotech, UK). PCRs were carried out using 
Phusion® High-Fidelity DNA Polymerase (Finnzymes) in order to reach the 
high denaturation temperature for the GC-rich Sox2 and Sox3 sequences. For 
20 l reactions, 40 ng of template DNA, 0.5 mole of each primer, 200 mole 
of dNTP, 1x GC buffer, 0.2 l (2U/l) of polymerase and 10% DMSO were 
mixed thoroughly. PCR was carried out using a G-storm thermocycler PCR 
following the Phusion® polymerase manufacturer’s instructions; 98 ºC for 30 
seconds as initial denaturation, 30 cycles at 98 ºC for 10 seconds denaturation, 
annealing under appropriate temperature as primers required for 20 seconds, 
and 72 ºC for 30 seconds per kb. The final extension was 72 ºC for 5 minutes. 
PCR products were stored at 4 ºC. 
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Table 2.1.1 Primer sequences 
2.1.9 TA cloning 
Before subcloning into an expression vector, the PCR products were cloned 
into a pJET vector using a CloneJETTM PCR Cloning Kit (Fermentas). Cloning 
into the pJET vector allowed DNA sequencing, to confirm insert sequence. The 
reactions were carried out following manufacturer’s instructions. Purified PCR 
products mixed with T4 DNA ligase (5 units), 1x ligase buffer, 50 ng vector 
and 150 ng PCR product and water to bring the final reaction volume to 20 µl. 
The mixture was incubated at room temperature for 5 - 30 minutes before 
transformation (see section 2.1.6). 
2.1.10 Site directed mutagenesis 
To produce Sox2 mutants, amino acid changes were created using the 
QuickChangeII Site-Directed Mutagenesis Kit (Stratagene). Primers were 
designed to cover 40 nucleotides with the mismatched bases placed in the 
middle of the primer. pcDNASox2 plasmid was used as template DNA. PCR 
reactions were carried out following the manufacturer’s instruction in the 
presence of 5% DMSO, for amplification of highly GC-rich DNA. The PCR 
program was set following the manufacturer’s instructions. After digestion of 
parental DNA by DpnI, the DNA products were then transformed into 
competent cells.  
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2.1.11 DNA sequencing 
Constructs were sequenced using the BigDye Terminator V3.1 kit (Applied 
Biosystems). Sequencing reactions contained 100 ng DNA, 2 µl BigDye 
Terminator V3.1, 2 µl sequencing buffer (1x), primer (1.6 pmol) and an 
appropriate volume of SDW to bring the final reaction volume to 10 µl. The 
PCR thermal cycler program was set according to the manufacturer’s 
instruction; 96 ºC for 2 minutes as initial denaturation, 30 cycles of 96 ºC for 
20 seconds denaturation, annealing under 50 ºC for 20 seconds, and 60 ºC for 1 
minute as extension. The sequencing reactions were then precipitated using 3M 
sodium acetate (pH5.2), 1 µl of glycogen (10 mg/ml) and 100% ethanol. The 
DNA pellets were dried at room temperature then sent for sequencing 
(GeneService DNA sequencing, Nottingham). 
  
46 
 
2.2 Cell culture 
2.2.1 COS-7 and P19 cell maintenance 
COS-7 cells were maintained in Duldecco’s Modified Eagle’s Medium (D-
MEM, GIBCO 31885) with 10% Fetal Bovine Serum (FBS, Sigma F7524), 
0.5% penicillin100 Unit/ml /streptomycin 100 g/ml (P/S, Sigma T3924), 1% 
L-Glutamate 200mM (GIBCO 250300) and 0.5% MEM non-essential amino 
acids 100x (GIBCO 11140). P19 cells were maintained in Alpha MEM (Lonza 
BE02-002F) supplied with 10% FBS and 0.5% P/S. Cells were cultured in a 
humidified 5% CO2 incubator at 37°C. 
2.2.2 hNSC cell maintenance 
ReNcellTMVM (Millipore) neural stem cells (hNSC) were maintained in 50% 
DMEM/F12 (GIBCO 21331), 50% NEUROBASALTM Medium(GIBCO 12348) 
supplied with 1% N2 supplement (Invitrogen), 2% B27 NeuroMix (Invitrogen), 
20 mg/ml basic fibroblast growth factor 2 (bFGF-2, Invitrogen), 200 mg/ml 
epidermal growth factor (EGF, Invitrogen) and 0.5% P/S. Cells were seeded 
onto a laminin-coated flask to grow as adherent cells. To coat the flask, 15 
µg/ml recombinant murine laminin (Sigma) in DMEM/F12 was applied to 
cover the surface of the flask and incubated at 37°C for 4 hours. Before use, the 
laminin solution was removed and the flask rinsed with phosphate buffered 
saline (PBS). 
2.2.3 Storage and revival of cells in frozen stocks 
To detach COS-7 and P19 cells, 0.05% Trypsin-EDTA (GIBCO 25300-062) 
was used, while for hNSCs, AccutaseTM (500 unit/ml) (Innovative Cell 
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Technologies) was used. A pellet of approximate 1x106 cells were obtained by 
centrifugation at 16.1 g and was resuspended in 1ml culture medium with 10% 
of DMSO (Sigma D2650). The mixture was then transferred into Cryotubes 
and stored at -80°C.  
To thaw and revive cells from frozen stocks, cells were defrosted quickly in a 
37°C water bath and transferred into 5ml of warm medium. After 
centrifugation at 16.1 g, cells were resuspended in fresh medium and seeded 
onto culture flasks. 
2.2.4 Cell transfection by electroporation 
COS-7 cells were cultured to 90% confluence and detached using Tripsine-
EDTA. For Co-immunoprecipitation (Co-IP) experiments, 6x106 cells were 
suspended in 700 µl of medium with up to 20 µg of DNA. For immunostaining, 
1x106 cells were suspended in 500 µl of medium with up to 1 µg of DNA. The 
mixture of cells and DNA were then transferred to 4 mm-gap, 22 mm electrode 
height electroporation cuvettes (Yorkshire Bioscience) and 210 volts of current 
was applied for 50 ms using a BTX, ECM 830 electroporator. Cells were then 
seeded in warm medium in flasks (for Co-IP) or on to poly-D-lysine coated 
coverslips (for immunostaining).  
To prepare the poly-D-lysine coated coverslips, the coverslips were cleaned 
using Trigene and rinsed with water. Coverslips were soaked in 38% HCl for 
30 minutes and rinsed with water. 95% EtOH was used to sterilise the 
coverslips which were then dried in the cell culture hood. The coverslips were 
covered by 500 µl of poly-D-lysine hydro-bromide (100 µg/ml, Sigma) 
overnight. After removing the poly-D-lysine, the coverslips were washed in 
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water and 95% EtOH. The coated coverslips could be stored in room 
temperature after being dried. 
2.2.5 Cell transfection by liposome reagent 
For P19 cells, DharmaFECT®3 transfection reagent (Thermo Scientific) was 
used following the manufacturer’s instruction. For hNSCs, Mouse Neural Stem 
Cell Nucleofector® (Lonza) was used following the manufacturer’s instructions. 
  
49 
 
2.3 Protein analysis 
2.3.1 Cell preparation and Co-immunoprecipitation  
Transfected cells were cultured for 24 hours before being used for to Co-IP 
experiments. The culture medium were removed from the flask and cells rinsed 
with PBS. Cells were detached by incubating with harvest solution (40 mM 
Tris-HCl pH7.4, 1 mM EDTA, 150 mM NaCl) for 10 minutes followed by 
scraping. The whole cell/harvest solution mixture was then transferred into 
eppendorf and centrifuged at 1844 g for 5 minutes. 300 µl of lysis buffer (0.1% 
NP40/PBS) and protease inhibitor cocktail (chymotrypsin, 1.5 µg/ml; 
thermolysin, 0.8 µg/ml; papain, 1 mg/ml; pronase, 1.5 µg/ml; pancreatic 
extract, 15 µg/ml; trypsin, 0.2 µg/ml; Roche 1 836 170) was added to lyse the 
cell pellet for 30 minutes at 4°C on a low speed rotating platform. The 
supernatant was obtained by centrifugation at 10625 g for 10 minutes at 4°C. 
30 µl of the supernatant was retained as whole cell lysate (WCE) and the rest 
was mixed with 25 µl Myc-agarose beads suspension (Sigma) and incubated at 
4°C overnight on a low speed rotating platform. The mixture of the cell lysate 
and beads were centrifuged very gently for 5 seconds and washed with lysis 
buffer 5-8 times. An equal volume of SDS-PAGE loading buffer was added to 
WCE and beads. The samples were heated to 100°C for 5 minutes before 
loading onto SDS-PAGE gels. 
2.3.2 Crosslinker treated cell lysate preparation 
For the Co-IP of Myc-Groucho and endogenous Sox2 in hNSC, 
Dithiobis[succinimidylpropionate] (DSP) was used to crosslink proteins. DSP 
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can form a β-mercaptoethanol breakable crosslink between molecules at a 
distance of 12Ǻ (Fujita and Wade, 2004; Lomant and Fairbanks, 1976).  
Before harvesting the cells, 1 ml of 2 mM DSP/PBS was added onto PBS 
washed cells and incubated at room temperature for 30 minutes. The 
crosslinking was stopped by “stop solution” (20 mM Tris-HCl, pH7.5) and the 
cells were rinsed in PBS twice. To lyse the cells, RIPA lysis buffer (25 mM 
Tris-HCl, pH7.5, 150 mM NaCl, 1% NP40, 1% Deoxycholate, 0.1% SDS) with 
cocktail protease inhibitor was used and incubated with cells for 30 minutes. 
The mixture was transferred into an eppendorf tube and centrifuged at 10625 g 
for 10 minutes. The cleared cell lysate was used for Co-IP as previously 
described. 
2.3.3 SDS-PAGE electrophoresis 
The ingredients of SDS-polyacrylamide gel, running buffer and western blot 
transfer buffer were made according to Molecular Cloning (Sambrook et al. 
1989). SDS-PAGE and western blot equipment were purchased from BioRad. 
Protein samples were prepared in sample buffer, (laemmli 2x concentrate; 
Sigma) and run through 4% stacking gel {4% acrylamide/bis-acrylamid, 0.125 
M Tris-HCl (pH6.8), 0.1% SDS mixture was polymerized by 0.025 % 
tetramethyl-ethylenediamine (TEMED) and ammonium persulphate (APS)} 
and 12% resolving gel {12% acrylamide/Bis-acrylamide (30%/0.8% w/v), 
0.375 M Tris-HCl (pH 8.8), 0.1% SDS mixture was polymerized by TEMED 
and APS in the same way as stacking gel} along side with SeeBlue® Plus2 
prestained standard (Invitrogen) ladder. The voltage applied for the stacking 
gel and resolving gel was 30v and 60v respectively (Laemmli, 1970). 
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2.3.4 Western blot 
The SDS-PAGE gel was placed on a Hybond-C extra nitrocellulose membrane 
(Amersham) and transferred overnight at 30v in cold transfer buffer (25 mM 
Tris-base; 192 mM glycine and 20% methanol). The membrane was then 
blocked in PBST (PBS with 0.3% Tween 20) with 5% skimmed milk (Marvel) 
for 1 hour. Table 2.2.1 lists all the antibodies used and their working 
concentration. Primary antibody was diluted in PBST with 3% skimmed milk. 
After incubation in primary antibody for 1-2 hours at room temperature, the 
membrane was washed 3x 10 minutes in PBST and then incubated in 
secondary antibody solution for 1 hour. The membrane was washed 3x 10 
minutes before detecting the signal. For all of phosphatase conjugated 
secondary antibodies, the ECL-plus kit (Amersham) was used following the 
manufacturer’s instructions. Koda medical X ray film (general purpose blue; 
MOL7010) was used to detect the emitted signal on the membrane. The film 
was then developed by machine. For Li-cor secondary antibodies, the 
membrane was scanned by Odyssey infrared imaging system (Li-cor) and the 
images were processed by the Odyssey 2.1 software. 
 
Table 2.3.1  Antibodies list 
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2.3.5 Cell preparation and immunostaining 
Cells were seeded on coverslips and cultured for 24 hours. After removing the 
culture medium, cells were rinsed by PBS. The cells were fixed by 4% 
paraformaldehyde (PFA) in PBS for 10 minutes and permeabilized with 0.2% 
Triton X-100 (Sigma) in PBS for 20 minutes. Blocking solution (10% 
skimmed milk, 0.1% Triton X-100/PBS) was added for 30 minutes. Primary 
antibodies were diluted in PBS according to Table 2.3.1 and incubation was 1 
hour at room temperature or overnight at 4°C. After washing three times in 
wash buffer (0.1% Triton X-100/PBS), cells were soaked in secondary 
antibodies for 1 hour at room temperature or overnight at 4°C. Cells were 
washed three times in wash buffer and mounted in DAPI (4,6 diamidino-2-
phynylinodole) mounting medium (Vector). Fluorescent signals were detected 
using a Leica DMRB light microscope connected with a Nikon Digital Sight 
DS-SM camera by NIS Elements (F2.30, SP2, Build332) image capture 
software.  
2.3.6 Cell preparation and Luciferase assay 
Luciferase assays were carried out following the manufacturer’s instructions 
(Dual-Luciferase Reporter 1000 Assay System, Promega), briefly described 
below. Cells were seeded in a 24 well plate 16 hours before transfection 
reagent treatment. Every transfection reagent/DNA mixture was prepared for 3-
5 wells for a set of repeats. 24 hours after transfection, cells were lysed by 50 
µl of passive buffer for 10 minutes at room temperature. The lysates were then 
transferred into eppendorf tubes and centrifuged at 1844 g for 5 minutes to get 
a cleared supernatant. 20 ul of the supernatant was transferred into a white 
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background flat bottom 96 well plate and the luciferase activity was measured 
by GloMax 96 microplate Luminometer (Promega). 
  
54 
 
2.4 Yeast manipulations 
2.4.1 Yeast maintenance 
The Matchmaker3TM two-hybrid system (Clontech) was used to test protein 
interactions. The yeast strain, AH109 (Clontech), contains ADE2, HIS3, lacZ, 
and MEL1 reporter constructs that are activated only when GAL4-based 
protein interactions take place. Yeast were grown on YPD agar plates (pepton 
20 g/L; yeast extract 10 g/L; D-glucose 20 g/L; agar 20 g/L pH 5.8) at 30°C 
until colonies reached 2-3 mm diameter. All the yeast plates could be stored at 
4°C for at least one month. For long term storage, the mixture of yeast culture 
medium with 25% glycerol were kept in cryotubes and stored at -80°C. 
2.4.2 Preparation of yeast competent cells 
To make competent cells, AH109 colonies were cultured in 10 ml of YPD 
media containing 0.003% of adenine hemisulphate at 30°C with shaking at 
230rpm overnight. The overnight culture was diluted in 50 ml YPDA media 
(OD600 = 0.2) and cultured for another 3 hours until they reached an OD600 = 
0.5. Cells were collected by centrifugation at 1000g for 5 minutes and washed 
with 40 ml 1x TE buffer (0.01M Tris-HCl; 1 mM EDTA pH7.5). 1.5 ml of 
freshly made 1x TE/LiAc (1x TE buffer with 100 mM LiAc) was used to 
resuspend the cells which were left standing for 10 minutes.  
2.4.3 Lithium acetate mediated yeast transformation 
The yeast expression vectors (pGAD-T7 containing GAL4 activation domain 
and pGBK-T7 containing GAL4 DNA binding domain) were used to construct 
the GAL4 fusion proteins. Here, LiAc transformation was used to introduce the 
55 
 
plasmids into AH109 yeasts. The mixture of transformation solution contained 
1 µg of plasmid DNA, 100 µg of denatured herring testes carrier DNA 
(Clontech), 100 µl of competent yeast cells and 700 µl of freshly made 1x 
LiAc/40% PEG-3350/1x TE. The mixture was vortexed vigorously and 
incubated at 30°C with 230rpm shaking for 30 minutes. 88 µl of DMSO 
(Sigma) was added and tubes gently inverted 2-3 times. Heat shock was carried 
out by placing the mixture at 42°C for 15 minutes and immediately setting on 
ice for 2 minutes. Cells were collected by centrifugation at 14000rpm for 5 
seconds and washed in 1 ml of 1x TE. Cells were pelleted by centrifugation 
and resuspended in 100 µl of 1x TE and plated on proper selective plates. The 
plates were incubated at 30°C for 4-5 days until colonies were visible. 
2.4.4 Protein detection in transformed yeast 
To test if the transformed yeast express the GAL4 fusion protein, a large 
colony was picked from the selective plates and inoculated in to 5 ml of 
selection media. After overnight incubation at 30°C while shaking at 230rpm, 
the cells were pelleted at 12470 g for 1 minute. To break the cells, half the 
weight of the pellet of Glass beads (Sigma) and 60 µl of Sample buffer 
laemmli (Sigma) were added and vortexed twice for 30 seconds with a 30 
second interval on ice. The cell lysate was boiled for 10 minutes and 
centrifuged at 664 g for 1 minute. The supernatant was resolved on SDS-PAGE 
gel.  
2.4.5 Detection of protein interaction by yeast-two-
hybridization 
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When the fusion proteins interacted with each other, the GAL4 DNA-binding 
domain (BD) and transcriptional activation domain (AD) were coopted onto 
the GAL4 responsive promoter to trigger the expression of the reporter genes. 
The interaction of the fusion proteins was therefore detected by growth of the 
co-transformed yeast on synthetic “drop out” (SD)-leu/-trp/-his/-ade plates. 
The co-transformed (pGAD-D7/pGBK-T7) yeast expressing LEU2 and TRP1 
respectively were grown on (SD)-leu/-trp plates. To detect the interaction of 
the fusion proteins, a single colony was picked and resuspended in 100 µl of 
sterile distilled water (SDW). 10 µl of the mixture was plated on a SD-leu/-
trp/-his/-ade plate and incubated at 30°C for 7 days. 
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2.5 hNSC mRNA manipulation 
2.5.1 hNSC transfection and harvest 
hNSCs were transfected using a Mouse Neural Stem Cell Nucleofector Kit 
(Lonza) according to the manufacturer’s instruction. Approximately 5x106 
early passage (10-20 passage) hNSCs were mixed with 100 µl of “Nucleofector 
solution” and the appropriate amount of required plasmid DNA. The cells were 
transferred into a cuvette and electroporated using a NucleofectorTM II 
(Amaxa). The transfected cells were seeded on to a laminin coated 75T flask 
and cultured for 14 hours. All the cells were collected after 5 minutes of 
AccutaseTM treatment by centrifugation at 1000 g for 5 minutes. The pellets 
were resuspended in 1 ml of fresh medium. 
2.5.2 Fluorescence Activated Cell Sorting (FACS) 
Freshly collected hNSCs were kept on ice before sorting. Around 5x106 GFP 
expressing cells were sorted into fresh medium using a Coulter Altra Flow 
Cytometer (Beckman). The cells were centrifuged at 1000 g for 5 minutes and 
the pellets were lysed in 1 ml of TRI reagent (Sigma) immediately. 
2.5.3 Total RNA extraction  
Extraction of total RNA from transfected hNSCs was carried out according to 
manufacturer’s instructions of TRI reagent, as briefly described below. 0.2 ml 
of chloroform was added into the mixture of TRI reagent and cell lysate (see 
section 2.5.2) and vortexed vigorously for 15 seconds. The samples were 
allowed to stand at room temperature for 15 minutes before being centrifuged 
at 12,000 g for 15 minutes at 4°C. For RNA extraction, the top clear aqueous 
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phase was transferred into a new eppendorf tubes and mixed with 0.5 ml of 
isopropanol by gentle inversions. The samples were allowed to stand for 15 
minutes at room temperature or overnight at -80°C before being centrifuged at 
12,000 g for 10 minutes at 4°C. The pellet was washed with 75% ethanol and 
centrifuged at 12,000 g for 5 minutes at 4°C. The pellets were then briefly air 
dried for 5-10 minutes and dissolve in 100 µl of DEPC treated water (Ambion).  
2.5.4 RNA purification 
Total RNA samples were purified using the RNeasy® Mini Kit (Qiagen) 
according to the manufacturer’s instructions. 100 µl of RNA sample was mixed 
with 350 µl of Buffer RLT and 250 ul 100% ethanol and centrifuged through 
the spin column at 8,000 g for 15 seconds. The spin column was washed with 
500 µl Buffer RPE twice. The purified RNA was eluted with 30 µl of RNase-
free water and centrifuged at 8,000 g for 1 minute. The total RNA samples 
were stored in -80°C for further use. 
2.5.5 Total RNA quality test 
The quality of total RNA samples was tested before use for microarray assay. 
The quality of purified total RNA was tested using a 2100 BioAnalizer with 
RNA 6000 Nano kit (Agilent) according to the manufacturer’s instructions. 
The RNA integrity number (RIN) was analysed by 2100 Expert software 
(Agilent) using the eukaryote total RNA Nano setting.   
2.5.6 GeneChip® Affymetrix HG-U133 plus 2 analysis 
Purified total RNA of hNSCs was sent to Nottingham Arabidopsis Stock 
Centre (NASC) for the Affymetrix HG-U133 plus 2 analysis. The brief 
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principle of Affymetrix HG-U133 plus 2 is described in this section. First, total 
RNA (1 µg) was used as a template to synthesize double-stranded cDNA using 
the T7-Oligo(dT) Promoter Primer in the first-strand cDNA synthesis reaction. 
RNaseH-mediated second-strand cDNA synthesis was carried out on the 
samples. Double-stranded cDNA was purified and used as a template to 
synthesize cRNA by in vitro transcription (IVT) reaction using T7 RNA 
Polymerase and a biotinylated nucleotide analog/ribonucleotide mix. The 
labelled cRNA was cleaned up and fragmented before performing 
hybridization on microarray chips. A streptavidin phycoerythrin conjugated 
antibody was used to detect the hybridization on the probe chip. After proper 
washing and staining, the probe chips were scanned by a GeneArray® Scanner 
(Affymetrix).  
2.5.7 Data analysis 
The raw data of Affymetrix array were analysed by GeneSpringGX10 (Agilent) 
and further manipulation was done using Microsoft Excel. The experimental 
noise cut-off level was set as a raw fluorescent reading of 100. 
2.5.8 Quantitative PCR (qPCR) 
Purified RNA was used for the synthesis of cDNA using SuperScriptTM III 
Reverse Transcriptase (Invitrogen) according to the manufacturer’s instructions. 
A mixture of 2 µg of RNA sample, 200 ng of Oligo(dT)18 Primer (Fermentase), 
1 µl of 10mM dNTP Mix (Bioline) and 14 µl of RNase-free water was heated 
at 65°C for 5 minutes and then put on ice for 1 minute. The following solutions 
were added to the mixture; 4 µl 5X First-Strand Buffer, 1 µl 0.1 M DTT and 1 
µl of SuperScriptTM III RT. The tubes were incubated on a Techne PHC-3 
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thermal cycler with the programme set to single cycle at 25°C for 5 minutes, 
50°C for 60 minutes and 70°C for 15 minutes. cDNA was stored at -80°C until 
used.  
qPCR was carried out using a Rotor-GeneTM 6000 (Corbett life science) with 
Brilliant SYBR® Green QPCR Master Mix (Agilent). All qPCR data was 
analysed by Rotor-GeneTM 6000 real-time rotary analyzer version 1.7. The 
primers used for qPCR were designed according to the following rules. First, 
the length should be between 100-150 bp. Second, the melting temperature 
should be around 58-60°C. Third, the target region should cross an intron or be 
nearby the probes used in the Affymetirx microarray. The sequence details of 
qPCR primers are listed in Table 2.5.1.  
The standard threshold of each set of primers was determined according to the 
qPCR results of serial template cDNA dilution (200 ng/µl, 40 ng/µl, 8 ng/µl 
and 1.6 ng/µl) by the auto-find function in Rotor-GeneTM 6000 real-time rotary 
analyzer version 1.7 software. To prepare the qPCR reaction, 7.2 µl of cDNA 
(50 ng/µl), 4.3 µl of each primer (20 nmole), 37.5 µl of 2X Brilliant SYBR® 
Green QPCR Master Mix and 26 µl of distilled water were carefully mixed in a 
0.5 ml tube and aliquoted in three 0.1 ml strip tubes (Qiagen). The samples 
were placed in the Rotor-GeneTM 6000 and the PCR programme set at 95°C for 
15 seconds, 60°C for 20 seconds and 72°C for 20 seconds. The threshold cycle 
(Ct) values of each sample was defined by standard threshold and the relative 
comparison with the housekeeping gene (Actin, GAPDH and Cyclophilin B) 
were calculated using the equation below (Pfaffl, 2001) : 
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Table 2.5.1 sequence of qPCR primers 
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2.6 Zebrafish manipulation 
2.6.1 Zebrafish (Danio rerio) maintenance and embryo 
collection 
Standard procedures (Westerfield, 2000) were followed in maintaining 
zebrafish (mix strain of Tübingen and AB). Embryo stages were determined 
according to Kimmel et al. (1995). System water containing fungicide 
(methylblue) was used during embryo manipulation procedures. All embryos 
were incubated at 28°C. 
2.6.2 in vitro transcription of mRNA for embryo injection 
Sense RNAs were produced from plasmids (Table 2.6.1) using a mMachine® 
high yield capped mRNA transcription kit (Ambion) according to the 
manufacturer’s instructions. 10 µg of plasmids was digested with an 
appropriate restriction enzyme (to cut 3’ of the insert) in 50 µl reactions at 
37°C overnight and the linearised plasmids were purified by a GENECLEAN® 
II kit (MP Biomedical) according to the manufacturer’s instructions. The 
mixture of template DNA (linearised plasmids), 1x NTP/CAP, 1x reaction 
buffer and 2 µl enzyme were incubated at 37°C for 2 hours. The template DNA 
was digested by adding 1 µl DnaseI (1Unit/µl; Sigma) and incubated at 37°C 
for 15 minutes. The reaction was stopped by adding 15 µl ammonium acetate 
(5M) and 115 µl nuclease free water (Ambion). RNA was purified by mixing 
with an equal volume of buffer-saturated phenol/chloroform (Sigma) and 
vortexed for 30 seconds. The mixture was centrifuged for 3 minutes at 16162 g 
and the clear upper layer was transferred into a clean eppendorf tube. An equal 
volume of chloroform was added, vortexed for 30 seconds and centrifuged for 
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3 minutes at 16162 g. The clear upper layer was again transferred into clean 
eppendorf tube. 0.1x volumes of 3 M sodium acetate and 1x volumes of 
isopropanol were added and kept at -20°C for 30 minutes to precipitate the 
RNA. The RNA was pelleted by centrifugation at 16162 g for 30 minutes at 
4°C. The pellet of RNA was resuspended in 30 µl nuclease free water and 
quantified by a NanoDrop 1000 Spectrophotometer. The RNA was stored at -
80°C for further use. 
 
Table 2.6.1 Vectors for sense mRNA synthesis. 
2.6.3 Zebrafish embryo microinjection 
The glass needles used for microinjection were prepared by Lab technicians 
using a needle puller (Sutter Instrument CO). Needles were loaded with 0.5 µl 
of the required concentration (as described in figure legend of chapter 6) of 
mRNA and mounted on the micromanipulator connected to a 
PICOSPRITZER®III picopump (Parker Instrumentation). For the 1-2 cell stage, 
0.5 nl of mRNA was injected. As for 16-32 cell stage, 0.25 nl of mRNA was 
injected. The volume of the drop size was adjusted to 100 µm in diameter for 
0.5 nl and 50 µm for 0.25 nl. The embryos were lined up along the side of a 
glass microscope slide and a defined volume of mRNA was injected through 
the chorion and yolk into the cell.  
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2.6.4 Preparation of digoxygenin (Dig) labelled RNA 
probe for in situ hybridization 
For anti-sense RNA probes, 10 µg of vectors was digested with an appropriate 
restriction enzyme (Table 2.6.2) and purified (see section 2.6.2). A mixture of 
1 µg of purified linearised DNA template, 5mM DTT (Promega), 10x DIG 
labelling mix (Roche), 1 µl of RNasin RNase inhibitor (40Unit/ µl ; Promega), 
5x transcription buffer (Roche), 2 µl of either T3/T7/SP6 polymerase (17Unit/ 
µl; Roche) and 7 µl RNase free water was incubated at 37°C for 3 hours. 
Probes were cleaned using MicrospinTM G50 columns (GE Health Care) and 
diluted 100x in hybridisation buffer I (hybeI) for -20°C long term storage. 
 
Table 2.6.2 Probes for in situ hybridisation. 
2.6.5 Zebrafish embryo in situ hybridisation 
The solutions used for in situ hybridisation are listed in Table 2.6.3. Embryos 
were fixed at the required stages by soaking in 4% PFA in PBS overnight at 
4°C. The PFA was washed out by soaking in PBS with 0.1% Tween20 
(PBSTw) 5 minutes 3 times before dechorionation. The embryos were 
manually dechorionated and dehydrated through a series of incubations in 25%, 
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50%, 75% and 100% methanol in PBSTw for 5 minutes in each step. 100% 
methanol was added to cover the embryos. The embryos were then stored 
at -20°C overnight or longer for future use. 
Rehydration was carried out through serial 5 minute incubations in 75%, 50% 
and 25% methanol in PBSTw and 4 times 5 minutes washing in PBSTw. The 
embryos were equilibrated for 5 minutes in 50% hybI in PBSTw at room 
temperature and prehybridized for 1 hour by hybI at 65°C. 1:200 dilution of 
RNA probe was used to incubate with embryos at 65°C overnight. 
Serial 10 minutes washes were carried out at 65°C in 100%, 75%, 50% and 
25% hybridisation buffer II (hybeII) in 2x saline-sodium citrate (SSC) and 
incubated in 2x SSC for 10 minutes. After 10 minutes washing in 0.2% SSC, 4 
times at 65°C, the embryos were taken through a series of 5 minutes 
incubations with 75%, 50% and 25% SSC in maleic acid buffer containing 
0.1% Tween20 (MABTw) and then 100% MABTw at room temperature with 
gentle shaking at 5rpm. 1 hour blocking with 2% Boehringer blocking reagent 
in MABTw was carried out to block the non-specific antibody binding. The 
blocking solution was replaced with blocking reagent containing 1:5000 anti-
Dig antibody and incubated at 4°C overnight. 
The embryos were washed 8 times in MABTw for 15 minutes at room 
temperature while shaking at 5rpm and then equilibrated with BCL buffer III 3 
times for 5 minutes. Colour development was performed in the dark by 
incubating with 50% BM Purple (Roche) in BCL buffer III while shaking 
gently. To stop the colour developing, embryos were washed 3 times for 5 
minutes in PBSTw and incubated in 4% PFA for 20 minutes. The PFA was 
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rinsed out by three 5 minute PBSTw washes. The embryos were stored in 80% 
glycerol at 4°C. 
The embryos were observed under a Nikon SMZ1500 microscope and the 
staining patterns were photographed by a Nikon ACT-2U 1.40 software 
controlled digital camera (Nikon DS-5M, DS-U1). 
 
Table 2.6.3 Solutions for in situ hybridisation 
2.6.6 Zebrafish embryo protein detection 
To detect protein expression in the Zebrafish embryos, around 20 
dechorionated embryos were collected. The embryonic yolk was dissolved by 
pipetting in 300 µl of deyolking buffer (Table 2.6.3) and 5 minutes rocking 
incubation in room temperature. After centrifugation at 73 g for 2 minutes, 20 
µl of 2X Sample Buffer Laemmli (Sigma) was added and sample analysed by 
SDS-PAGE and western blotting with appropriate antibodies (see section 
2.3.4). 
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Chapter 3 Sox2 interacts with Grouchos 
3.1 Introduction 
 
The Tcf family are downstream effectors of the Wnt signalling. In the absence 
of a Wnt signal, Tcf interacts with Groucho keeping target genes suppressed as 
shown in Figure 3.1.1 (Brantjes et al., 2001). Tcf is a well-studied 
transcriptional repressor which suppresses down-stream genes via recruited co-
repressors such as Groucho and CtBP. Since the HMG domain on Tcf is highly 
conserved within the SoxB1 family members, the same repression mechanism 
is very likely to occur within the SoxB1 family.  
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Figure 3.1.1 Schematic representation of canonical Wnt signalling cascade. 
When a Wnt signal is absent, β-catenin forms a complex containing Axin, APC, CKIα and 
GSK3β. The phosphorylation of β-catenin by GSK3β results in ubiquitination and 
degradation of β-catenin and keeps the downstream genes repressed by the Tcf and 
Groucho complex. The Wnt signalling prevents the β-catenin complex forming which leads 
to the accumulation of β-catenin in the nuclear. β-catenin replaces the co-repressor in the 
Tcf complex. The interaction of β-catenin and Tcf triggers the downstream genes 
transcription. 
 
Previous research in our lab has shown that Sox3, a SoxB1 family protein, 
interacts with the co-repressor Groucho (PhD thesis, Caroline Hirst, 2009). 
This interaction of transcription factor and co-repressor implies a repressor 
function for the SoxB1 family, which are generally regarded as transcriptional 
activators (Kamachi et al., 1999; Uchikawa et al., 1999). A repressor function 
for Sox3 in various aspects of early embryo developmental has also been 
demonstrated in xenopus, zebrafish, chicken and mouse (Shih et al., 2010; 
Zhang et al., 2004; Zhang et al., 2003a). Hence, it is conceivable that the highly 
similar SoxB1 family members may all function as repressors through 
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interactions with the Groucho co-repressors. In this chapter, experiments were 
designed to test the interaction of Sox2 and Groucho. 
 
3.2 Sox2 changes Groucho subcellular 
localization 
Interaction between proteins can be tested by many methods including protein 
affinity chromatography, immunoprecipitation and yeast two hybrid assays. 
One rapid assay of protein interactions is to observe the subcellular localization 
change after co-expression in cells. Sox2 has three nuclear localization signals 
in its HMG DNA binding domain, therefore the majority of overexpressed 
Sox2 locate in the nucleus (Figure 3.2.1). The long forms of Groucho (Groucho 
1-4) have casein kinase II/cdc2 phosphorylation sites and a nuclear localization 
sequence (CcN) which allows them also to locate to the nucleus, whereas 
Groucho5 lacks a nuclear localization signal and in both nuclear and 
cytoplasmic localization (Figure 3.2.2).  
  
70 
 
 
 
Figure 3.2.1 Sox2 subcellular localiziation 
COS7 cells were transfected with Sox2 by electroporation and seeded on poly-D-lysine 
coated coverslips. After 24 hours, the cells were immunostained using anti-Sox2 antibody. 
DAPI staining identified the nucleus of the cells. Sox2 was detected in the nucleus.  
 
 
 
Figure 3.2.2 Groucho protein subcellular localization 
COS7 cells were transfected with Myc-Groucho3 or Myc-Groucho5 by electorporation and 
seeded on poly-D-lysine coated coverslips. After 24 hours, the cells were immunostained 
using anti-Myc antibody. Groucho3 was detected in the nucleus and 10% of the Groucho3 
stained cells exhibited nuclear bodies which did not co-localize with the nucleolus. 
Groucho5 was detected in the cytoplasm and nucleus, with a brighter staining in the 
nucleus than the cytoplasm. (N: Nucleolus; NB: Nuclear body) 
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According to the previous studies in our lab, the Sox3 and Groucho5 
interaction was demonstrated using a nuclear translocation assay (PhD thesis, 
Zulfiqar Laghari, 2010). Here, the same experiment was carried out to 
investigate the interaction of Sox2 with Groucho5. As a positive control, COS7 
cells were transfected with Sox3 and a Myc-tagged Groucho5 either alone or 
together and immunostaining was used to detect their subcellular localization 
(Figure 3.2.3). Sox3 localized to the nucleus and, also expressed alone, Myc-
tagged Groucho5 was broadly distributed in cytoplasm and nucleus. When co-
expressing both Sox3 and Groucho5, Groucho5 was mainly relocated to the 
nucleus together with Sox3 which implied an interaction with Sox3. These 
results agree with the previous studies in our lab.  
 
Figure 3.2.3 Sox3 translocates Groucho5 to the nucleus 
COS7 cells were transfected with Sox3 or Myc-Groucho5 by electorporation and seeded on 
poly-D-lysine coated coverslips. After 24 hours, the cells were immunostained using anti-
Sox3 and anti-Myc antibody. When expressed alone, Sox3 was detected in the nucleus 
while Myc-Groucho5 was detected in the cytoplasm and nucleus, with a brighter staining in 
the nucleus than the cytoplasm. Co-expressing Sox3 with Groucho5 caused Groucho5 to 
translocates into nucleus. 
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A similar analysis was carried out for Sox2 and Groucho5 interaction. When 
transfected alone, Groucho5 was distributed throughout the cells but staining 
was more intense in the nuclei (Figure 3.2.4.A). When both Sox2 and 
Groucho5 were overexpressed in COS7 cells, the nuclear Groucho5 was still 
detected whereas the cytoplasmic Groucho5 was significantly reduced (Figure 
3.2.4.B; p <0.001). This nuclear restricted localization of Groucho5 represents 
co-localization with Sox2. This co-localization of Sox2 and Groucho5 implied 
the interaction between two proteins. Quantification of these data demonstrated 
a distinct increase in the nucleus of cells that had nuclear only Groucho5 
(Figure 3.2.4.C).  
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Figure 3.2.4 Sox2 translocates cytoplasmic Grouch5 to the nucleus 
COS7 cells were transfected with Sox2, Myc-Groucho3 or both by electorporation and 
seeded on poly-D-lysine coated coverslips. After 24 hours, the cells were immunostained 
using anti-Sox2, anti-Myc or both antibodies. (A.) When co-transfected with Sox2, 
Groucho5 was detected in the nucleus, but no Groucho5 was detected in the cytoplasm. (B.) 
Quantification of cytoplasmic Groucho5. The unsaturated Groucho5 immunostaining 
picture were analysed by ImageJ software. The pixel number of cytoplasm was calculated 
as whole cell pixel number minus the nucleus pixel number. 15 cell pictures were analysed 
per set. (C) Quantification of Groucho5 nuclear localization. 100 Groucho5-expressing 
cells were counted. The number of cells express no cytoplasmic Groucho5 were counted 
and the percentage was calculated. 
  
A. 
B. C. 
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In order to test the interaction between Sox2 with Groucho, a construct 
encoding Sox2 and/or Myc-tagged Groucho3 was introduced into cells either 
alone or together and the subcellular localization of the proteins produced was 
detected using immunostaining. When cells were transfected with Myc-
Groucho3 construct alone, Myc-Groucho3 protein inclusion bodies were seen, 
which did not co-localize with the nucleolus. When both Sox2 and the Myc-
Groucho3 were introduced into COS7 cells simultaneously, the inclusion 
bodies of Groucho3 stained brighter in the periphery of than the centre and 
Sox2 now also formed inclusion bodies which co-localized with Groucho3 
(Figure 3.2.5.A). This subcellular localization change of both Sox2 and 
Groucho3 when co-expressed in the cell implied interaction between the two 
proteins. To further quantify the frequency of the phenomena, the cells with or 
without Groucho3 nuclear bodies were counted in cells transfected with 
Groucho3 alone or with both Groucho3 and Sox2 co-expressed. The results in 
presented in Figure 3.2.5.B as percentage of the dots formed in the nucleus. 
When Groucho3 was expressed alone, 1% of cells had Groucho3 inclusion 
bodies with bright peripheral staining. When Groucho3 was co-transfected with 
Sox2, approximately 16% of Groucho3 positive nuclear bodies were 
colocalized with Sox2 and exhibited bright peripheral staining.  
To sum up, the subcellular localization change of Grouchos after introducing 
Sox2 into cells suggests some kind of connection between Sox2 and Grouchos 
75 
 
 
  
Figure 3.2.5 Sox2 co-localized in the nucleus with Groucho3 
COS7 cells were transfected with either Sox2, Myc-Groucho3 or both constructs by 
electroporation and seeded on poly-D-lysine coated coverslips. After 24 hours, the cells 
were immunostained using anti-Sox2, anti-Myc or both antibodies. (A) When co-
transfected with Groucho3, Sox2 formed inclusion bodies which colocalized with 
Groucho3. Groucho3 was detected in the nucleus and the inclusion bodies of Groucho3 
only stained in the periphery inclusion bodies with bright edge were counted. The number 
of cells expressing Groucho3 was counted and the percentage of inclusion bodies with 
bright edge was calculated (first column). The number of cells co-localized Sox2 and 
Groucho3 in inclusion bodies was counted and the percentage was calculated (second 
column). 
. 
A. 
B. 
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3.3 Groucho proteins interact with Sox2 as 
demonstrated by Co-immunoprecipitation 
The change of Sox2 and Groucho subcellular localization when co-expressed 
implies interaction between these two molecules. However, the image under 
the microscope is a merged vision of the whole depth of the cell. Therefore, it 
could give a false positive result such as overlapping signal of different depths 
of focus and could also be due to indirect interaction via an intermediate 
protein complex. To further investigate the relationship between Sox2 and 
Grouchos, co-immunoprecipitation (Co-IP) was carried out to test the protein-
protein interaction. Using the affinity of antibody and antigen, complexes in a 
cell lysate can be precipitated with a specific antibody conjugated to sepharose 
beads. The complexes are then separated by SDS-PAGE and analysed by 
western blot.  
After transfection with appropriate plasmids, cells were recovered and 
harvested after being grown for 48 hours. The cell lysates were then used for 
co-immunoprecipitation assay. Here Myc antibody conjugated sepharose beads 
were used to precipitate the Myc tagged proteins. The precipitated samples 
were run through SDS-PAGE to separate the proteins according to their 
molecular weight and transferred onto a nitrocellulose membrane. Myc-
Groucho was detected by Myc-antibodies and Sox2 detected using Sox2 
antibodies.  
3.3.1 Myc-bead specificity test 
A control for the Myc-bead specificity was carried out in Sox2 and Myc-
Groucho overexpressing cell lysates respectively (Figure 3.3.1). The 
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expression of Sox2 was shown in 5% whole cell extract (WEC). Lanes 1 and 2 
show Sox2 expression at approximately 64kDa which is different from the 
predicted size of Sox2 (~34kDa). Since the Sox2 was overexpressed in the cell, 
it might trigger a specific degradation mechanism. The ubiquitin-proteasome 
pathway is one of the key protein degradation mechanisms (Ciechanover, 1998) 
and sumoylation is also involved in this pathway (Tatham et al., 2008). Hence 
the molecular weight difference of Sox2 might be caused by these post-
transcriptional modification (Baltus et al., 2009b; Van Hoof et al., 2009). 
However, a single ubiquitination or sumoylation event only adds 
approximately 11kDa. The molecular weight difference of exogenous Sox2 is 
30kDa larger than the predicted size. Hence other modifications seem likely. 
After immunoprecipitation using Myc-beads, no Sox2 band was seen (lane 3, 
4), which indicates that Myc-beads alone could not precipitate Sox2. The 
expression of Myc-Groucho3 and Myc-Groucho5 in 5% whole cell extract was 
not detectable (lane 6, 7). However, the Myc-beads could precipitate and 
concentrate Myc-tagged Groucho from the rest of whole cell extract (lane 9, 10) 
whereas the non-transfected cell lysate showed nothing has been precipitated 
(lane 8). 
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Figure 3.3.1 Myc beads specificity test 
Sox2 expression in COS7 cells was detected using anti-Sox2 antibody in 5% whole cell 
extract (WCE). After immunoprecipitation (IP), the Myc beads did not precipitate 
overexpressed Sox2 (left panel). Myc-Groucho3 and Myc-Groucho5 expression could not 
detected by anti-Myc antibody in WCE (middle panel), but immunoprecipitation 
concentrated Myc-tagged proteins, which were detected by the anti-Myc antibody (right 
panel). 
 
3.3.2 Co-immunoprecipiation of Sox2 and Groucho 
To test the interaction between Sox2 and Groucho, COS7 cells were 
transfected with Sox2 and Myc-tagged Groucho3 or Groucho5. Co-
immunoprecipitations were carried out with Myc-beads. The whole cell extract 
and the protein eluted from the Myc-beads after co-immunoprecipitation were 
analysed by western blotting with anti-Myc and anti-Sox2 antibodies. The 
exogenous expression of Myc-Groucho3, Myc-Groucho5 and Sox2 was faintly 
detected in 5% whole cell extract (Figure 3.3.2) (lane 1-4; 9-12). Myc-beads 
precipitated Myc-Groucho3 (lane 5, 6) and Myc-Groucho5 (lane 7, 8) 
suggesting that both Myc-Groucho3 and Myc-Groucho5 were expressed. 
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However, the molecular weight of Myc-Groucho5 is very close to the light 
chain of immunoglobulin (approximate 36kD), it is hard to distinguish the 
slightly higher Myc-Groucho5 bands and the bands of immunoglobulin (lane 7, 
8). Although no obvious bands was detected by the Sox2 antibody in the whole 
cell lysate, the Sox2/Groucho interaction allowed Sox2 to be precipitated with 
Myc-beads and allowed Sox2 to be detected in lane 14 and 16. No similar 
molecular weight protein was precipitated by Myc-beads in the absence of co-
transfected Sox2 (the negative control which had no Sox2 co-expression; lane 
13, 15) which suggests the bands in lane 14 and 16 are genuinely Sox2. 
Nevertheless, the anti-Myc antibody detected a band at about the same position 
as Sox2 (lane 6, 8) which implied that the anti-Myc antibody might weakly 
cross-react non-specifically in this overexpression system. To further confirm 
the interaction of Sox2 and Groucho, it was necessary to co-immunoprecipitate 
endogenous Sox2. 
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Figure 3.3.2 Co-immunoprecipitation of exogenous Sox2 through Myc-Groucho 
 
COS7 cells were transfected with Sox2 and Myc-Groucho3 or Myc-Gruocho5. After 48 
hours, the cell lysates were used for Myc immunoprecipitation. Western blots were carried 
out and detected with anti-Myc (lane 1-8) and anti-Sox2 antibodies (lane 9-16). The 
expression of transfected proteins was weakly detected in the whole cell extract (WEC; 
lane 1-4 and 9-12) whereas immunoprecipitation concentrated the proteins which could 
then be detected more clearly on the membrane (lane 5-8 and 13-16). Anti-Myc antibody 
detected the immunoprecipitated Myc-Groucho3 (*) and Myc-Groucho5 (▲). Anti-Sox2 
antibody detected Sox2 (●) that had been precipitated with Groucho.  (WCE: 5% of whole 
cell extract; IP: Immunoprecipitation; Grg3: Groucho3; Grg5: Groucho5.)  
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3.3.3 Co-immunoprecipiation of endogenous Sox2 and 
Groucho 
In order to test the Grocho/Sox2 interaction in a more endogenous context, 
COS7 cells (which express endogenous Grouchos) were transfected with Myc-
Sox2 and the interaction of Myc-Sox2 with endogenous Grouchos was tested 
by co-immunoprecipitation (Figure 3.3.3). The expression of Myc-Sox2 was 
shown in the whole cell extract (lane 8). After immunoprecipitation, Myc-Sox2 
could only seen in the transfected cells (lane 5). A anti-pan TLE antibody was 
used that detected the C-terminus of long form Grouchos. Therefore, the anti-
pan TLE antibody detected a high molecular weight band at approximate 98 
kDa as predicted. In the whole cell extract, Grouchos could be detected in 
lysated of both transfected and non-transfected cells (lane 1, 2). After co-
immunoprecipitation, only the Myc-Sox2 transfected cell lysate showed a 
Groucho band (lane 3). This indicates that the endogenous Grouchos in COS7 
cells could also be precipitated together with Myc-Sox2 using Myc beads 
(Figure 3.3.3).  
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Figure 3.3.3 Co-immunoprecipitation of endogenous Groucho with Myc-Sox2 in COS7 
cell 
COS7 cells were transfected with Myc-Sox2. The expression of Myc-Sox2 was detected by 
anti-Myc antibody (lane 5-8). The Myc-beads did precipitate Myc-Sox2 after IP (lane 5, ●). 
The expression of endogenous Groucho was detected by anti-pan TLE antibody (lane 1-4). 
When overexpressing Myc-Sox2, the endogenous Groucho could be detected in the Myc-
Sox2 pulled down complex (lane 3, *). 
 
On the other hand, to test if the endogenous Sox2 also interacts with Groucho, 
human neural stem cells (hNSC) (which express high levels of endogenous 
Sox2) were used (Figure 3.3.4 A, B). Co-immunoprecipitation was carried out 
using Myc-Groucho3 and Myc-Grouch5 transfected hNSC cell lysates. The 
expression of Myc-Groucho3 and Myc-Groucho5 were shown in whole cell 
lysate (Figure 3.3.4 A lane 1, 2) and Myc-beads successfully precipitated both 
Myc-Groucho3 and Myc-Groucho5 (Figure 3.3.4 A lane 3, 4). Endogenous 
Sox2 expression was detected by anti-Sox2 antibody in whole cell extract at 
approximate 40 kDa (Figure 3.3.4 A lane 5, 6), which is close to the predicted 
Sox2 molecular weight. Several other bands were also detected by the anti-
Sox2 antibody, one of them located at approximate 64 kDa, just like the 
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exogenous expression of Sox2 in COS7 cells. This implies the post-
translational modification occurred also on the endogenous Sox2. However, the 
co-immunoprecipitation did not precipitate the endogenous Sox2 in this 
experiment (Figure 3.3.4 A lane 7, 8). Since the previous experiments all 
indicate that Sox2 might interact with Groucho, the failure of this co-
immunoprecipitation might be because the interaction is not sufficiently stable. 
Previous studies have applied cross-linkers to solve this difficulty, such as 
Formaldehyde and DSP (Dithiobis [succinimidypropionate]) (Fairbanks, 1976; 
Fujita and Wade, 2004; Valerio Orlando, 1997). The study of the Oct4 and 
Nanog interaction is a good example for the use of DSP to overcome such an 
unstable interaction reference. Since both Oct4 and Nanog are partners of Sox2. 
I used DSP as a cross-linker and repeated the co-immunoprecipitation 
experiment. After treating with DSP, the cells lysates were used for co-
immunoprecipitation. The expression of Myc-Groucho3 and Myc-Groucho5 
could be detected by anti-Myc antibody (Figure 3.3.4 B lane 1, 2). Myc-beads 
precipitated Myc-Groucho3 and Myc-Groucho5 (Figure 3.3.4 B lane 3, 4). The 
endogenous Sox2 expression was detected by anti-Sox2 antibody in whole cell 
extract (Figure 3.3.4 B lane 5, 6, 7). After co-immunoprecipitation, endogenous 
Sox2 could be precipitated only when Myc-Groucho3 and Myc-Groucho5 was 
expressed (Figure 3.3.4 B lane 8, 9, 10). These results indicate that Grouchos 
interact weakly with Sox2. 
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Figure 3.3.4 Co-immunoprecipitation of endogenous Sox2 and Myc-Groucho in hNSC 
cells 
hNSCs were transfected with Myc-Groucho3 or Myc-Groucho5. After 48 hours, the non-
treated cell lysates (A) or the DSP treated cell lystaes (B) were immunoprecipitated using 
Myc-beads. Myc-Groucho3, Myc-Groucho5 and endogenous Sox2 were detected in whole 
cell extract using anti-Myc (A lane 1, 2; B lane 1, 2) and anti-Sox2 antibodies (A lane 5, 6; 
B lane 5, 6, 7). Myc-Groucho3 (*) and Myc-groucho5 (▲) were immunoprecipitated and 
detected clearly by Myc-antibody. Endogenous Sox2 was detected in both Myc-Groucho3 
and Myc-Groucho5 immunoprecipitated complex (B lane 9, 10) whereas the Myc beads 
alone cannot precipitate endogenous Sox2 (B lane 5). (WCE: 5% of whole cell extract; IP: 
Immunoprecipitation; Grg3: Groucho3; Grg5: Groucho5.)  
 
A. 
B. 
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3.3.4 Summary of co-immunoprecipitation experiments 
In this section, the interaction between Sox2 and Groucho was demonstrated. 
However, the interaction revealed by the co-immunoprecipitation assay could 
be rather indirect. It is possible that the protein interaction demonstrated by Co-
IP was not direct but through one or more intermediate proteins. To clarify this 
point further investigation was needed. The co-IP results show that Sox2 exists 
with Groucho3 and/or Groucho5, but the interaction with Groucho could be 
direct or indirect. 
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3.4 Groucho interacts directly with Sox2 in a 
yeast-two-hybrid assay 
To test if the interaction between Sox2 and Groucho is direct, a modified 
yeast-two-hybrid was used. The yeast two-hybrid system has been used to 
investigate protein-protein interaction since 1989 (Field and Song, 1989). The 
advantage of using the yeast-two-hybrid system to investigate mouse protein 
interactions is that no potential intermediate mouse factors exist in the cellular 
environment. Therefore, indirect interactions are minimized. In other words, 
the yeast two-hybrid system could be used to test the direct interaction of 
proteins.  
In this chapter, a modified yeast two-hybrid system was used. The GAL4 
DNA-binding domain (BD) and activation domain (AD) were fused with 
Groucho and Sox2 respectively. The BD vector (pGBK-T7) and AD vector 
(pGAD-T7) carry leucine and tryptophan selection markers respectively 
(Figure 3.4.1). The AH190 modified yeast strain, which lacks the ability to 
make leucine, tryptophan, adenine and histidine, was used as the host cell in 
this system. The BD and AD carrying yeasts were selected on plates lacking 
both leucine and tryptophan (-2 SD plates). If a Groucho and Sox2 interaction 
took place in the yeast cells, the BD and AD of GAL4 would be recruited to 
the GAL4 binding promoter region which could then trigger downstream 
adenine and histidine synthase expression (Figure 3.4.1). Only when the 
interaction occurred could AH190 cells survive without an exogenous supply 
of adenine and histidine. This would therefore allow growth on plates which 
lack leucine, tryptophan, adenine and histidine (-4 SD plate). 
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Figure 3.4.1 Schematic representation of the yeast two-hybrid system 
Yeast carrying the BD and AD fusion protein express LEU2 and TRP1 that allows the yeast 
to grow on leucine and tryptophan “drop out” plates (-2 SD). To test the interaction of 
Groucho and Sox2, yeasts were spread on plates lacking leucine, tryptophan, histidine and 
adenine. The BD fusion protein will bind to the GAL4 promoter and the interaction 
between fusion proteins recruits the AD domain bring it close to the BD domain. Therefore, 
the interaction between the BD and the AD domain triggers down-stream reporter gene 
(adenine and histidine synthase) expression which allows the formation of yeast colonies.   
 
To make the Sox2 AD construct, the full-length coding sequence of Sox2 
with EcoRI and BamHI restriction enzyme sites on both ends was amplified 
using PCR using the pcDNA-Sox2 plasmid as template (appendix 1). In order 
to test the interaction of Sox2 with both long and short forms of Groucho, 
Groucho1 was used to represent the long form and Groucho5 was used as the 
short form. The Sox2 AD plasmid was then introduced into the host yeast 
containing either empty BD, Groucho1 BD and Groucho5 BD plasmid 
(plasmids constructed by Caroline Hirst). The expression of exogenous fusion 
proteins was detected using western blotting with appropriate antibodies 
(Figure 3.4.2). Anti-Myc antibody detected Myc tagged Groucho1 and 
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Groucho5 BD fusion protein (Figure 3.4.2.A lane 1, 2) whereas anti-HA 
antibody detected HA tagged Sox2 AD fusion protein (Figure 3.4.2.B lane 3, 4, 
5). When grown on -4 SD plates, the BD vector carrying strain was used as a 
negative control and the Sox3 AD/ Groucho5 BD expressing strain was used as 
a positive control (Sox3 was shown to interact with Groucho5 in this assay 
previously; PhD thesis, Caroline Hirst, 2009) (Figure 3.4.3). 
Unlike Sox2, yeast expressing Sox3 AD/ Groucho1 BD failed to grow on -4 
plate in previous studies in our lab (PhD thesis, Caroline Hirst, 2009). This 
suggests that Sox2 might interact with long form Groucho more strongly than 
Sox3. The growth of Sox2 AD/ Grouchos BD yeast on -4 plates indicates that 
the interaction between Sox2 and Grouchos is likely to be direct.  
 
Figure 3.4.2 Sox2 AD expression 
Yeast cells were analysed by SDS-PAGE and western bloting. (A) Anti-Myc antibody was 
used to detect Groucho1 (*) and Groucho5 (▲) BD fusion protein expression (Experiment 
performed by Caroline Hirst). (B) Sox2 AD fusion vector was transformed into AH190 
yeasts carrying Groucho BD fusion vector. The expression of the Sox2 AD fusion protein 
was detected using anti-HA antibody (●).  
  
A. B. 
89 
 
 
 
Figure 3.4.3 Yeast two hybrid assay shows Sox2 interaction with Groucho 
Transformed yeasts were grown on -4 SD plates. The colonies of the negative control BD 
vector and the positive control Sox3 AD/ Groucho5 BD. A single colony was picked and 
resuspended in 10ul (lst column of BD vector carrying yeasts) or 100ul (2nd column of BD 
vector carrying yeast and all other yeasts) of sterile distilled water. 10ul of the mixture was 
plated on -4 SD plates.  
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3.5 Groucho represses Sox2 transcriptional 
activity 
Having demonstrated that Groucho and Sox2 interact, I then set out to 
determine if the interaction affected the function of Sox2 as a transcription 
factor. To test the transcriptional regulator activity of Sox2, a luciferase 
reporter assay was used. Firefly luciferase reporter plasmids contained three 
copies of Sox binding sites (3xSX) was used as the reporter of Sox2 
transcriptional activity (Figure 3.5.1).  
 
Figure 3.5.1 Schematic representation of luciferase assay 
Cells transfected with 3xSX firefly and TK Renilla luciferase vectors which only express 
Renilla luciferase that continuously activated TK promoter in mammal cells act as controls. 
When co-expressed with Sox2 or Sox2 with Groucho, the firefly luciferase expression 
change indicates the transcriptional function of Sox2 on the 3xSX promoter. 
 
The firefly luciferase reporter plasmid was constructed by Dr. Feist in 
pTATAluc vector plasmid (Kuhlbrodt et al., 1998). Renilla luciferase (with 
continuous activation from a tyrosine kinase (TK) promoter) (Promega) was 
used as the internal control in order to normalize the transfection efficiency. 
When transcription factors were co-transfected with both the Renilla and firefly 
luciferase reporters into cells, the relative luciferase activity could be 
calculated by the normalization equation: 
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In the equation, the control indicates the reading from cells transfected with 
Renilla and firefly luciferase reporters but no transcription factors.  
Cells were transfected using liposome reagent and the luciferase assays were 
carried out 24 hours after transfection. Three wells were transfected with the 
same liposome reagent and DNA mixture as repeats in every individual test. 
Every test was repeated at least two times.  
In order to test the optimal plasmid DNA quantity of pcDNA3 Sox2, different 
doses of Sox2 plasmid DNA were introduced into cells and analysed using the 
luciferase assay. Here, three cell lines, COS7, P19 and mouse embryonic stem 
cells (mES), were used for the test (Figure 3.5.2). Sox2 was found to only 
efficiently affect the 3xSX reporter in mES and P19 cells but not in COS7 cells. 
This suggests that Sox2 function on the 3xSX promoter might need specific co-
factors that only exist in embryonic stem cells (mES) or embryonic carcinoma 
cells (P19) but not in COS7 cells. pcDNA3 Sox2 (1 µg) transfection increased 
the luciferase reporter expression approximate 2 fold compared to controls in 
both mES and P19 cells. However, compared to mES cells, P19 cells are easier 
to grow and transfect. For this reason, P19 cells were used for luciferase assay 
in the following work unless otherwise indicated. According to the results in 
mES and P19 cells, the transcriptional activator function of Sox2 reached 
maximum when 1 µg of pcDNA3 Sox2 plasmid was transfected. Therefore, 
from here onward, the amount of Sox2 in all luciferase assays was 1 µg unless 
stated otherwise.  
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Figure 3.5.2 Sox2 acts as a transcriptional activator of a 3xSX luciferase reporter 
Luciferase assays were carried out in COS7, mES, and P19 cells 24 hours after transfection. 
(A) In COS7 cells, Sox2 failed to activate luciferase reporter expression. In mES (B) and 
P19 (C) cells, Sox2 functioned as a transcriptional activator increasing the luciferase 
reporter expression. A paired t test was used to access significance. p< 0.05 is defined as 
significant difference. 
 
A. 
B. 
C. 
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In P19 cells, the 3xSX luciferase reporter was activated 2 fold when co-
transfected with Sox2. However, when co-transfected with Groucho3, the 
Sox2-induced increase was ablated and the relative luciferase activity was 
decreased to the level of the control (Figure 3.5.3). This suggests that long 
form Grouchos, such as Groucho3, function as repressors of Sox2 
transcriptional activation activity. The same effect was also seen when Sox2 
was co-transfected with Groucho5. Groucho5 is a short form of Groucho, 
which has no C-terminal protein-protein interaction domain and can function as 
a dominant negative form of Groucho (Brantjes et al., 2001). However, the N-
terminal Q domain in Groucho5 has been demonstrated as a protein-protein 
interaction domain that interacts with TCF (Pickles et al., 2002). Also, 
Groucho5 has been shown to function as a co-repressor of the androgen 
receptor (Yu et al., 2001). The luciferase assay results in this session, together 
with the data shown in chapter 3, indicate that Groucho5, the short form 
Groucho, could function as a co-repressor of Sox2 transcriptional activation 
activity. 
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Figure 3.5.3 Groucho co-expression represses Sox2 transcriptional activity 
3xSX promoter driven luciferase expression was increased when Sox2 was overexpressed 
in P19 cells. When Sox2 and Groucho3 or Groucho5 were co-expressed, the transcriptional 
activation by of Sox2 was repressed. A paired t test. p< 0.05 is defined as significant 
difference. 
 
In order to test the affect of Groucho on endogenous Sox2 target promoters, 
luciferase reporter vectors containing the Nanog, Rex and GFAP promoter 
were constructed (Appendix 2-4). Previous studies had shown that Sox2 
activates Nanog and Rex but represses GFAP expression (Cavallaro et al., 
2008; Rodda et al., 2005; Shi et al., 2006).  
To test if the Grouchos could repress the luciferase reporter expression by 
itself, Groucho3 or Groucho5 and the various promoter-containing luciferase 
reporters were introduced into cells without Sox2 (Figure 3.5.4). The results 
show that neither Groucho3 nor Groucho5 had any effect on 3xSX, Rex, 
Nanog and GFAP luciferase reporters at the level of transfection used. 
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Figure 3.5.4 Groucho does not affect Sox2 target gene reporter expression 
Luciferase assays were carried out on different Sox2 target gene promoter luciferase 
reporters 24 hours after transcription. In the presence of overexpressed Groucho3 or 
Groucho5 the luciferase reporter expression was not significantly different to the vector 
control (lysate from Renilla and firefly luciferase vectors transfected cells). p< 0.05 is 
defined as significant difference. 
 
The transcriptional activity of Sox2 was first tested on the Rex luciferase 
reporter (Figure 3.5.5 A). Sox2 dramatically activated the Rex promoter-driven 
luciferase expression by over 20 fold when compared with the control. When 
co-expressed with Groucho3, the increase caused by Sox2 was suppressed by 
about 50% to only 10 times the control. Groucho5, the short form Groucho, 
suppressed Sox2 transcriptional activation activity to the same level as 
Groucho5. On the 3xSX luciferase reporter, Groucho3 or Groucho5 co-
expression suppressed its transcriptional activation by Sox2 to the control level 
(Figure 3.5.3). However, transcription of the Rex reporter was still activated to 
approximately 10 times control level even when Groucho3 or Groucho5 were 
co-expressed with Sox2. These results suggest that the repression of Sox2 
activation by Grouchos is restricted by context. When the Sox2 is able to 
induce a massive activation of a downstream gene, like Rex, the suppression 
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function of Groucho could only decrease the Sox2 transcriptional activation 
activity to a certain level but not eliminate it. 
As for Nanog, Sox2 also acted as a transcriptional activator but not as 
effectively as on the Rex promoter (Figure 3.5.5 B). Groucho3 co-expression 
slightly suppressed Sox2 transcriptional activation activity whereas Groucho5 
co-expression almost diminutal the Sox2 activation ability. These results show 
that Grouchos can repress Sox2 transcriptional activation, but the degree to 
which they achive this depends on the long-form or short-form of Groucho and 
the contact of target.  
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Figure 3.5.5 Grouchos repress Sox2 transcriptional activator function on target gene 
promoter reporter 
Sox2 increased luciferase expression on both Rex (A) and Nanog (B) target gene promoters. 
However, when Sox2 was co-expressed with Groucho3 or Groucho5, the Sox2 activator 
function was repressed dramatically. p< 0.05 is defined as significant difference. 
 
 
Cavallaro et al. (2008) demonstrated that GFAP expression was down 
regulated by Sox2 and also identified a Sox2 binding region on the GFAP 
promoter (Cavallaro et al., 2008). Here, the Sox2 binding region was cloned 
into a luciferase reporter and the transcriptional activity was tested. The result 
of my experiments of Sox2 function on their GFAP luciferase reporter were in 
A. 
B. 
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agreement with Cavallaro’s data that Sox2 repressed the GFAP luciferase 
reporter expression to 50% of the control (Figure 3.5.6). The co-expression of 
Grouchos with Sox2 could further suppress the GFAP reporter by 
approximately 70%. These data suggest that Sox2 functions as a repressor and 
that the Grouchos can act as co-repressors to enhance repression of GFAP. In 
other words, Grouchos interfere with Sox2 transcriptional activation activity 
and also function as co-repressors of Sox2 transcriptional repression activity. 
 
 
 
Figure 3.5.6 Down regulation of a GFAP-Luciferase reporter was enhanced by Groucho 
co-expression.  
The expression of Sox2 repressed the luciferase activity driven by the GFAP promoter. The 
repression of GFAP reporter was even greater when Sox2 was co-expressed with Groucho3 
or Groucho5. p< 0.05 is defined as significant difference. 
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3.6 Discussion 
Although the SoxB1 family members are generally regarded as transcriptional 
activators, there is increasing evidence that SoxB1 factors act as bifunctional 
transcription factors. (Kan et al., 2004; Zhang et al., 2003a; Cavallaro et al., 
2008; Muotri et al., 2005; Navarro et al., 2008). Unpublished data in our lab 
has demonstrated that the interaction of Sox3 and Groucho also represses the 
transcriptional activity of Sox3 (PhD thesis, Zulfiqar Laghari, 2010). Sox3 
could translocate Groucho5 into the nucleus, in addition, the co-expression of 
Groucho5 interfered with Sox3 transcriptional activation activity on the 3xSX 
luciferase reporter. However, the mechanism of the repressor function of the 
SoxB1 family remained unknown. 
In this chapter, the interaction between Sox2 and Groucho was tested firstly by 
observing the change of the subcellular localization. When overexpressing 
Sox2 with Groucho5, Groucho5 tended to accumulate in the nucleus instead of 
being distributed out through the cell. Nevertheless not all of the subcellular 
localization was changed by the co-expression (Figure 3.2.3 C; Figure 3.2.4 B).  
Co-IP was carried out to test the physical interaction between Sox2 and 
Groucho. COS7 cells were used as a neutral enviroment to test the interaction 
without other intermediate factors that would be presented in embryonic stem 
cells, for example. The results show that Sox2 could interact with both 
exogenous and endogenous Grouchos (Figure 3.3.2; Figure 3.3.3). However, 
the interaction of endogenous Sox2 with exogenous Groucho in human neural 
stem cells could be detected only after crosslinking (Figure 3.3.4). This 
indicates that the interaction of endogenous Sox2 with Groucho might be either 
very weak or only occurs very transiently. The yeast-two-hybrid system was 
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used to test the direct interaction of Sox2 and Groucho. In previous studies in 
our lab, transformation with sufficient Sox3 BD alone was enough to allow the 
host yeast cells to survive on -4 plates. In other words, the transcriptional 
activation of Sox3 could activate the expression of the reporter genes (PhD 
thesis, Caroline Hirst, 2009). This could cause a false positive result in yeast-
two hybrid system. Therefore, the Sox2 AD but not Sox2 BD was used 
demonstrating the yeast-two hybrid assay in this chapter. The slow growth of 
the Sox2 AD/Groucho3 BD and Sox2 AD/ Groucho5 BD colonies implies a 
weak interaction of Sox2 with Groucho3 and Groucho5 (Figure 3.4.3). 
Using a luciferase assay, it was shown that Grouchos suppress the Sox2 
transcriptional activity both on artificial (3xSX) and endogenous (Nanog, Rex) 
Sox2 binding motifs (Figure 3.5.6). However, the ability of Sox2 to repress a 
GFAP luciferase reporter shows that Sox2 could also act as a transcriptional 
repressor. This result agrees with the data of Cavallaro et al., (2008). 
Co-expression of Groucho3 or Groucho5 with Sox2 only slightly enhanced 
repression of the GFAP reporter (Figure 3.5.7). This might be because the 
Sox2 repression complexes were already saturated with endogenous Groucho. 
Therefore, the effect of Groucho co-expression would not be obvious. These 
data indicate that Groucho functions as a co-repressor of Sox2 transcriptional 
repression activity.  
Most transcription factors have been reported to interact with Groucho 
through the C-terminal WD domain (Brantjes et al., 2001). Since Groucho5, 
the short version of Groucho, has no C-terminal SP and WD domain, it had 
been defined as a de-repressor or dominant negative form of long form 
Groucho (Brantjes et al., 2001; Roose et al., 1998). However, some 
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transcription factors such as Runx2, Nolz1, and Pax5 interact with the N-
terminus of Groucho proteins (Eberhard et al., 2000; Ji et al., 2009; Wang et al., 
2004). This suggests that the short form Groucho is able to interact with 
transcription factors just like other members in the Groucho family. The data I 
present in this chapter indicate that Sox2 also interacts with both Groucho3 and 
Groucho5 (Figure 3.3.2). Therefore, both Groucho3 and Groucho5 could 
function as co-repressors with Sox2 (Figure 3.5.3) 
In summary, all of the results in this chapter suggest an interaction between 
Sox2 and Groucho and this interaction helps Sox2 to function as a 
transcriptional repressor. 
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Chapter 4 Mapping the Sox2-Groucho interaction 
domain 
4.1 Introduction 
The mapping of protein-protein interaction domains is a critical step in 
protein function research. By mapping where in the protein the domain is 
located, a major protein-protein interaction domain could be revealed and a 
functional mutant could be generated. Comparison of the behaviour of the wild 
type protein and the “interaction domain mutant” (loss-of-function mutant) will 
shed a light on the in vivo role of the protein interaction. A previous study of 
Pax5 assigned the engrailed-like Groucho interaction domain to the region of 
amino acids 179-186 and the single point mutation of Y179E disrupted 
Groucho interaction (Figure 4.1.1) (Eberhard et al., 2000).  
In this chapter, the mapping of the Sox2-Groucho interaction domain is 
demonstrated by various C-terminal deletions and point mutations. 
 
Figure 4.1.1 Mapping of the Pax5-Groucho interaction domain   
(A) Schematic representing the wild type and mutant Pax5 sequence. (B) GST pull-down 
assay showing that OP and Y179E lose the interaction with Groucho4 (Eberhard et al., 
2000). 
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4.2 Sox2 C-terminal deletions  
Many studies of the C-terminus of the Sox family of proteins have 
demonstrated that this is where the trans-activation domain or repression 
domain reside (Hosking et al., 1995; Pusch et al., 1998; Uchikawa et al., 1999). 
Studies in our lab during the time of my PhD (PhD thesis, Caroline Hirst, 2009, 
PhD thesis, Zulfiqar Laghari, 2010) mapped two regions of Sox3 which were 
essential for the Sox3-Groucho interaction (Figure 4.2.1).  
 
Figure 4.2.1 Schematic representation of potential Groucho interaction domains on 
mouse Sox3 
The HMG domain of mouse Sox3 is shown as a black box (67-153) and the Sox3-Groucho 
interaction regions are shown as grey box (175-262 and 351-366). The Sox3-Groucho 
interaction region sequence from the yeast-two hybrid system (Caroline Hirst) is shown in 
the grey box beneath. The boxed sequences mark the predictive motifs which were 
sufficient in the subcellular localization change assay (Zulfiqar Laghari). 
 
Since Sox2 and Sox3 are highly conserved in their amino acid sequence, it 
seemed likely that Sox2 also interacts with Groucho in a similar manner. In 
order to identify the possible Groucho interaction domain(s) of Sox2, six serial 
deletions of the Sox2 C-terminus were generated. The Sox2 C-terminal 
deletions were designed according to the alignment of Sox2 and Sox3 amino 
acid sequence of the broad Sox3-Groucho interaction region (Figure 4.2.2).  
104 
 
 
Figure 4.2.2 Schematic representation of the Sox2 C-terminal deletion design 
The mouse Sox2 and Sox3 alignment is illustrated in the figure. The sequence of Sox3 is 
shadowed with grey. The boxed sequences mark the predictive motifs which were 
sufficient for Groucho interaction in the subcellular localization change assay in Sox3 
(Zulfiqar Laghari). Sox2 C-terminal deletion designs are shown as d1-d6. The amino acid 
numbering of Sox2 is marked at the top. 
 
Due to the high GC content of Sox2, the insert fragments of Sox2 C-terminal 
deletions were amplified by PCR in the presence of 10% DMSO. The Sox2 C-
terminal deletions were cloned into pcDNA3 and pEGFPC1 vectors (Appendix 
5-16). The pEGFPC1 Sox2 C-terminal deletions were introduced into COS7 
cells and the expression of the GFP-tagged Sox2 deletions were detected by 
western blot (Figure 4.2.3). All of the Sox2 deletions retained the entire HMG 
DNA-binding domain where the NLS resident and localized in the nucleus 
(Figure 4.2.4).   
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Figure 4.2.3 Expression of Sox2 C-terminal deletions 
The GFP-tagged Sox2 C-terminal deletions were expressed in COS7 cells and detected by 
anti-GFP antibodies on a western blot membrane. 
 
 
Figure 4.2.4 The subcellular localization of Sox2 C-terminal deletions 
Sox2 C-terminal deletions were expressed in COS7 cells and the subcellular localization 
was observed after DAPI staining. The left panel of each set was GFP tagged Sox2 C-
terminal deletions which show up green in colour. The right panel contains DAPI stained 
nucleus which show up blue in colour. 
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4.3 Sox2 deletions functional analyses 
Firstly, analysis of subcellular localization was used to test the Sox2-Groucho 
interaction. COS7 cells were transfected with Myc tagged Groucho3 or 
Groucho5 alone or together with various Sox2 C-terminal deletions and the 
subcellular localization of Myc-Groucho3 or Groucho5 was detected by 
immunostaining with anti-Myc antibody. The Sox2 C-terminal deletions, d4-d6, 
changed the subcellular localization of Groucho3 (Figure 4.3.1) and Groucho5 
(Figure 4.3.2) in a similar way to the wild type Sox2. Furthermore, the Sox2 C-
terminal deletions, d4-d6, had almost the same level of translocation ability 
(50% in Groucho3, 80% in Groucho5). By contrast, the Sox2 C-terminal 
deletions, d1-d3, almost entirely lost the ability to change the subcellular 
localization of both Groucho3 and Groucho5. These data indicate that the 
amino acids between 203-209 might play an important role in the Sox2-
Groucho interaction. 
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Figure 4.3.1 Subcellular localization of Groucho3 with Sox2  C-terminal deletions 
COS7 cells were transfected with Myc-Groucho3 and various Sox2 C-terminal deletions. 
The subcellular localization of Myc-Groucho3 was detected by anti-Myc antibodies. Five 
fields across the coverslips (that of around 100 cells counted) were observed in every set of 
experiments. WT: Wild type Sox2; d1-6: Sox2 C-terminal deletion 1-6. 
 
 
 
Figure 4.3.2 Subcellular localization of Groucho5  with Sox2  C-terminal deletions 
COS7 cells were transfected with Myc-Groucho5 and various Sox2 C-terminal deletions. 
The subcellular localization of Myc-Groucho3 was detected by anti-Myc antibodies. Five 
fields across the coverslips (that of around 100 cells counted) were observed in every set of 
experiments. WT: Wild type Sox2; d1-6: Sox2 C-terminal deletion 1-6. 
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In order to test if the truncation of C-terminal Sox2 changed the 
transcriptional activity of Sox2, the 3xSX luciferase reporter assay was carried 
out (Figure 4.3.3). The transcriptional activity of Sox2 C-terminal deletions 
was generally weaker than that of wild type Sox2. However, the deletion d5 
and d6 had slightly stronger transcriptional activity than the deletion d1-d4. 
Consistent with published data, these results imply that amino acids in the C-
terminal region from 203-209 are important for transcriptional activation 
activity. This result indicates that the longer the truncation is the more serious 
the effect on the transcriptional activity function of Sox2.  
 
Figure 4.3.3 Groucho5 affects Sox2 C-terminal deletion d4-6 transcriptional activity 
Sox2 C-terminal deletions have lower transcriptional activity than wild type Sox2 on 3xSX 
luciferase reporter. The transcriptional activity of activation Sox2 C-terminal deletion d4-
d6 was repressed when co-expressed with Groucho5. Nevertheless, the representation of 
Groucho did not affect the transcriptional activity of Sox2 C-terminal deletion d1-d3. 
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If some of the C-terminal deletions remove the domain of Sox2 responsible 
for Groucho interaction this would predict that Groucho might no longer have 
any effect on Sox2 transcriptional activation activity. To analyse the function 
of Groucho5 on the Sox2 C-terminal deletions, Groucho5 was introduced into 
the luciferase assay system. As for wild type Sox2, the transcriptional activity 
of Sox2 C-terminal deletions d4-d6 was suppressed by Groucho5 to about 50% 
of its original value. By contrast, Groucho5 failed to affect the transcriptional 
activity of Sox2 C-terminal deletion d1-d3. However, the Sox2 deletion d1-d4 
had lost much of their transcriptional activation activity which did not leave 
much opportunity for Groucho5 to exert suppressive function. But even so, 
Groucho5 still suppressed Sox2 deletion d4 transcriptional activation activity 
by 40%. The different response to Groucho5 is consistent with the mapping of 
the Groucho interaction domain to amino acids 203-209.  
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4.4 Targetted mutation of the Groucho-interaction 
domain of Sox2 
Although the C-terminal deletions of Sox2 caused a loss of interaction with 
Groucho these truncations deleted almost one-third of the full length of Sox2. 
These deletions might therefore cause large conformation change and lead to 
functional difference. In order to minimize the difference between wild type 
and mutant and to define the function of the Groucho interaction region, point 
mutation was carried out to generate the loss-of-interaction mutants of Sox2. 
As mentioned in the previous section, the Sox2 C-terminal deletion d4 acted 
similarly to the wild type Sox2 in terms of Groucho5 interaction while the 
Sox2 C-terminal deletion d3 which has only 6 amino acids fewer than d4 acted 
differently to the wild type. Examination of this 6 amino acids sequence 
showed, there is a conserved motif, LQY, within the whole SoxB1 family 
(Figure 4.4.1).  
 
Figure 4.4.1 Schematic representation of LQY motif 
The partial peptide sequence of the SoxB1 family is shown in the diagram. The conserved 
LQY motif is boxed. The C-terminal ends of various Sox2 C-terminal deletions d3-d5 are 
illustrated in the lower panel.  
 
This implies the importance of the LQY motif in the SoxB1 family. On the 
other hand, Groucho interaction normally involves an hydrophobic aromatic 
amino acid (W, F, Y) and aliphatic amino acid (I, L, V) which are also present 
in the LQY motif. Therefore, site directed mutagenesis was carried out to 
replace the LQY motif with three neutral amino acids AAA (referred to as 
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Sox2LQY/AAA). pcDNA3 Sox2 was used as template in the site directed 
mutagenesis and 5% DMSO was added to overcome the high GC content in 
Sox2. The resulting mutant was validated by sequencing.   
In order to test the expression of Sox2LQY/AAA, pcDNA3 Sox2LQY/AAA was 
transfected into COS7 cells followed by immunostaining using Sox2 antibody. 
The subcellular localization of Sox2LQY/AAA in COS7 cells was mainly in the 
nucleus similar to the wild type Sox2 (Figure 4.4.2). 
 
 
Figure 4.4.2 Sox2LQY/AAA subcellular localization 
Sox2LQY/AAA was overexpressed in the COS7 cells. After 24 hours, the subcellular 
localization of Sox2LQY/AAA was detected using anti-Sox2 antibodies (left panel). The 
nucleus was stained using a DAPI mounting medium (middle panel). The right panel shows 
the merged image of green and blue. 
 
 In order to test if this mutation affected the ability of Sox2 to affect 
Groucho5 subcellular localization, Myc-Groucho5 was transfected in COS7 
cells with either wild type Sox2 or Sox2LQY/AAA and immunostaining was 
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carried out using anti-Myc antibody. The results showed that Sox2LQY/AAA had 
a significantly reduced ability to change Groucho5 subcellular localization 
when compared to wild type Sox2 (p<0.001; Figure 4.4.3 A). Quantification 
demonstrated that Sox2LQY/AAA exhibited a 50% decrease in ability to alter the 
subcellular localization of Groucho5 with Sox2 wild type (Figure 4.4.3 B).  
 
 
 
Figure 4.4.3 Sox2LQY/AAA mutant shows a reduced ability to translocate Groucho5 
COS7 cells were transfected with Myc-Groucho5, Sox2 or Sox2LQY/AAA by electroporation 
and seeded on poly-D-lysine coated coverslips. After 24 hours, the cells were 
immunostained using anti-Myc antibodies. (A) Groucho5 was translocated into the nucleus 
by wild type Sox2 but not Sox2LQY/AAA. (B) Quantification of Groucho5 nuclear 
localization. Five fields across the coverslips (that of around 100 cells counted) were 
observed in each experiment. (***: p< 0.001) 
 
To further investigate if Sox2LQY/AAA could interact with Groucho5, Co-IP 
was carried out (Figure 4.4.4). Wild type Sox2 or Sox2LQY/AAA were introduced 
into COS7 cells either alone or with Myc-Groucho5. After Co-IP with Myc-
B. 
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beads samples were analysed by western blot. The results showed that 
Sox2LQY/AAA failed to be pulled-down by Myc-Groucho5 whereas wild type 
Sox2 was co-precipitated. These data indicate that the Sox2LQY/AAA mutant has 
lost the ability to interact with Groucho5.  
 
Figure 4.4.4 Sox2LQY/AAA lacks the ability to interact with Groucho5 
COS7 cells were transfected with Myc-Groucho5, Sox2 or Sox2LQY/AAA by electroporation. 
Co-IP was carried out after 48 hours of culture using Myc-beads. The left panel shows the 
expression of exogenous proteins as 5% input. The right panel shows the proteins 
precipitated by MYC beads.  Anti-MYC antibody detected the MYC-Groucho5 in the 5% 
input (lane 3, 4 upper panel) and the MYC beads precipitated samples (lane 7, 8 upper 
panel). Anti-Sox2 antibodies detected Sox2 expression in the 5% input (lane 1-4 lower 
panel). The wild type Sox2 was detected in the MYC-bead precipitated samples (lane 7 
lower panel) but not the Sox2LQY/AAA mutant (lane 8 lower panel).  
 
To test if the loss of Grouch5 interaction affects the transcriptional activity of 
Sox2, luciferase assays were carried out. Both Sox2 and Sox2LQY/AAA acted as 
transcriptional activators of the 3xSX luciferase reporter. In fact Sox2LQY/AAA 
acted similar with wild type Sox2 and activated the reporter expression more 
than 2 times (Figure 4.4.5 A; p=0.2071). As for the Rex luciferase reporter, 
Sox2LQY/AAA also activated Rex luciferase reporter to the level similar to wild 
type Sox2 (Figure 4.4.5 B; p=0.8821). These data indicate that Sox2LQY/AAA 
had no difference to wild type Sox2 in transcriptional activation function.  
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Figure 4.4.5 Sox2LQY/AAA retained transcriptional activation activity 
P19 cells were transfected with 3xSX (A) or Rex (B) luciferase reporter. The transcriptional 
activity of Sox2 and Sox2LQY/AAA was tested by co-transfecting with the reporters. Both 
Sox2 and Sox2LQY/AAA activated reporters to a similar expression level. 
 
As for the transcriptional repression function, Sox2LQY/AAA was tested in the 
GFAP luciferase reporter system. Interestingly, Sox2LQY/AAA failed to repress 
the GFAP luciferase reporter whereas the wild type Sox2 repressed the reporter 
to the level of 50%. On the other hand, Grouchos only further suppressed 
GFAP luciferase reporter with wild type Sox2 (p=0.0016) but not with 
Sox2LQY/AAA (p=0.0514) (Figure 4.4.6). These results imply that the 
A. 
B. 
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Sox2LQY/AAA mutant only loses its transcriptional repressor function but retains 
the activator function of Sox2. Therefore, the Sox2LQY/AAA mutant could be 
used as a loss-of-repressor-function form of Sox2 in further investigations.  
 
 
Figure 4.4.6 Sox2LQY/AAA lacks the ability to repress expression of a GFAP luciferase 
reporter 
P19 cells were transfected with a GFAP luciferase reporter with various combinations of 
Sox2 and Groucho. The expression of the GFAP reporter was repressed by Sox2 co-
expression and the Groucho co-expression suppressed the GFAP reporter even further. 
However, the Sox2LQY/AAA mutant alone or Sox2LQY/AAA mutant with Groucho did not affect 
the GFAP reporter expression.  
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4.5 Discussion 
In this chapter, the Groucho-Sox2 interaction motif has been identified. The 
ability of Sox2 to repress expression of a GFAP luciferase reporter could be 
eliminated by mutating only the Groucho-Sox2 interaction motif, LQY, while 
the transcriptional activator function was retained (Figure 4.4.5; Figure 4.4.6). 
These results indicate that Sox2 acts as a bi-functional transcription factor 
through different motifs.  
Previous studies on cSox3 in our lab (PhD thesis, Zulfiqar Laghari, 2010) 
have shown that there are two important domains involved in Sox3-Groucho 
interaction (domain1 and domain2 in Figure 4.5.1). A C-terminal deletion of 
chick Sox3 which lost domain1 was shown to lose the ability to translocate 
Groucho5. However, the internal deletion of domain1 and the point mutation of 
LQY in domain1 still retained the Groucho5 translocation ability. This 
suggests that another Groucho interaction domain exists in the internal deletion 
and point mutation. When delete both domain1 and domain2, the mutant chick 
Sox3 totally lost the ability to translocate Groucho5. This implies that not only 
LQY domain but the two domains (domain1 and domain2) are required for 
Sox3-Groucho5 interaction in chicken.  
Although the domain2 in chick Sox3 is needed for Groucho interaction, the 
interaction assay in Sox2 deletions shows that is not necessary in mouse Sox2 
(Figure 4.3.1; Figure 4.3.2). In mouse Sox2, the domain2 is interrupted by gaps 
and has less similarity than the one near the N-terminus (Table 4.5.1). 
Therefore, the interaction ability of the domain2 in mouse Sox2 might be 
weakened.  
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Figure 4.5.1 Schematic representation of Sox-Groucho interaction domain 
The sequence of the two Sox-Groucho interaction domains in chick Sox3 are shown in grey. 
The homolog in mouse Sox3 and Sox2 are listed below cSox3 as mSox3 and mSox2. The 
various amino acids are marked in bold. The relative position of the domains in mouse 
Sox2 are illustrated. 
 
 
Table 4.5.1 Alignment of Sox-Groucho interaction domain in chick Sox3 and mouse Sox2 
Asterisks mark the amino acid identity between in cSox3 and mSox2. Dashed lines shows 
gaps. The identity and gap frequency were calculated by SIM – Alignment Tool for protein 
sequences, ExPASy (http://www.expasy.ch/tools/sim-prot.html). 
 
To date, two Groucho interaction motifs have been defined, the WRPW/Y 
motif and the engrailed homology (FxIxxIL) interaction motif (Fisher et al., 
1996; Goldstein et al., 2005; Kang et al., 2005). However, these two motifs 
interact mainly with the C-terminal WD domain of Groucho. Transcription 
factors that interact with the N-terminal Q domain of Groucho such as Six3 and 
TCF, were reported to function through an engrailed-like motif (Brantjes et al., 
2001; Zhu et al., 2002). Runx2 (Wang et al., 2004) and Nolz1 (Ji et al., 2009) 
also interact with the N-terminus of Groucho5 but via a long, poorly defined 
region of C-terminal amino acids. Sequence comparison of the engrailed-like 
motif of Goosecoid, Pax5, Six3 and TCF1 revealed loose similarity of the first 
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hydrophobic aromatic amino acid (W, F, Y) and sixth aliphatic amino acid (I, L, 
V) (Table 4.5.2). The Sox2-Groucho interaction domain identified in this 
chapter also has loose similarity with the engrailed-like motif. Therefore, when 
the conserved LQY motif was mutated, a possible engrailed-like motif was also 
disrupted.  
 
Table 4.5.2 Sequence comparison of the engrailed-like motif 
The engrailed-like motif sequences are aligned in the list. An asterisk indicates the 
conserved hydrophobic aromatic amino acids (W, F, Y) and the cross indicates the 
conserved aliphatic amino acid. The species of genes are marked in front of the gene name 
(d: Drosophila; m: mouse; h: human) and the numbering of the amino acids are listed. 
 
The C-terminal deletions of Sox2 might have dramatic structural changes 
which affect the interaction with Groucho. Therefore, the LQY mutant was 
made to minimize the change of the Sox2 protein structure. Using the I-
TASSER service (http://zhanglab.ccmb.med.umich.edu/I-TASSER/), the 
structure and the predicted protein interaction residues of wild type and LQY 
mutated Sox2 were modelled (Figure 4.5.2). Although the LQY motif did not 
appear to be associated with the protein interaction residues, the YVV within 
the predicted engrailed-like motif did (Figure 4.5.2 A). The change of LQY 
into AAA inverts the surface position of the predicted engrailed-like motif 
(Figure 4.5.2 A; Figure 4.5.2 B). This might interrupt the function on 
engrailed-like motif function and weaken the interaction of Sox2 and Groucho. 
Further mutational analysis of this region is therefore merited. 
119 
 
 
 
 
Figure 4.5.2 Sox2 protein interaction domain prediction 
The amino acid sequence of wild type and LQY mutated Sox2 were sent to the I-TASSER 
website to analyse the possible structure. The sequence in (A) represents the predicted 
protein interaction residues of wild type Sox2 (marked red and bold). The 3D structure is 
shown in (B) The helix is marked in pink, protein interaction residues in yellow and the 
white arrows point LQY/AAA domain in blue. The protein interaction residues are listed 
below.  
 
The results of this chapter indicate that there is an engrailed-like motif from 
199-209 in mouse Sox2. Changing three amino acids (LQY) within the 
engrailed-like motif resulted a loss-of-function mutant of Sox2 (Sox2LQY/AAA) 
in Groucho interaction and transcriptional repressor function by altering the 
engrailed-like motif surface position.  
A. 
B. 
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Chapter 5 Sox2 repressor function in human 
neural stem cells 
5.1 Introduction 
For over a decade, Sox2 has been regarded as a transcriptional activator that is 
widely expressed in the nervous system during development (Kamachi et al., 
1995; Kamachi et al., 1998). In 2006, Takahashi and Yamanaka implicated 
Sox2 in their discovery of induced pluripotency. They successfully 
reprogrammed somatic cells to pluripotent cells by overexpressing only four 
key transcription factors Oct4, Klf4, c-myc and Sox2 in mouse embryonic 
fibroblasts (MEF) and named the ES-like cells “induced pluripotent stem (iPS) 
cells” (Takahashi and Yamanaka, 2006). Since then, many studies have 
focused on dissecting the core transcriptional network in embryonic stem cells. 
Genome wide searches for the DNA binding sites and genes regulated by Sox2, 
one of the “Yamanaka factors”, have been described in recent studies. Boyer 
(2005) and Sharov (2008) identified the DNA binding sites of Oct4, Sox2 and 
Nanog using ChIP-chip (Chromatin immunoprecipitation on chip) in human 
and mouse embryonic stem cells respectively (Boyer et al., 2005; Sharov et al., 
2008). Furthermore, Kim (2008) and Zhou (2007) used the next-generation 
sequencing technique, ChIP-PET (the combination of ChIP and paired-end tags) 
to analyse the DNA binding sites of Sox2 in human and mouse embryonic stem 
cells (Kim et al., 2008a; Zhao et al., 2007). ChIP-seq (ChIP-sequencing) was 
carried out to map the locations of Sox2 binding sites in mouse embryonic 
stem cells by Chen and colleagues (Zhou et al., 2007) and gene expression 
profiles were investigated in human embryonic stem cells in which Sox2 
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knock-down and embryonic carcinoma cells and Sox2 null mouse embryonic 
stem cells (Greber et al., 2007; Masui et al., 2007).  
Together these studies show that the expression of a number of genes 
decreased in Sox2 knock–down cells. Among these genes were several 
encoding transcription factors (e.g., Oct, Nanog, STAT3) and components of 
the Tgf-β and Wnt signalling pathway (eg., Lefty2, Dkk1). This implicates 
Sox2 as a transcriptional activator, consistent with previous studies of Sox2 
transcription factor function (Miyagi et al., 2009). On the other hand, 
expression of almost the same number of genes increased in Sox2 knock-down 
cells (623 up-regulated; 648 down-regulated; (Masui et al., 2007)) which 
means that Sox2 normally represses the expression of these genes, either 
directly or indirectly. Intriguingly, when compared with the Sox2 ChIP assay 
results, a number of these Sox2 down-regulated genes also been bound by 
Sox2 in their promoter regions. This suggests that a number of genes are 
directly repressed by Sox2 in the human or mouse embryonic stem cells.  
Through a meta analysis of the results of these studies I identified several 
genes that were up-regulated in Sox2 knock-down cells and could also bind 
Sox2 potential binding sites (Table 5.1.1). some of these related to embryonic 
development, such as left-right axis formation (Bmp4 (Monsoro-Burq* and 
Douarin, 2000), Nodal (Lowe et al., 1996) and Zic3 (Gebbia et al., 1997)), eye 
development (Pax6 (Hever et al., 2006)) and brain formation (Hesx1 (Dattani 
et al., 1998), Id2 (Toma et al., 2000), Nfib (Deneen et al., 2006) and Nedd9 
(Aquino et al., 2009)).  
In order to test the role of Sox2 transcriptional repressor function in human 
neural stem cells (hNSC), wild type Sox2 and the Groucho-binding mutant 
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form (Sox2LQY/AAA) were introduced into the human NSC line, RNA was then 
isolated for Affymetrix expression array. The results of three expression arrays 
are presented and discussed in this chapter.  
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Table 5.1.1 Summary of possible Sox2 down-regulated target genes. 
Possible Sox2 down-regulated genes are listed on the left. Expression array data originate from 
Sharov and Masui (Masui et al., 2007; Sharov et al., 2008). The ChIP assay data originate from 
Sharov, Chen, Kim and Boyer (Boyer et al., 2005; Chen et al., 2008; Kim et al., 2009b; Sharov 
et al., 2008). The ticks represent the up-regulation of genes in expression array or signals in 
ChIP assay. 
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5.2 Preparation of samples for expression array 
In order to understand the transcriptional repression role of Sox2 in hNSCs, 
Sox2 and Sox2 LQY/AAA expression plasmid were introduced into hNSCs. In 
theory, the faster a gene’s response to a transcription factor, the more likely the 
effect of the transcription factor function is direct. Hence, in order to obtain 
data that reflect possible Sox2 directly regulated genes, it was considered better 
to collect cells at the earliest time point of Sox2 expression.  
To monitor the expression level of an exogenous gene in hNSCs, a GFP 
expression vector was co-transfected into hNSC with Sox2 and the cells 
expressing GFP were observed (Figure 5.2.1). The results show that exogenous 
gene expression increased dramatically 14 hours after transfection (Figure 
5.2.2). Therefore, this time point was used to collect hNSC for the expression 
array analysis. Since the transfection efficiency of hNSCs was always below 
100%, non-transfected cells still exist within the transfected cell population. 
The observation under the fluorescent microscope showed approximately 40% 
of the cell population were non-transfected, therefore the noise from the non-
transfected cells would have a significant potential affect on the expression 
array data. In order to avoid the noise from these non-transfected cells, 
Fluorescence Activated Cell Sorting (FACS) was carried out on the cells 14 
hours after transfection.  
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Figure 5.2.1 Timecourse of GFP expression in transfected hNSCs 
hNSCs were transfected with GFP/Sox2 and the green and non-green fluorescent cells were 
observed at different time points (8-24 hours) and the cells counted.  
 
Figure 5.2.2 Flow chart of Affymetrix experiment 
hNSCs were collected 14 hours after transfection with either GFP alone, GFP with wild type 
Sox2 or GFP with Sox2 LQY/AAA. Fluoresence Activated Cell Sorting (FACS) was carried out to 
sort out the untransfected (GFP negative) cells. The GFP positive cells were collected and the 
total RNA extracted immediately. Total RNA was purified and applied to the Affymetrix 
expression array system. 
 
During the electroporation procedure, it is very likely that cells take up GFP 
and Sox2 plasmid DNA simultaneously. Previous data in our lab suggested 
more than 90% co-transfection. Therefore, the cells expressing GFP are very 
likely to also express exogenous Sox2. According to this hypothesis, the Sox2 
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expressing cells could be sorted through the expression of GFP. FACS allowed 
the separation of the healthy and GFP positive cells from a group of cells 
(Figure 5.2.3). 
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Figure 5.2.3 FASC sorting charts 
FACS detected the volume of cells by light scatter intensity (Figure 5.2.4 A). The healthy cells in region A were selected and the green strength of cells was detected (B). The 
fluorescence intensity of GFP expressing cells was measured and the cells which had higher fluorescence intensity (higher than 10 units) was shown in panel C. Cells which 
expressed fluorescence higher than 10 units were selected (region C in panel C) as the green positive cells whereas the low green level cells were selected as green negative 
(region F in panel C). Panel E-G show the distribution of fluorescence in GFP, GFP/Sox2 or GFP/Sox2LQY/AAA transfected cells. The cells in R1 region were collected. Panel 
H shows the relative graph of fluorescence intensity with cell numbers. The region R1 in panel E-G is marked as M1 in panel H. 
A. B. 
C. D. 
E. F. 
G. H. 
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The FACS technique detected the volume of cells by light scatter intensity 
(Figure 5.2.3 A). The parameters of every cell were shown as a dot on the 
SS/FS cytogram. More than 90% of cells were healthy in the transfected 
hNSCs population (Figure 5.2.3 D). The healthy cells in region A were 
selected and the green fluorescence level of cells were detected (Figure 5.2.3 B, 
C). Cells expressing more than 10 units of fluorescence were selected (region 
C in Figure 5.2.3 C, approximate 27% of region A selected cells) Figure 5.2.3 
E-G shows the distribution of fluorescence in GFP, GFP/Sox2 or 
GFP/Sox2LQY/AAA transfected cells. The cells in R1 region were collected and 
the relative graph of fluorescence intensity with cell numbers is showed in 
Figure 5.2.3 H.  
In order to avoid the degradation of RNA, cells were lysed immediately in TRI 
reagent. The total RNA of GFP positive cells was purified using RNeasy® 
Mini column (Qiagen). The quality of the total RNA was checked using a 2100 
BioAnalizer (Agilent) (Figure 5.2.4). The RNA integrity number of all three 
sets of total RNA (GFP, GFP/Sox2 and GFP/ Sox2 LQY/AAA) was 10 which 
indicated the quality of the total RNA was good enough. 
The Affymetrix GeneChip® Human Genome U133 plus2 array was chosen to 
detect the expression profile in this chapter. There are up to 1.3 million 
different oligonucleotide probes attached on the chip which offers a rapid and 
thorough assay of human gene expression. Figure 5.2.2 illustrates the 
experimental strategy to determine the effect of Sox2 overexpression in hNSC 
using Affymetrix expression arrays. Further analysis of the expression array 
data will be discussed in the next section. 
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Figure 5.2.4 RNA quality checking 
The total RNA of GFP, GFP/Sox2 and GFP/ Sox2 LQY/AAA transfeced hNSCs were analysed by 
2100 Bio Analizer (Aglient). Simulated electrophoresis images are presented on the right.The 
ladder graph shows the marker peaks as control. The 18s and 28s peaks are shown in graphs 
from GFP, Sox2 and Sox2 LQY/AAA transfected cells.  
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5.3 Affymetrix array result 
The quality control reports of Affymetrix arrays are listed in Table 5.3.1. The 
background signal shows the autofluorescence of the array surface and non-
specific binding of target molecules. The ideal value of background signal is 
less than 100. The background signals of three arrays were approximate 50. 
The ideal value of the number of present cells is 40-50%. The number of 
present cells in three arrays was higher than 45%. The scale factor is the 
number that was used to normalize the signal. The ideal value of scale factor is 
around 3. The scale factors of three arrays fit this condition. The sig (3’/5’) of 
β-Actin and GAPDH indicate the ratio of the labelling reaction and the value 
should be less than 3. The value of sig (3’/5’) of β-Actin and GAPDH in all 
three arrays agreed with the standard. Together, the quality control reports 
showed all three arrays are successful and reliable. 
 
Table 5.3.1 Quality control report of three arrays 
The quality control results of three arrays are listed in the table. The background signal should 
be less than 50, number present should be 40-50%, scale factor should be around 3, sig(3’/5’) 
of β-Actin and Gapdh should be less than 3. 
 
 Raw data from the Affymetrix arrays was normalized using the Affymetrix 
Microarray Suite software according to the reading of control probe sets. The 
Affymetrix array gave raw data of 54675 probe sets. Expression levels could 
be presented in different colours as a heat map. Figure 5.3.1 shows part of the 
heat maps for the arrays performed. The expression level of 372 genes was 
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increased following overexpression of wild type Sox2 or Sox2LQY/AAA 
including Hes5 (GFP: 139.672; GFP/Sox2: 1239.22; GFP/Sox2LQY/AAA: 538.51) 
which has been shown to be up-regulated following Sox2 or Sox2LQY/AAA 
overexpression in mouse neural stem cells (Bani-Yaghoub et al., 2006). The 
expression level of 486 genes was decreased follow overexpression of wild 
type Sox2 when compare to the overexpression of GFP alone. This implies that 
Sox2 might repress the expression of these genes. Interestingly, some of the 
putative Sox2 repressed genes showed a higher expression level following 
overexpression of Sox2LQY/AAA when compared with overexpression of wild 
type Sox2. These genes included NNMT, PLAUR, LAMP and RAC3 (Table 
5.3.2). Since Sox2LQY/AAA lacks the ability to interact with Groucho, the 
decrease of Sox2 suppression might relate to the co-repressor function of 
Groucho.   
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Figure 5.3.1 Partial of heat map of Affymetrix array result 
The heat map represents the expression level of genes in hNSCs overexpression GFP, 
GFP/Sox2 or GFP/Sox2LQY/AAA. Gene names are listed on the right. Red to blue colour 
represents the high to low expression level (colour scale shows on the bottom right). This 
part of the heat map, has been selected because it features genes that repressed by 
overexpression wild-type Sox2 but less so by the overexpression of Sox2LQY/AAA. 
 
 
Table 5.3.2 Gene expression raw data 
Raw data from all the probes of Sox2 and possible Sox2 repressed genes in each set of 
experiment are listed and underlined. The position of genes on the chromosome shows on the 
right column. 
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5.3.1 Signal for Sox2 probes on mRNAs 
There were several probe sets for Sox2 on the U133 arrays. The raw data for 
the Sox2 probes on the arrays showed a wide variation in levels of increase of 
Sox2 expression in each array (Table 5.3.2 underlined). The possible reason of 
this inconsistent result might be the 3’-end bias appears quite obvious from the 
poly-dT primers reverse transcription reaction. The closer the probe to the 3’-
end the stronger the signal will be. Figure 5.3.2 shows the relative position the 
Sox2 probes on the transcript. Since the wild-type Sox2 and Sox2LQL/AAA that 
were overexpressed were mouse genes, the probes that to detected the Sox2 
coding region would match both human and mouse sequence, whereas the 
probes located in the for 5’ and 3’ UTR would only able to detect human Sox2. 
Together with the raw data of each set of probes, the 3’-end bias appears quite 
obvious. On the other hand, according to the raw data, the increase in Sox2 
expression level could not clearly be determined. Therefore, further analysis of 
Sox2 expression of the same RNA sample was needed, in order to validate the 
experimental strategy. 
 
Figure 5.3.2 Sox2 probe position 
Illustrated relative position of Sox2 probes on the Sox2 transcript. The raw data in each 
experiment is shown beneath the probe ID. The sequence of the probes in Sox2 coding region 
is matched with both mouse and human Sox2 gene, whereas the sequence of the probes in 5’ 
and 3’ UTR is matched only with human Sox2.  
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5.4 QRT-PCR analysis of Sox2 overexpression 
In order to check the exact expression level of Sox2, QRT-PCR was carried out 
(Figure 5.4.1).  
 
Figure 5.4.1 Illustration of sample preparation for SYBR QRT-PCR 
hNSCs were transfected with GFP, GFP/Sox2 or GFP/Sox2LQY/AAA. After 14 hours culture, the 
GFP expressed cells were collected by FACS sorting and the total RNA were extracted. 
DNaseI was used to digest the remaining genomic DNA. The total RNA were used to generate 
cDNA by reverse transcriptase. The cDNA samples were used as template and applied to 
SYBR QRT-PCR. 
 
The same total RNA samples that were sent for Affymetrix expression array 
analysis were used to measure the Sox2 RNA level by QRT-PCR. The total 
RNA samples were used to generate cDNA by reverse transcription reaction 
(RT) with the mixture of random primer and poly-dT primer to avoid the 3’-
end bias. The cDNA samples were then applied to SYBR Green QRT-PCR. 
Contamination with genomic DNA in the cDNA sample would affect the QRT-
PCR result. Therefore, a control sample with no reverse transcriptase (non-RT) 
was included (Figure 5.4.2 A). If the RNA sample contained no genomic DNA, 
then the non-RT sample would not produce a signal in QRT-PCR. In order to 
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test if there were any primer dimer signals in the QRT-PCR, a no template 
control (NTC) was also subjected to QRT-PCR reaction. Each experiment was 
performed in triplicate. 
In order to test if the overexpression of wild type mouse Sox2 or Sox2LQY/AAA 
was succesful, primers for the 5’-end, coding region and 3’-end of Sox2 were 
designed. Since the expression plasmid only contained the mouse Sox2 coding 
region sequence, primers for the non-coding regions were designed to target 
only human sequence whereas the primers for the coding region were designed 
to target both human and mouse Sox2 (Figure 5.4.2 B). 
 
 
Figure 5.4.2 QRT-PCR experiment design 
(A) The purified total RNA from GFP, GFP/Sox2 and GFP/Sox2LQY/AAA transfected hNSCs 
were used to generate cDNA by reverse transcriptase. Every set of reverse transcription has a 
no-RT (no reverse transcriptase) control in order to detect the genomic DNA contamination. 
The cDNA was used as template in QRT-PCR reaction. Every set of primer has a NTC (no 
template control) to test primer dimer existence. QRT-PCR using control gene primer 
(housekeeping gene, such as Actin) was carried out in order to normalize the expression level 
of test gene. (B) Sox2 5’-end, cording region and 3’-end QRT-PCR primers were designed as 
close to the Affymetrix probe as possible. The relative position of QPR-PCR primers are 
marked as arrows and the Affymetrix probes are marked as black band. Sox2 coding region 
primers were designed to match both human and mouse Sox2 and surround the Affymetrix 
probe set. The alignment of human and mouse sequence is showed beneath.  
 
A. 
B.
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QRT-PCR monitors the PCR product in real time, reflected in the SYBR green 
signal on the plot (Figure 5.4.3 A). After 40 cycles of PCR reaction, the 
product was taken through a temperature gradient (50°C to 90°C) to denature 
the DNA product. This would show peaks at different time point on the melting 
curve plot when primer dimers exist in the PCR product. The melting curve of 
Sox2 coding region QRT-PCR reaction showed a single peak in every sample 
(Figure 5.4.3 B). This means the result of Sox2 coding region QRT-PCR is 
reliable. According to the QRT-PCR signal curve, the PCR products of 
GFP/Sox2 and GFP/Sox2LQY/AAA transfected hNSCs appeared earlier and 
higher than the GFP transfected hNSCs. This indicates that Sox2 expression 
levels in GFP/Sox2 and GFP/Sox2LQY/AAA transfected hNSCs were much 
higher than the GFP transfected set (Figure 5.4.3 A). As for the human Sox2 
3’-end and 5’-end primers, the signal curves were similar in GFP, GFP/Sox2 
and GFP/Sox2LQY/AAA transfected hNSCs (Figure 5.4.3 C, E). This result means 
the expression of endogenous human Sox2 transcripts in each set was similar. 
However, the melting curve of human Sox2 5’-end primers shows two peaks 
(Figure 5.4.3 F). This might imply that the primers are not specific. On the 
other hand, the melting curve of human Sox2 3’-end primers shows only one 
peak (figure 5.4.3 D) which means these primers are very specific and reliable. 
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Figure 5.4.3 QRT-PCR checking Sox2 expression 
The signal curves of QRT-PCR using Sox2 3’-end, coding region and 5’-end primers and no 
template control (NTC) in GFP, GFP/Sox2, GFP/Sox2LQY/AAA transfected hNSCs total RNA 
are shown in (A)(C)(E). The cycle threshold (Ct) value was determined according to the 
cutting through (lable as threshold on the plot) which was calculated by software from the 
QRT-PCR of the same primers on serial dilutions of template. The melting curves from 50°C 
to 90°C of each set of QRT-PCR reaction are shown in (B)(D)(F). The colour code of the plots 
is showed underneath. 
 
The relative expression level of Sox2 was calculated according to the Pfaffl 
equation (2001) (Figure 5.4.4). The QRT-PCR result shows that the Sox2 
expression level in GFP/Sox2 and GFP/Sox2LQY/AAA transfected hNSCs was 
more than 5 times higher than the GFP transfected hNSCs whereas the human 
Sox2 expression level are similar in all three sets. This result indicates that the 
overexpression of Sox2 was successful and the Affymetrix expression array 
data truly reflected the changes due to increasing levels of Sox2 in hNSCs. 
With respect to the array data for Sox2 expression shown in Table 5.3.2, these 
data also fit, since the probe for the 5’ UTR and 3’ UTR showed similar signal 
A. 
B. 
C. 
D. 
E. 
F. 
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in the presence or absence of overexpressed Sox2. In fact, the only anomaly is 
that one of the coding sequence probes failed to show a response in the 
Sox2LQY/AAA transfected cells. Therefore, we assume that this is a technical 
error. It is interesting to note, however, that the level of increase of Sox2 on the 
array for the coding sequence probes bears little resemblance to the QRT-PCR 
data. We can only calculate that this in a technical problem specific to Sox2 
analysis since validation of QRT-PCR shown later was consistent with array 
data for other gain. 
 
Figure 5.4.4 Quantification of QRT-PCR checking Sox2 expression 
The relative expression level was calculated according to the equation in Pfaffl (2001). The 
result of QRT-PCR using Actin primers was used to normalize the result of Sox2 5’-end, 
coding region and 3’-end primers. The expression level of Sox2 in GFP/Sox2 and 
GFP/Sox2LQY/AAA were compared with GFP which was represented as one.   
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5.5 Affymetrix data analysis 
Having established that the overexpression of wild type Sox2 and Sox2LQY/AAA 
was successful, the data from the Affymetrix expression arrays was analysed to 
determine the roles of Sox2 and Sox2 repressor function in hNSCs. The 
Affymetrix expression arrays give data from up to 54,676 probe sets. However, 
many probes gave very low signals which could not be distinguished from 
background noises. In accordance in Aris et al (2004), signals lower than 100 
were be excluded in order to eliminate false results arising from such noise. 
Here, I compare the data from cells overexpressing GFP, GFP+Sox2 or 
GFP+Sox2LQY/AAA as summarized below. Figure 5.5.1 shows the number of 
genes for which the expression level changed in cells overexpressing Sox2 or 
Sox2LQY/AAA.  
When the raw number of given genes from cells overexpressing GFP+Sox2 
was divided by the value for the same genes from cells overexpressing GFP 
greater than 1.5, the gene was defined as up-regulated in GFP+Sox2 
overexpressing cells (676 genes in total, approximately 6%). On the other hand, 
if the raw number of GFP divided by the one of GFP+Sox2 was greater than 
1.5, the gene was defined as down-regulated in GFP+Sox2 overexpressing 
cells (786 genes in total, approximately 8%). The change in expression of most 
genes did not exceed 1.5 (8975 genes in total, approximately 86%). A similar 
trend was seen in the GFP+Sox2LQY/AAA set, Sox2LQY/AAA up-regulated 513 
genes (approximately 5%), down-regulated 791 genes (approximately 7%) and 
most of the genes were unaffected (9194 genes in total, approximately 88%). 
This result implies that Sox2 or Sox2LQY/AAA overexpression affects the 
expression of less than 20% of genes in a largely similar manner. According to 
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the expression array data of Sox2 knock-down mice published by Masui et al. 
(2009), 623 genes were up-regulated and 648 genes were down-regulated. The 
similarity of these analyses to my study implies that the overexpression study is 
not causing significant artefactual effects. When the genes up-regulated by 
Sox2LQY/AAA were compared to the genes which had been up-regulated by Sox2, 
most of them were the same (555 genes, approximately 80%). Moreover, in 
Sox2LQY/AAA overexpressing cells the expression of 136 genes (19%) was not 
up-regulated to the level as wild-type Sox2 overexpressing cells. On the other 
hand, only four genes in Sox2LQY/AAA overexpressing cells have expression 
greater than wild-type Sox2 overexpressing cells (1%). Intriguingly, within the 
genes which were down-regulated by overexpressing wild-type Sox2, 53 genes 
(7%) were not down-regulated as much in the Sox2LQY/AAA overexpressing 
cells whereas only 16 genes (2%) were repressed more. This result is consistent 
with the loss-of-repressor function of Sox2LQY/AAA which was demonstrated in 
the previous chapters. 
  
142 
 
 
Table 5.5.1 Gene expression analysis 
The raw number of GFP/Sox2 was divided by GFP for analysis the up-regulated genes. Raw 
number of GFP divided by GFP/Sox2 was used as down-regulated ratio. The definition of 
greater is the ratio larger than 1.5 and the rest of genes are defined as non-affected. The same 
method was applied to compare the expression of genes in GFP/Sox2LQY/AAA with GFP; Sox2 
up-regulated genes with GFP/Sox2LQY/AAA; Sox2 down-regulated genes with GFP/Sox2LQY/AAA.  
 
5.5.1 Sox2 repressed genes 
Among genes repressed by Sox2 in hNSCs, the suppression of some was not as 
great in cells overexpressing Sox2LQY/AAA (Table 5.5.2; Figure 5.5.1). GFAP 
has been reported as a target of Sox2 repression (Cavallaro et al., 2008). In my 
data, GFAP was repressed by wild type Sox2. However, the expression level of 
GFAP in cells overexpressing Sox2LQY/AAA was not reduced as much as it was 
in cells overexpressing Sox2 (Figure 5.5.1). This implies that the Sox2LQY/AAA 
mutant might lost the repression function on GFAP. Since my previous data 
showed that the Sox2LQY/AAA mutant had lost its interaction with Grouchos, the 
mechanism of the decreasing of Sox2 repression in Sox2LQY/AAA overexpressed 
hNSCs might be related to Sox2-Groucho down-regulation machinery. A 
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similar trend could be seen for NNMT, SOX8, SERPINE1, HELLS, IGFBP2 
and IGFBP3, which have also been reported to be Sox2 directly regulated 
genes (Masui et al., 2007; Greber et al., 2007; Chen et al., 2008; Kim et al., 
2008; Boyer et al., 2005). Therefore, further validation of these genes was 
carried out as described in the next section. 
 
 
Table 5.5.2 Raw data of top choices of Sox2/Groucho regulated gene 
The probe set and raw data of genes down-regulated in Sox2 overexpressing cells that were 
less affected in Sox2LQY/AAA overexpressing cells are listed in this table. The agreement of 
Sox2 induced down-regulation and existence of Sox2 binding sites of these genes in previous 
studies are listed.  (Masui et al., 2007; Greber et al., 2007; Chen et al., 2008; Kim et al., 2008; 
Boyer et al., 2005)  
 
 
Figure 5.5.1 Top choices of Sox2/Groucho regulated gene expression. 
The relative expression level of genes was calculated (normalized by the expression raw data 
of GFP). The relative value of genes which have raw data from more than one probe set was 
averaged.  
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5.5.2 GO term analysis of Affymetrix data 
GO terms (gene ontology term) of Sox2 activated and repressed genes were 
analysed using the DAVID Bioinformatics Resources 6.7 website 
(http://david.abcc.ncifcrf.gov/; NIH) (Table 5.5.3). Overexpression of Sox2 
in hNSCs activated 143 genes that related to transcriptional regulation and 37 
genes that related to cell cycle. Surprisingly, not even one gene is related to 
transcriptional regulation amongst the Sox2 repressed genes. This suggests that 
the effects of Sox2 in hNSCs might function through activating downstream 
transcription factors. On the other hand, overexpression of Sox2 repressed 118 
genes that related to cell cycle and 0 genes that related to transcriptional 
regulation. 
 
Table 5.5.3 Top name GO term of Sox2 regulation genes 
The probe set list was analysed by DAVID Bioinformatics Resources 6.7 website 
(http://david.abcc.ncifcrf.gov/; NIH). The top name GO terms of Sox2 activated and 
repressed genes are showed in the list. The GO number, GO term, gene number and the 
percentage are listed in the table. Genes been categorised in different name classes share many 
genes in common. All the genes in transcription, regulation of RNA metabolic process, 
regulation of transcription, DNA-dependent and cell surface receptor linked signal transduction 
are including in regulation of transcription. Also, all the genes in cell cycle process, DNA 
metabolic process, cell cycle phase and M phase are included in cell cycle. 
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When compared with the data from previous studies of Chip-on-chip and 
expression arrays, 37 genes were identified as strong candidates for direct 
repression by Sox2 (Table 5.5.4). These genes were repressed by Sox2 more 
than 1.5 times in hNSCs and the repression was in agreement with data from 
Sox2 knock down mice or human embryonic stem cells. Also, their promoter 
regions had been shown to be bound by Sox2 in previous studies. Among these 
genes, IL11, CXCL14, CCL2 and CAMK1D are related to cytokine signal 
pathways, E2F8, EMP2 and AXL are related to cell cycle regulation and 
BASP1, PITX1, ARHGEF10 and GLIPR1 are related to neuron formation.  
 
Table 5.5.4 Comparison of the Sox2 repressed genes with previous studies 
The expression of genes that been repressed by Sox2 more than 1.5 times were compared with 
published data of expression arrays and ChIP on chip analysis (Masui et al., 2007; Greber et al., 
2007; Chen et al., 2008; Kim et al., 2008; Boyer et al., 2005; Sharov et al., 2008).  
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5.6 QRT-PCR validation of Affymetrix data 
In order to validate the results of the Affymetrix analysis, QRT-PCR was 
carried out to detect the expression level of the possible Sox2/Groucho 
regulated genes. The primers used in QRT-PCR were designed as near to the 
Affymetrix probe as possible to minimize the difference between QRT-PCR 
and Affymetrix expression array data due to their text difference. To avoid 
non-specific recognition and secondary structure of primers, the best primer 
pair for each gene was chosen from the suggestion of the primer-BLAST 
website (http://www.ncbi.nlm.nih.gov/tools/primer-blast/; NCBI).  
In order to confirm the repression of Sox2 on these genes, the same 
transfection and RNA purification procedure was repeated on hNSCs (Figure 
5.4.1). All the QRT-PCR results were normalized by the expression of the 
housekeeping gene, Actin. In Affymetrix expression array data, the expression 
level of these possible Sox2/Groucho regulated genes was decreased following 
overexpression of Sox2 but little or no decrease was seen in Sox2LQY/AAA 
overexpressing hNSCs (Figure 5.5.1). The results of QPT-PCR showed a 
similar trend except in the data of TAGLN which showed similar expression 
level in GFP, GFP/Sox2 and GFP/ Sox2LQY/AAA overexpressing hNSCs (Figure 
5.6.1).  
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Figure 5.6.1 QRT-PCR result of possible target genes 
The relative values of possible Sox2/Groucho regulated genes are represented. Triplicate QRT-
PCR was carried out and the result was normalized by the housekeeping gene actin.  
 
The QRT-PCR result showed the relative expression level of GFAP and 
NNMT in GFP, GFP/Sox2 and GFP/ Sox2LQY/AAA overexpresing hNSCs was 
very similar with the result of Affymetrix expression array. This implies that 
Sox2 represses the expression of GFAP and NNMT in hNSCs. The repression 
of SOX8, SERPINE1, HELLS, IGFPBP2 and IGFBP3 by Sox2 as detected by 
QRT-PCR was not as pronounced as see in the Affymetrix array. However, the 
results still showed a decrease in Sox2 overexpressing hNSCs and Sox2LQY/AAA 
overexpressing hNSCs showed milder repression of these genes. These QRT-
PCR results confirm the data from Affymetrix expression array and imply that 
GFAP, NNMT, SOX8, SERPINE1, HELLS, IGFBP2 and IGFBP3 are possible 
Sox2/Groucho regulated target genes.  
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Figure 5.6.2 Comparison of Affymetrix data with QRT-PCR results of possible 
Sox2/Groucho regulated genes. 
The relative values of Affymetrix data and QRT-PCR results of possible Sox2/Groucho 
regulated genes are showed as bar graph. The expression level of genes in GFP expressing 
cells was set as 1 which does not shown in the graph. The black and grey bars show the value 
from cells overexpressing wild type Sox2 and the dark blue and light blue bars show the value 
from cells overexpressing Sox2LQY/AAA. Actual numbers of the relative value are listed in the 
table on the right.  
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5.7 Discussion 
In this chapter, Sox2 regulated genes in hNSCs were identified using 
Affymetrix expression arrays. Although the Affymetrix signal of probes of 
Sox2 expression did not show a consistent increase in the level of Sox2 in 
overexpressing cells (Figure 5.3.2). QRT-PCR validation of the same RNA 
samples showed the expression of Sox2 in cells overexpressing GFP+Sox2 and 
GFP+Sox2LQY/AAA was consistently higher than cells overexpressing GFP 
(Figure 5.4.4).  This inconsistency might be because of the 3’-end bias of the 
poly-dT primer used to generate the probes for the arrays. The validation by 
QRT-PCR showed a more than 5 times increase in Sox2 expression both the 
wild type Sox2 and Sox2LQY/AAA transfected cells. The overexpression of Sox2 
or Sox2 LQY/AAA affected a similar number of genes (Table 5.5.1). The 
expression level of more than 80% of genes is similar in GFP, GFP/Sox2 and 
GFP/Sox2LQY/AAA overexpressing hNSCs. This implies that the overexpression 
did not have a general non-specific effect since these numbers are similar to the 
numbers seen in Sox2 knock-down experiments reference. Only 1% of genes 
that were activated in cells overexpressing wild type Sox2 should relatively 
lower expression in cells overexpressing Sox2LQY/AAA. This implies that the 
Sox2LQY/AAA mutant retains its activation function. Among the Sox2-repressed 
genes, 7% showed lower repression by Sox2LQY/AAA. This indicates that a part 
of the Sox2 repressor function is mediated through Groucho interaction. The 
decreases in gene expression might also be caused by indirect regulation by 
Sox2. Sox2 might regulate other transcription factors and affect the expression 
of down-stream genes indirectly. On the other hand, Groucho might not be the 
only co-repressor for Sox2 repression function. Previous studies had shown 
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that Sox2 can interact with transcriptional regulatory proteins such as mSin3A, 
HDAC1 and HDAC2 (Baltus et al., 2009a). Therefore, it is very likely that 
Sox2 functions as a transcriptional repressor through interaction with various 
co-repressors.  
According to the ch-IP study of Boyer et al., (2005), SOX2, OCT4 and 
NANOG occupied 1303 actively transcribed genes and 957 inactive genes in 
human embryonic stem cells. Among the inactive genes a large part of them 
were transcription factors. In contrast to these data, our data indicates that Sox2 
mainly activates transcription factors in human neural stem cells (Table 5.5.2). 
This implies a different role for Sox2 during embryonic stem cell 
differentiation. Interestingly, within the Sox2 regulated transcription factors, 
MEIS1 and PAX6 are inactivated in embryonic stem cells but activated in 
neural stem cells. Previous studies showed that both MEIS1 and PAX6 are 
important regulator of eye development (Zhang et al., 2003b). Meis1 was 
showed to directly regulate Pax6 in chicken (Zhang et al., 2002) and Pax6 and 
Sox2 function as partners to regulate lens development in chicken (Kamachi et 
al., 2001). Therefore, the switching of Sox2 transcriptional regulation role 
during embryonic stem cell is a necessary procedure for specific cell type 
differentiation.  
Among the Sox2 repressed genes, 14% of genes are related to cell cycle (Table 
5.5.2). Some of the Sox2 repressed genes also showed increased expression in 
Sox2 knock-out mouse embryonic stem cells (Masui et al., 2007). During 
embryogenesis, embryonic stem cells undergo rapid cell division in order to 
increase cell number for further differentiation (White and Dalton, 2005). 
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According to our data, the cell division rate might be slowed down through 
Sox2 in hNSCs. 
GFAP has been shown to be directly repressed by Sox2 (Cavallaro et al., 2008). 
In chapter 4, luciferase assay data implied that repression of GFAP might be 
through a Sox2-Groucho interaction (Figure 4.4.6). Affymetrix expression 
array data and QRT-PCR validation show that Sox2 repressed GFAP 
expression whereas Sox2LQY/AAA did not affect the GFAP expression level 
(Figure 5.5.1; Figure 5.6.1). This confirms that Sox2 might regulate GFAP 
expression through a Groucho interaction. According to my Affymetrix 
expression array data and QRT-PCR results, I have identified 7 strong 
candidates that might also be down-regulated by Sox2 through Groucho 
interaction; namely NNMT, SOX8, SERPINE1, HELLS, IGFBP2 and IGFBP3. 
NNMT (nicotinamide N-methyltransferase) catalyzes the N-methylation of 
nictotinamide and other pyridines in liver (Aksoy et al., 1994). SERPINE1 
(SERPIN peptidase inhibitor, clade E, member 1) also name as PAI1 
(plasminogen activator inhibitor 1) inhibits plasminogen activation and 
negatively regulates fibrinolysis (Ginsburg et al., 1086; MEHTA and 
SHAPIRO, 2008). HELLS (helicase, lymphoid-specific) is involved in DNA 
strand separation during replication and transcription (Jarvis et al., 1996). 
IGFBPs (insulin-like growth factor-binding protein) bind with IGFs and affects 
cell growth and cancer cell differentiation. SOX8 belong to SOX E subgroup 
which is involved in neural crest development (Bell et al., 2000; Cheng et al., 
2001), oligodengrocyte specification and differentiation (Stolt et al., 2005). All 
of these genes are repressed in Sox2 overexpressing hNSCs but not in 
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Sox2LQY/AAA overexpressed hNSCs. This result implies that Sox2 keeps genes 
silenced and this silencing requires Groucho interaction domain.  
In summary, the data from expression arrays revealed that Sox2 down-
regulates more genes then it up-regulates in human neural stem cells. The main 
group of genes that are activated by Sox2 overexpression is transcription 
factors, while it represses genes related to cell cycle. When the Sox2-Groucho 
interaction was lost the Sox2 repression of a group of genes was decreased. 
This suggests the importance of the Sox2-Goucho interaction in Sox2 
transcriptional repression function. However, within the Sox2 repressed genes, 
91% of them are not affected by the Groucho interaction mutant, Sox2LQY/AAA. 
This implies that other repression mechanism might involve in Sox2 repression 
function, such as the interaction with HDACs, CtBP or other co-repressors. 
Also, it is possible that some of the gene repression resulted from indirect 
effects of Sox2 overexpression. 
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Chapter 6 Role of Sox2/Groucho interaction in 
vivo 
6.1 Introduction 
SoxB1 family members are the earliest known transcription factors expressed 
in response to neural induction (Rex et al., 1997). In Zebrafish, all members of 
the SoxB1 family are expressed before 24 hours post fertilized (hpf). Although 
the SoxB1 family used to be classified as transcriptional activator (Uchikawa et 
al., 1999), recent evidence indicates that the SoxB1 family plays a different 
role during early embryonic development. Sox3, one of the SoxB1 family 
members, has been shown to act as a transcriptional repressor in early Xenopus 
and Zebrafish embryos (Shih et al., 2010; Zhang et al., 2003a). Previous 
studies in our lab, injecting sox3 mRNA at the one cell stage repressed 
organizer markers such as squint, goosecoid and cordin (Figure 6.1.1). 
However, the effect of sox2 at these early stages of development was not 
studied. In this chapter, sox2 was injected into one cell stage zebrafish embryos 
and the expression of organizer markers was analysed in order to provide an in 
vivo assay of its repressor functions.  
 
Figure 6.1.1 Sox3 represses markers of the Zebrafish organizer. 
sox3 injected zebrafish embryos show dramatic reduction in the expression of the organizer 
markers, squint (sqt), goosecoid (gsc) and chordin (chd). (Shih et al., 2010) 
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6.2 Overexpression of sox2 affects early zebrafish 
embryo development 
In order to test the function of sox2 in early zebrafish embryos, overexpression 
of zebrafish sox2 in early zebrafish embryos was carried out. To do this, the 
first step was to create an expression vector which allowed the zebrafish sox2 
to be expressed in zebrafish embryos and allowed the expressed protein to be 
easily detected. Therefore, HA tagged zebrafish sox2 and sox2LQY/AAA were 
constructed (Figure 6.2.1). Zebrafish sox2 was amplified using pCS2-sox2 
plasmid as template with primers which contained XbaI and XhoI restriction 
sites (Table 6.2.1). The fragment was then inserted in pBUT2-HA vector which 
resulted in an HA tag being attached at the 3’end of the zebrafish sox2 (Figure 
6.2.1). The pBUT-zfsox2-HA plasmid was then used as template to create the 
zebrafish sox2LQY/AAA construct using site directed mutagenesis (Table 6.2.1). 
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Figure 6.2.1 Zebrafish sox2 and sox2LQY/AAA mutant expression vector map 
Zebrafish sox2 was cloned from pCS2-zfsox2 and inserted into the pBUT2 expression vector 
with an HA tag at the 3’ end. The sox2LQY/AAA mutant was generated using site direct 
mutagenesis kit using pBUT2-zfsox2-HA as the template. 
 
 
Table 6.2.1 Primers used in creating zebrafish sox2 and sox2LQY/AAA mutant expression 
vectors. 
The primers used in constructing zebrafish sox2 and sox2LQY/AAA mutant expression vectors are 
listed in the table. The capitalized letters in zfsox2 HA F XbaI and zfsox2 HA R XhoI mark the 
restriction sites. The bold letters in zfsox2LQY/AAA mut F and zfsox2LQY/AAA mut R mark the 
nucleotides that differ from wild type sox2.  
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The DNA sequence of pBUT2-zfsox2-HA and pBUT2-zfsox2LQY/AAA-HA 
constructs was confirmed by GeneService DNA sequencing. In vitro mRNA 
transcription was carried out to generate mRNA of zebrafish sox2-HA and 
sox2LQY/AAA–HA using T3 promoter oligonucletide as primer and EcoRI 
digested plasmid as template. The mRNA was injected into 1-2 cell stage 
zebrafish embryos and 4.5 hours after fertilization, the embryos were collected 
and lysed in deyolk buffer. The expression of zfsox2-HA and zfsox2LQY/AAA-HA 
was detected by western blot using anti-HA antibody (Figure 6.2.2). Both 
zfsox2-HA and zfsox2LQY/AAA-HA were clearly expressed in these injected 
zebrafish embryos.  
 
Figure 6.2.2 Zebrafish sox2 and sox2LQY/AAA mutant expression in early embryos 
The mRNA of zebrafish sox2 or sox2LQY/AAA mutant was injected into 1-2 cell stage zebrafish 
embryos. 4.5 hours after fertilization, the embryos were collected and analysed using western 
blotting. Anti-HA antibody was used to detect the expression of sox2-HA or sox2LQY/AAA-HA. 
Anti-Actin antibody was used to detect the endogenous actin as loading control. 
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6.3 Repressor function of sox2 in early zebrafish 
embryo development 
In the previous studies in our lab, overexpressing sox3 at 1-2 cell stage resulted 
in headless embryos at 24 hpf (Figure 6.3.1; experiments performed by Cheng 
Liang, Kuo). When sox3 mRNA was local-injected into ectoderm precursor 
cells at the 16-32 cell stage, duplications of the central nervous system were 
seen at 24 hpf (Figure 6.3.2) (Dee et al., 2008). The interpretation of these 
phenomena is that sox3 repressed the organiser but at later stages induced 
formation of neural ectoderm. Due to the high similarity of sox2 and sox3 
(64% identity in 326 amino acid overlap; Figure 6.3.3), it was considered that 
sox2 might also function as a repressor in early zebrafish embryos.  
 
Figure 6.3.1 sox3 overexpression causes headless embryos. 
Sox3 mRNA was injected in 1-2 cell stage zebrafish embryos. The picture was taken at 24 hpf. 
Pictures were taken by Cheng Liang, Kuo.  
 
 
Figure 6.3.2 sox3 overexpression causes duplication of the central nervous system. 
sox3 mRNA was injected into ectoderm precursors at the 16-32 cell stage. At 24 hpf, the 
embryos were collected and in situ hybridization was carried out to detect the neural marker 
ncad. The uninjected embryo is marked as WT in (G). The central nervous system duplication 
is shown in head (H) and tail (I) when overexpressing sox3 (Dee et al., 2008). 
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Figure 6.3.3 Alignment of zebrafish sox2 and sox3. 
Amino acid sequence of zebrafish sox2 and sox3 alignment is shown. Analysis was carried out 
using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
In order to test the function of the Sox2/Groucho interaction in early zebrafish 
embryo development, 300ng mRNA of zebrafish sox2 or sox2LQY/AAA was 
injected into zebrafish embryos at the 1-2 cell stage and the neural marker ncad 
was detected using in situ hybridization at 24 hpf (Figure 6.3.4). The ncad in 
situ hybridization of uninjected embryos showed a normal central nervous 
tissue distribution (Figure 6.3.4 A, a). GFP injected embryos were used as a 
negative control and they showed no obvious difference in ncad expression as 
compared to uninjected embryos (Figure 6.3.4 B, b). However, sox2 injected 
embryos showed various levels of abnormal neural development (47 out of 98 
embryos; Figure 6.3.4 C-f). 7% of sox2 overexpressing embryos showed 
duplication in central nervous system (Figure 6.3.4 C, c). 29% of sox2 
overexpressing embryos showed either weak or severe shortening of the 
anterior/posterior axis (Figure 6.3.4 D-e). 11% of the sox2 overexpressing 
embryos showed reduced staining in the trunk (Figure 6.3.4 F, f). This implies 
159 
 
that overexpression of sox2 could expand neuronal tissue and duplicate the 
central nervous system in the same way as was seen with sox3.  
On the other hand, the overexpression of sox2LQY/AAA resulted in less 
abnormality (19 out of 89 embryos). Only 1% of the sox2LQY/AAA 
overexpressing embryos exhibited duplication of the central nervous system 
and 20% showed shortening of body length. This results implies that the loss of 
Groucho interaction reduces the effects of sox2 on zebrafish central nervous 
development. 
 
 
Figure 6.3.4 sox2 and sox2LQY/AAA affect embryonic development. 
300ng mRNA of zebrafish sox2 or sox2LQY/AAA was injected into zebrafish embryos at the 1-2 
cell stage. At 24 hpf, the neural marker ncad was detected using in situ hybridization. The 
percentage of different appearance of embryos is listed in the table. RST: reduce signal in trunk. 
(32 embryos were uninjected, 29 GFP injected, 98 sox2 injected and 89 sox2LQY/AAA injected.) 
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In order to test the effect of sox2 on organizer formation, 50ng instead of 
300ng of sox2 or sox2LQY/AAA was injected into zebrafish embryos at the 1-2 cell 
stage. Previous experiments detected ncad expression in the injected embryos 
at 24 hpf which require higher sox2 overexpression, presumably to compensate 
for the degradation of sox2 protein during the longer developmental time. The 
organizer markers goosecoid, and chordin were detected at 4.5 hpf using in situ 
hybridization. Uninjected wild type embryos and GFP injected embryos were 
used as negative controls. Also, embryos overexpressing sox3 were used as a 
positive control and to determine any functional differences to sox2. Goosecoid 
could be detected in the organizer by in situ hybridization at 4.5 hpf. In 
uninjected and GFP overexpressing embryos, the expression of goosecoid was 
located at the dorsal margin where the organizer is found (Figure 6.3.5 A, B). 
In contrast, goosecoid expression was hardly detected in most sox3 
overexpressing embryos (Figure 6.3.5 C). This result agrees with the previous 
studies in our lab (Shih et al., 2010). When sox2 was overexpressed, a very 
different result was seen; a substantial expansion of goosecoid expression was 
observed (Figure 6.3.5.D). The expression of goosecoid was detected not only 
at the organizer but also over half of the animal pole in sox2 overexpressing 
embryos. These results imply that sox2 function is the opposite of sox3 with 
respect to the effects on goosecoid expression in early zebrafish embryo. Why 
this might be so, is discussed below. When overexpressing sox2LQY/AAA, the 
goosecoid expression pattern was similar to uninjected and GFP injected 
embryos (Figure 6.3.5 E). The loss of the ability to activate goosecoid 
expression by the sox2LQY/AAA mutant, suggests two possible models. First, the 
Sox2/Groucho interaction represses the transcriptional activator of goosecoid 
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expression. Alternatively, sox2 might directly activate goosecoid expression 
and the sox2LQY/AAA mutation is causing the loss of an activation function of 
sox2. However, 20% of the sox2LQY/AAA overexpressing embryos showed 
similar goosecoid expression pattern to that seen in sox2 overexpressing 
embryos. This suggests that the mutant form has not lost the ability to affect 
goosecoid expression seen for wild-type sox2, but that this ability is 
dramatically reduced. 
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Figure 6.3.5 goosecoid in situ hybridization of sox2 or sox2LQY/AAA overexpressing 
zebrafish embryos. 
50ng of mRNA of GFP, sox3, sox2 and sox2LQY/AAA was injected into zebrafish embryos at 1-2 
cell stage. Embryos were collected at 4.5 hpf and in situ hybridization was carried out using a 
goosecoid probe. The numbers at the bottom-right show how many embryos exhibit expression 
patterns similar to that shown in the pictures (number of embryos have similar pattern/ number 
of total embryos). The expression of goosecoid was compared with uninjected embryos (as 
shown in A) and classified into three expression levels (more, same and less). The percentage 
of each expression level in different mRNA injected embryos is showed in F. 
F 
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Another organizer marker, chordin, was also shown to be a target of sox3 
repressor function (Shih et al., 2010). The normal chordin expression pattern 
was detected by in situ hybridization in uninjected embryos and GFP injected 
embryos (Figure 6.3.6 A, B). The expression pattern of chordin was again 
located at the dorsal side of the margin in the region of the organizer. In the 
sox3 overexpressing embryos, most showed very weak or no chordin 
expression at the dorsal margin (Figure 6.3.6 C). The definition of the strength 
of gene expression is dependent on the colour that was seen in the majority of 
embryos. The probes, colour developing reagents and colour developing time 
of in situ hybridization were all the same in the same batch of embryos. With 
these same conditions, the comparison of gene expression level could be 
distinguished by its colour stain after in situ hybridization. This result agrees 
with the previous studies in our lab that chordin was repressed when 
overexpressing sox3 in early zebrafish embryos (Shih et al., 2010). When 
overexpressing sox2 in embryos, the expression of chordin was only slightly 
weaker than in uninjected or GFP injected embryos (Figure 6.3.6). This implies 
that sox2 might also down regulate chordin expression, but the repressor 
function of sox2 on chordin is weaker than sox3. The chordin expression 
pattern in sox2LQY/AAA injected embryos was similar to uninjected or GFP 
injected embryos indicating that this weak repression of chordin is also 
Groucho dependent.  
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Figure 6.3.6 chordin in situ hybridization of sox2 or sox2LQY/AAA overexpressing zebrafish 
embryos. 
50ng of mRNA of GFP, sox3, sox2 and sox2LQY/AAA was injected into zebrafish embryos at 1-2 
cell stage respectively. Embryos were collected at 4.5 hpf and in situ hybridization was carried 
out using chordin probes. The number marked at the bottom-right shows how many embryos 
have similar expression pattern to that shown in the pictures (number of embryos have similar 
pattern/ number of total embryos). The expression of chordin was compared with uninjected 
embryos (as shown in A) and classified into three expression levels (more, same and less). The 
percentage of each expression level in different mRNA injected embryos is showed in F. 
F 
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According to the previous studies in our lab, another gene that is regulated by 
sox3 is sox19b. sox19b, also known as sox31, has only been identified in 
zebrafish (Girard et al., 2001). sox19b was categorized in the SoxB1 family 
due to the high conservation of its HMG domain and its C-terminal amino acid 
sequence. It has recently been shown, in early zebrafish embryos, that 
overexpression of sox19b results in impaired organizer formation (Hu et al., 
2011). The normal expression of sox19b was detected in uninjected and GFP 
injected embryos by in situ hybridization (Figure 6.3.7 A, B). sox19b was 
distributed evenly in the animal cap of the whole embryo. In sox3 
overexpressing embryos, the area of sox19b expression was increased into a 
large patch on the embryo and the expression was stronger than the uninjected 
embryos (Figure 6.3.7 C). This result agrees with the previous studies in our 
lab that sox19b was expanded when overexpressing sox3. sox2 overexpressing 
embryos showed a similar expression pattern to sox3 overexpressing embryos 
(Figure 6.3.7 D). This indicates that sox2 might function similarly with sox3 in 
the regulation of sox19b expression. However, the Groucho interaction mutant, 
sox2LQY/AAA, had no effect on the sox19b expression pattern whereas the wild-
type sox2 seems to activate the expression of sox19b (Fiugre 6.3.7 E). This 
implies that sox2 might activate sox19b indirectly through its repressor 
function. 
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Figure 6.3.7 sox19b in situ hybridization of sox2 or sox2LQY/AAA overexpressing zebrafish 
embryos. 
50ng of mRNA of GFP, sox3, sox2 and sox2LQY/AAA was injected into zebrafish embryos at 1-2 
cell stage respectively. Embryos were collected at 4.5 hpf and in situ hybridization was carried 
out using sox19b probes. The number marked at the bottom-right shows how many embryos 
have similar expression pattern to that shown in the pictures (number of embryos have similar 
pattern/ number of total embryos). The expression of sox19b was compared with uninjected 
embryos (as shown in A) and classified into three expression levels (more, same and less). The 
percentage of each expression level in different mRNA injected embryos is showed in F. 
F 
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6.4 Discussion 
In this chapter, RNA encoding the sox2 or sox2LQY/AAA mutant was injected into 
zebrafish embryos at 1-2 cell stage which allows the injected mRNA to be 
translated in the whole embryo. Therefore, the effects of overexpressing these 
proteins in the earliest stages of embryo development could be observed. 
However, in normal zebrafish embryo development, the expression time point 
of sox2 is not as early as the 1-2 cell stage. The expression of sox2 is slightly 
later than sox3 in early zebrafish embryos (Okuda et al., 2006). Reverse 
transcriptase-polymerase chain reaction (RT-PCR) shows that sox3 expression 
could be detected at the 32 cell stage whereas sox2 expression could not be 
detected until 30% epiboly stage (Figure 6.4.1). In other words, there is no 
maternal/zygotic sox2 expression at the 1-2 cell stage. At this stage of zebrafish 
development the overexpressed sox2 might function on soxb1 target genes or 
the genes that will be targeted by sox2 at a later stage. Therefore, the effects of 
overexpressing sox2 do not reflect its normal function in the zebrafish embryo 
development. However, this assay provides a way to distinguish any change of 
the function between the wild-type sox2 and sox2LQY/AAA. The results in this 
chapter show that sox2LQY/AAA acts differently to wild-type sox2, which suggests 
that the loss of Groucho interaction indeed alters the function of sox2.  
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Figure 6.4.1 SoxB1 family member expression time point in early zebrafish embryos. 
RT-PCR shows the temporal expression profiles of SoxB1 family members. The β actin and 
ef1α were used as controls (Okuda et al., 2006). Note that endogenous sox2 appears (30% 
epiboly) later than sox3 (32 cells) in early zebrafish embryos. 
 
When looking at the general effects of sox2 on zebrafish embryo development, 
wild-type sox2 overexpressing embryos showed axis duplication and reduced 
ncad expression in the trunk, which was consistent with the effects of sox3 
overexpression (Figure 6.3.2; Figure 6.3.4 C-f). One effect of sox3 
overexpression is to restrict the formation of mesoderm through its repressor 
function, therefore causing the expansion of the central nervous system (Shih et 
al., 2010). This interpretation could also apply to the axis duplication of sox2 
overexpressing embryos. However, the sox2LQY/AAA mutant overexpressing 
embryos showed a less severe effect on the central nervous system. Since the 
LQY sequence is essential to the activities of wild-type sox2, it is likely that 
the same interaction is important for the function of endogenous sox2. 
In situ hybridization analysis showed that overexpression of sox2 affected the 
expression of goosecoid, chordin and sox19b. Wild-type sox2 functioned 
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similarly to sox3 in activating sox19b and repressing chordin, but leaded an 
opposite effect on goosecoid expression (Figure 6.3.5-7). Previous studies in 
our lab demonstrated that sox3 can directly repress the expression of chordin 
and goosecoid. Similar effects of sox2 and sox3 on repressing chordin indicates 
that sox2 might also repress chordin directly. The opposite effect of sox2 on 
regulating goosecoid with sox3 implies an indirect function of sox2 on 
goosecoid. For sox19b, both sox2 and sox3 activate its expression which might 
be caused by the indirect effect of sox2 and sox3 transcriptional repression 
function. Nonetheless, sox2LQY/AAA mutant overexpressing embryos showed no 
obvious difference in the expression of any these genes compared to the 
unjected or GFP injected embryos. This indicates that the effect of 
overexpressed sox2 on these genes depends on the LQY sequence which 
implies that the Sox2/Groucho interaction is required for sox2 function in 
regulating these genes.   
Since both sox2 and sox3 belong to the soxb1 subgroup, they might have the 
same effect on regulating genes. In this chapter, the similar effect of sox2 and 
sox3 on repressing chordin and activating sox19b fits this hypothesis. However, 
an opposite effect of sox2 and sox3 was also observed in regulating goosecoid. 
This could be due to the protein structural and functional differences between 
sox2 and sox3. Their highly similar HMG DNA-binding domain might lead 
them to bind to similar binding sites, but difference in other parts of the sox2 or 
sox3 proteins might result in different biological functions. According to my 
data, sox2 and sox3 could affect the same gene but they do not necessarily have 
the same effect on the gene.  
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The experiments in this chapter are primarily pilot experiments for further 
research. To confirm the primary observations, more experiments would be 
required. For example, the effect of specific gene overexpression on organizer 
marker expression was determined by the colour strength of in situ 
hybridization. Although all the probes and colour developing conditions were 
the same in every experiment, it is still not a truly quantitative and precise 
evaluation. QRT-PCR is a better method which might be used in the future to 
measure the level of gene expression. In addition, in situ hybridization does not 
provide evidence that any effects are direct or indirect. Further experiments for 
this purpose could include chromatin-immunoprecipitation (Chip) or 
electrophoretic mobility shift assay (EMSA) to confirm the binding of the 
transcription factor to the promoter region of target genes.  
Data in this chapter show that the sox2LQY/AAA mutant acts very differently from 
the wild-type sox2, which strongly suggests that the Sox2/Groucho interaction 
is needed for the function of sox2 in embryonic development (Figure 6.3.5-7). 
However, the effect of losing Groucho interaction might be indirect. Previous 
studies of sox3 used fusion of the repression domain of engrailed or the 
activation domain of VP16 with sox3 to mimic the transcriptional repression or 
activation function of sox3 respectively (Shih et al., 2010; Zhang et al., 2004).  
Through this strategy, the direct function of transcriptional repression or 
activation function of sox3 could be elucidated.  
Since the lack of Groucho interaction of the sox2LQY/AAA mutant results in a 
different function from wild-type sox2, it would be very interesting to test if 
restoring the Groucho interaction, by attaching Groucho or a Groucho 
repression domain, could recover the repressor function. On the other hand, 
171 
 
replacing the LQY domain with a canonical Groucho binding domain (WRPW 
or FRPW) to enhance Sox2-Groucho interaction might result in a stronger 
Sox2 repression effect. This could be a good way to determine if my results are 
due to a direct effects of Sox2/Groucho interaction in target genes rather than 
an artificial change in the secondary structure of the Sox2 protein. 
To sum up, in this chapter, the loss of Sox2/Groucho interaction mutant 
sox2LQY/AAA was showed to act distinctly from the wild-type sox2 in regulating 
goosecoid, chordin and sox19b expression. This implies that the Sox2/Groucho 
interaction might be crucial for the regular function of sox2. However, further 
research is needed to validate the results and confirm the direct effects of the 
Sox2/Groucho interaction. 
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Chapter 7 Discussion 
In this thesis I have shown that Sox2 interacts with the transcriptional co-
repressor, Groucho. By mapping, the motif by which Sox2 interacts with 
Groucho was defined. Disruption of the Sox2/Groucho interaction was 
analysed by changing only three adjacent amino acids, LQY. I have also shown 
that Sox2 acts as a transcriptional repressor in human neural stem cells, 
repressing almost as many genes as it activates. Mutation of the Sox2/Groucho 
interaction motif disrupted a small percentage of those repressive events. I also 
demonstrate that, in zebrafish, mutation of the Sox2/Groucho interaction motif 
has a dramatic impact on Sox2 function.  
In this chapter, some of questions raised from this thesis will be discussed. The 
functional domains of SoxB1 proteins will be reviewed followed by a 
consideration of the regulation of the Sox2 bifunctional transcription activity. I 
also will discuss the role of Sox2 transcriptional repression in neural 
development. 
7.1 The complexity of Sox2 function 
7.1.1 Bifunctional transcription factors 
Many transcription factors have roles both as activators and repressors which 
are therefore regarded as bifunctional transcription factors. Krüppel (Kr) is 
essential for the development of the thoracic and abdominal segments in early 
Drosophila embryos (Gaul and Jäckle, 1987). The N-terminus of Kr contains 
both transcriptional activation and repression domains (Licht et al., 1994). The 
action of Kr as a transcriptional activator or repressor depends on the context 
of its binding site (Frasch and Levine, 1987; Licht et al., 1990; Ruppert et al., 
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1988). Likewise YY1, which has a similar zinc finger domain sequence to Kr, 
can repress in the absence and activate in the presence of the adenovirus 
protein E1A (Shi et al., 1991). Pax6, which is required for early eye 
determination in animals, was reported as a bifunctional transcription factor 
(Duncan et al., 1998). Pax6 contributes to the transcriptional activation of δ1-
crystallin and repression of β-crystallin in the chicken lens. Pax6 functions as a 
repressor through binding to positive acting cis elements (Duncan et al., 1998; 
Richardson et al., 1995; Shinohara and Piatigorsky, 1976). Post-translational 
modification has been demonstrated to switch some transcriptional activators 
to repressors, such as Sp3 (specificity protein 3) (Valin and Gill, 2007). Sp3 
represses transcription by competing with Sp1 for DNA binding (Hagen et al., 
1994). However, in other cases, Sp3 functions as a transcriptional activator 
(Lania et al., 1997; Liang et al., 1996). Ross et al. reported that the 
SUMOylation of Sp3 is sufficient to convert Sp3 from a transcriptional 
activator to a repressor (Ross et al., 2002). Therefore, the dual function of 
transcriptional regulators is not a rare phenomenon.   
7.1.2 Structure function of Sox2 
As a bifunctional transcription factor, Sox2 might have independent regions 
which are responsible for either its transcriptional activator or repressor activity. 
A number of domains have been identified in Sox2. Next to the HMG DNA 
binding domain (39-126 aa) is located the group B homology motif (126-137 
aa). At the C-terminus of Sox2 is a serine rich domain (205-263 aa) which 
includes the LEF homology domain (218-263 aa) (Figure 7.1.1). Serine rich 
domains have been reported to be important regulatory regions for some 
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transcription factors, such as v-Rel and CREB (Chen et al., 1999; Karin, 1992). 
The transcriptional activation region of Sox2 was first defined in the C-
terminus which includes the serine rich domain (Bowles et al., 2000; Yuan et 
al., 1995). According to Gal4-luciferase data in chicken lens cells, the 
transcriptional activation domain might be located in aa 269-275.  
  
Figure 7.1.1 Sox2 protein structure and post-translational modification map. 
The mouse Sox2 amino acid map of domains, functional motifs and post-translational 
modification sites is shown. (Baltus et al., 2009b; Ciechanover, 1998; Cox et al., 2010; Gao 
et al., 2009; Kamachi et al., 1999; Tsuruzoe et al., 2006; Van Hoof et al., 2009) 
 
Also, putative internal inhibition domains might locate in the N-terminus (1-40 
aa) and C-terminus (120-180 aa) (Figure 1.3.1 A, B) (Kamachi et al., 1998). As 
described in chapter 4, the luciferase assays have implied a possible 
transcriptional activation domain in the region of aa 209-213 (Figure 4.3.3). 
This complex map of Sox2 transcriptional activation function suggests that 
Sox2 not only acts as a transcriptional activator, but also regulates its 
transcriptional activation via an internal inhibition domain. Given the large 
number of genes affected by Sox2 in vivo, this subtle adjustment within Sox2 
might be crucial to its function. 
Some possible protein interaction domains in Sox2 have been identified in 
previous studies. The Sox2 self-associated domain was demonstrated as the N-
terminus (1-123 aa). A putative HDAC1 and HDAC2 interaction region lies in 
175 
 
aa 120-180 (Cox et al., 2010). In chapter 3 and 4, the Groucho interaction 
domain was demonstrated in 207-209 aa. Therefore, the transcriptional 
repression function of Sox2 might be mediated via interaction with different 
co-repressors such as HDACs directly and Groucho. In order to further 
understand how Sox2 plays a role as a transcriptional repressor, we will also 
need to investigate the relationship of Sox2 with other co-repressors such as 
CtBP or chromatin remodelling factors.  
7.1.3 Functional structure within SoxB1 subgroup 
proteins 
As described in chapter 1, SoxB1 subgroup proteins have a highly conserved 
HMG DNA-binding domain. However, poly-alanine intervals exist in Sox1 
and Sox3 but not Sox2. The similarity of the other putative functional domains 
was analysed by ClusterW (http://www.ebi.ac.uk/Tools/msa/clustalw2/) the 
results of which are discussed below. In the mouse SoxB1 subgroup, the 
similarity of the HMG DNA-binding domains is higher than 90%, which 
suggests that the preference of their binding sequence might be the same 
(Figure 7.1.2). The slightly lower similarity of the adjacent group B homology 
motif might contribute to the interaction with different partners and therefore 
regulate the different functions of the three members of the SoxB1 subgroup 
(Uchikawa et al., 1999).  The similarity of the putative internal inhibition 
domain within SoxB1 subgroup proteins is approximate 40%. It has been 
reported that the internal inhibition domain can interfere with the 
transcriptional activation function of Sox1 and Sox2 (Kamachi et al., 1999). 
Since homology with Sox3 is similar this domain might function the same in 
Sox3. The similarity of the domain which was reported to be important for 
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interaction with co-repressor HDAC is 45-54% where the same Groucho 
interaction motif exists in all SoxB1 subgroup proteins suggesting that the 
interaction with the Groucho co-repressors might be shared by all SoxB1 
subgroup proteins.  
 
Figure 7.1.2 Comparison of organization of mouse SoxB1 subgroup proteins. 
The similarity of inhibition domain, HMG domain, group B homolog motif, LEF homolog 
motif and Groucho interaction motif are labelled in the relative boxes. The similarity are 
calculated using Sox2 as 100 percent by ClustalW2.  
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
If the structure and function of SoxB1 subgroup proteins are so alike, why have 
they all been retained during evolution? The possible explanation could be 
found from evolution point of view. Three possible theories have been 
proposed to interpret the fate of gene duplication (Figure 7.1.3) (Mazet and 
Shimeld, 2002). Degeneration eliminates a redundant gene; 
neofunctionalisation develops a new function of the duplicated gene; 
subfunctionalisation specifies the multi-function duplicated gene to different 
function. Unlike vertebrates, there is only one SoxB1 protein in Drosophila 
(SoxNero) and amphioxus (AmphiSox1/2/3) (Chao et al., 2007; Holland et al., 
2000). This implies the duplication of SoxB1 genes during evolution. In 
vertebrates, all SoxB1 subgroup genes are not only expressed in the central 
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nervous system as in the invertebrate, but are also expressed in vertebrate-
specific tissues, such as the epibranchial placodes (Ishii et al., 2001). This 
suggests that neofunctionalisation occurred during evolution from invertebrates 
to vertebrates (Mazet and Shimeld, 2002). 
As described in chapter 1, the temporal and spatial patterns of experission of 
the three SoxB1 members in early embryo development is slightly different in 
different species. In chicken and zebrafish embryos, Sox3 is the first expressed 
SoxB1 gene whereas Sox2 and Sox3 are both expressed before Sox1 (Okuda et 
al., 2006; Wood and Episkopou, 1999). Sox1 expression could be detected in 
CNS, lens and urogenital ridge. Sox2 expression could be detected in inner cell 
mass, primitive ectoderm, trophoblast stem cells, CNS and lens. Sox3 
expression could be detected in epiblast, CNS, lens and urogenital ridge 
(Miyagi et al., 2009). The genes regulated by the three SoxB1 subgroup 
proteins also vary (Kamachi et al., 2001; Nishiguchi et al., 1998; Rogers et al., 
2009). Sox1 was reported to induce γ-crystallin expression (Nishiguchi et al., 
1998), Sox2 is involved in FGF4, Oct4, Nanog, etc. expression (Kuroda et al., 
2005; Okumura-Nakanishi et al., 2005; Yuan et al., 1995) and Sox3 regulates 
chordin, goosecoid, xvent etc. (Rogers et al., 2009). Although knockdown 
experiments show the redundancy of SoxB1 factors, knockout of Sox2 or Sox3 
led to lethality of the early embryo (Avilion et al., 2003; Rizzoti et al., 2004). 
This suggests that they have distinct and critical function in embryonic 
development, implying that either neofunctionalisation or subfunctionalisation 
has occurred.  
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Figure 7.1.3 Scheme of fate of duplication genes.  
(A) Degeneration model. One copy of duplication vanished. (B) Neofunctionalisation 
model. The duplicated genes acquire new functions. (C) Subfunctionalisation model. The 
multi-functional gene duplicates into two separate genes. The dash line box shows the 
possible subsequent neofunctionalisation of these genes  (Mazet and Shimeld, 2002). 
 
7.2 Regulation of Sox2 transcriptional function 
If Sox2 is a bifunctional transcription factor, how could it determine when to 
act as an activator and when to act as a repressor? In the discussion section of 
chapter 5, the differing roles of Sox2 in affecting transcription factors in human 
neural stem cells and embryonic stem cells was mentioned. This suggests that 
the different type of cell or different developmental stage could alter Sox2 
function. On the other hand, in human neural stem cells, Sox2 could function 
as a transcriptional activator of genes such as Hes5 and as a transcriptional 
repressor of genes such as GFAP simultaneously. This implies that Sox2 could 
be a bifunctional transcription factor depending on the context of target genes. 
In this section, some possible mechanisms are discussed. 
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7.2.1 Post-translational modification 
Many transcription factors are modified after translation. Such modifications 
change the electronic charge or structure of the transcription factor, hence, 
potentially regulating their function. Sox2 has been reported to be subject to 
SUMOylation, ubiquitination, acetylation, phosphorylation and poly(ADP-
ribosyl)ation. SUMOylation of proteins covalently conjugates one or many 
small ubiquitin-related modifier (SUMO) polypeptides to lysine residues 
(Wilkinson and Henley, 2010). Sox2 has a consensus SUMOylation motif 
(ψKxD/E; ψ is a large hydrophobic residue) at 246-249 aa within which the 
lysine 247 is the target residue of SUMOylation (Figure 7.1.1). SUMOylation 
has been reported to affect protein stability, alter protein-protein interactions 
and transcription factor function (El McHichi et al., 2010; Garcia-Dominguez 
and Reyes, 2009; Snow et al., 2010). SUMOylation was found to decrease the 
transcriptional activation activity of Sox2 via inhibiting Sox2 DNA binding 
ability (Figure 7.2.1 A) (Tsuruzoe et al., 2006). On the other hand, the 
SUMOylation site on Sox2 was demonstrated as a phosphorylation-dependent 
SUMOylation motif (PDSM; ψKxExxSP) (Van Hoof et al., 2009). The 
replacement of serine 249-251 to aspartic acid, which mimics constitutive 
phosphorylation, led to a high level of SUMOylation of lysine 245 in human 
Sox2. 
SUMO modification could affect transcriptional regulatory proteins and lead to 
transcriptional repression through HDAC-mediated transcriptional repression 
(Yang and Sharrocks, 2004). The ETS domain transcription factor Elk1 was 
reported to be SUMOylated and recruits HDAC2 to repress target gene. When 
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the SUMOylation on Elk1 was removed, the transcriptional repression function 
of Elk1 was reversed. 
A decrease in the protein level of a transcription factor could also represses its 
target gene expression. Ubiqutination is the most common post-translational 
modification involved in protein degradation. Similar to SUMOylation, 
ubiquitination also conjugates one or multi polypeptides on to lysine residues 
covalently. However, ubiquitination sites are not as conserved as SUMOylation 
sites. The most well-studied function of ubiquitination is to regulate the 
stability of a protein via proteasomal degradation (Ciechanover, 1998). Sox2 
has been shown to be ubiquitinated but the specific ubiqutination sites on Sox2 
have not been identified experimentally. However, using the prediction 
software UbPred (http://www.ubpred.org/) (Radivojac et al., 2010), three 
possible ubiquitination sites (lysine 10, 247, 310) were predicted (Figure 7.1.1). 
In addition, the acetylation of Sox2 lysine 75 has been demonstrated to retain 
the nuclear localization and reduce the levels of ubiquitination of Sox2 (Figure 
7.2.1 A) (Baltus et al., 2009b). Moreover, the poly(ADP-ribosyl)ation of Sox2 
was reported to regulate Sox2 protein levels and decrease activator of  FGF4 
by Sox2 (Gao et al., 2009). 
Since different post-translational modifications on transcription factors can 
lead to different functions, this has been proposed as a subtle functional 
adjustment of a transcription factor on its target genes. Post-translational 
modification can alter the surface charge and protein structure of transcription 
factors. These differences might change their protein-protein interaction and 
change the components of the transcription regulatory complex, therefore, 
leading to a different function of transcription factors.  
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7.2.2 Context of the regulatory region of Sox2 target 
genes 
Bifunctional transcription factors could also determine their role through the 
specific context of target sequences (Boyle and Despres, 2010). As a 
transcription factor, Sox2 binds to specific sequences of target genes. It is 
possible that target genes contain the information which indicates to Sox2 
whether to act as a transcriptional activator or repressor (Figure 7.2.1 B). A 
good example of the regulatory region context of a gene triggering different 
functions of a transcription factor is Sp3. Sp3 functions as a repressor when 
bound to multiple DNA-binding sites but acts as an activator when bound to 
single DNA-binding sites (Majello et al., 1997). Another factor, WRKY53 
which was found in Arabidopsis, acts either as a transcriptional activator or 
repressor depending on the sequence surrounding the binding site on its target 
gene (Miao et al., 2004). 
7.2.3 Existence of partners in the environment 
As described in chapter 1, the DNA-binding ability of Sox2 alone does not 
appear to be strong enough to allow it to regulate its target genes. Therefore, 
cooperation with other transcription factors is necessary to stabilize the 
interaction. However, different tissues or cells have different gene expression 
profiles which create various micro-environments for transcription factors. The 
availability of partner proteins would therefore vary. On the other hand, Sox2 
needs specific partners on different target genes. For example, Pax6 and Sox2 
activate lens-specific δ-crystallin (Kamachi et al., 2001), whereas Oct4 and 
Sox2 activate another group of genes such as Nanog. There has to be a specific 
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binding site for Sox2 and its partner protein in close proximity. Therefore, 
whether the transcriptional regulation of Sox2 could have function on the target 
genes depends largely on the location of nearby transcription factor binding 
sites and whether there is a correct partner binding to the adjacent binding site 
(Figure 7.2.1 C).  
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Figure 7.2.1 Scheme of the possible regulation of Sox2 transcriptional activity.  
(A) Post-translational modification affects Sox2 transcriptional regulation. Phosphorylation 
dependant SUMOylation decreases Sox2 transcriptional activation. Acetylation-induced 
Sox2 ubiquitination leads to Sox2 export from the nucleus to the cytoplasm and processing 
by the proteasome. (B)  Context of regulatory region of Sox2 target genes in front of 
transcription start point affects Sox2 transcriptional regulation. The flanking sequence of 
Sox2 binding sites or the secondary structure of the nearby DNA might contain the 
information for Sox2 to determine its transcriptional regulation role. (C) Existence of 
partner factors affects Sox2 transcriptional regulation. Different cell types have different 
gene expression profiles which supplies different partners for Sox2 to complete the 
transcriptional activation/repression of target genes.  
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7.3 Function of Sox2 transcriptional repression  
7.3.1 Role of Sox2 in neural stem cells 
The data presented in chapter 5 shows that approximate the same number of 
genes are repressed as are activated by overexpression of Sox2 (Table 5.5.1). 
This indicates the importance of Sox2 transcriptional repression in neural stem 
cells. Previous studies have shown that a constitutive activator form of SoxB1 
subgroup proteins inhibited neural stem cell differentiation, while a constitutive 
repressor form of SoxB1 led to the early stages of differentiation (Bylund et al., 
2003; Graham et al., 2003). This suggests that the ability of SoxB1 subgroup 
proteins to regulate the differentiation of neural stem cells depends on their 
transcriptional activator function. However, the differentiation induced by the 
constitutive repressor form of SoxB1 was not entirely complete. Fully 
differentiated neuron markers such as neurofilament or beta-tubulin were not 
detected. On the other hand, the constitutive activator form of SoxB1 proteins 
also did not fully inhibit the differentiation of neural stem cells, as shown by 
the expression of beta-tubulin. Together with the findings in this thesis, we 
propose a possible model of the mechanism of action of Sox2 in neural stem 
cells, as shown in Figure 7.3.1. The transcriptional activation function of Sox2 
maintains neural stem cell features and inhibits differentiation via regulating 
down-stream transcription factors. The transcriptional repression function of 
Sox2 is required to inhibit differentiation through repressing effectors which 
will be activated after release from the neural stem cell state. 
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Figure 7.3.1 Putative model of the function of Sox2 in neural stem cell differentiation. 
The transcriptional activation function of Sox2 activates the expression of down-stream 
transcription factors whereas the transcriptional repression function of Sox2 represses other 
effectors to inhibit differentiation of neural stem cells. 
 
In chapter 5, I showed a relatively large proportion (143 out of 676 genes) of 
the genes activated by Sox2 in neural stem cells are transcription factors, 
whereas a large portion of Sox2 repressed genes are factors involved in 
regulating cell cycle (118 out of 786 genes). Surprisingly, amongst the Sox2 
repressed genes not a single gene falls in the category of GO term as 
transcription factor. This indicates that Sox2 transcriptional activation and 
repression functions are very distinct in terms of their target genes in neural 
stem cells.  
As discussed in chapter 5, Sox2 acts as a transcriptional activator of 
transcription factor genes in hNSCs (62 out of 704 genes in GO:0003700), but 
Sox2 was reported to bind to transcriptionally inactive transcription factor 
genes that have been implicated in developmental processes in human 
embryonic stem cells (Boyer et al., 2005). Although Sox2 also binds a small 
number of transcriptionally active transcription factor genes, this situation 
opposite to that I have described for human neural stem cells might result from 
the different stage of differentiation between embryonic stem cells and neural 
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stem cells. Embryonic stem cells are pluripotent whereas neural stem cells are 
multipotent cells. This implies that the role of Sox2 during embryonic 
development changes significantly. Further investigations are needed to dissect 
the transcriptional function of Sox2 more detail. 
Sox2 has been reported to prevent neural stem cells from processing through 
differentiation which includes keeping self-renewal or proliferation of cells 
(Avilion et al., 2003; Bylund et al., 2003). Interestingly, in my data, Sox2 
repressed many cell cycle related genes which might conflict with these 
previous findings. However, among the 118 cell cycle related genes, only 24 
genes function as positive regulators of cell cycle, such as CCNA2 and CCNE1, 
while 18 genes function as negative regulator of cell cycle, such as BRCA1 and 
BRCA2. The rest of the genes are related to other cell cycle processes, such as 
chromosome segregation, centrosome duplication, etc., rather than the 
regulation of cell cycle. Similar with this finding, some cell cycle related genes 
such as PLAGL1, MYH9, NEK6, E2F8 and GSPT1are repressed by Sox2 both 
in human neural stem cells and mouse embryonic stem cells (Masui et al., 
2007). Therefore, Sox2 might encourage self-renewal through repressing the 
negative regulation of genes of the cell cycle and adjusting the cell cycle rate 
by repressing the positive regulation genes. The possible hypothesis of 
different functions of Sox2 might be adjusted by the partners of Sox2 or other 
factors. 
This indicates that Sox2 represses at least some of the same biological function 
in different species and developmental stage. The mechanisms behind this 
phenomemon need further investigation.  
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7.3.2 Sox2 in zebrafish 
In human and mouse, sox2 expression is earlier than sox3 in the ectoderm. 
However, in chicken, zebrafish and frog, the earliest sox2 expression is in the 
neural ectoderm whereas sox3 is expressed at much earlier stages. Because of 
the high similarity within soxb1 subgroup proteins, they might have redundant 
function on the target genes. sox3 has been reported to regulate organizer 
formations in zebrafish through directly repressing the expressions of organizer 
marker genes (Shih et al., 2010). Therefore, it is difficult to study sox2 
endogenous biological function in zebrafish. We assume the effect of 
overexpressed sox2 and sox2 mutant in the 1-2 cell stage might lead to some 
functional effects on sox3 target genes, even though these events might not be 
the normal function of sox2. Therefore, this system was used in chapter 6 to 
test the effects of Sox2-Groucho interaction. 
The data represented in chapter 6 show that, like sox3, sox2 represses chordin 
expression, but unlike sox3 it also represses sox19b but it has opposite effect on 
goosecoid. In addition, the expression pattern of sox2 at the 80% epiboly stage 
in zebrafish embryos (mid-gastrula stage) is restricted to the dorsal-anterior 
ectoderm whereas sox3 is expressed in almost the whole prospective neural 
ectorderm (Figure 7.3.2). This indicates that the function of sox2 in early 
zebrafish development might be slightly different from that of sox3.  
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Figure 7.3.2 sox2 and sox3 expression pattern at 80% epiboly zebrafish embryo. 
The 80% epiboly zebrafish embryos were processed through in situ hybridization using 
sox2 or sox3 probes. The pictures were took from lateral view. (Data were done by Yu-
Haun Shih) 
 
Although sox3 plays an important role in early zebrafish development, sox3 
null mutant zebrafish which express only the dysfunctional N-terminus of sox3 
have no obvious phenotype when compared with the wild-type (unpublished 
data in our lab). However, using sox3 morpholinos (MO1 and MO2) to knock-
down endogenous sox3 at the 1-2 cell stage produced a severe brain defect 
(Figure 7.3.3) (Dee et al., 2008). When the morpholino sequences were 
compared to the other SoxB1 subgroup members, MO2 showed high similarity 
with sox2 which might have led to an off-target effect decreasing sox2 leads 
simultaneously (Figure 7.3.4 A). In order to test if the off-target effect could 
happen on sox2, the 1-2 cell stage zebrafish embryos were co-injected with 
GFP-sox2 or sox3 alone with different combinations of sox3 morpholinos 
(Figure 7.3.4 B-I). The results show that sox2 expression indeed decreased 
when sox3 morpholino MO2 were injected, but not MO1. Therefore, the brain 
defects in sox3 morpholino (MO1 and MO2) injected zebrafish might be due to 
loss of both sox2 and sox3 rather than sox3 alone. This indicates that sox2 not 
only regulates the organizer but is also involved in brain development. 
However, the unpublished data in our lab have shown that sox3 induces sox2 
expression in a cell-autonomous manner. Therefore, a decrease of sox3 might 
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also affect sox2 expression levels indirectly. This possibility could be ruled out 
by the single knock-down of sox2 or sox3 by a more specific morpholino was 
done by Okuda et al. and the result showed no serious defective phenotype 
(Figure 7.3.5) (Okuda et al., 2010). These data suggest a compensat function 
between sox2 and sox3 during neural development, explaining the lack of 
phenotype in sox3 mutant zebrafish. Nevertheless, a more detailed 
investigation of sox2 and sox3 function is needed to reveal their specific 
functions. 
 
Figure 7.3.3 Brain defect caused by sox3 morpholinos (MO1/2). 
The immunostaining of brain section of wild-type and sox3 morpholinos injected zebrafish 
brain was carried out using Anti-Sox3 antibody (From Dee et al., 2008). 
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Figure 7.3.4 The specificity of sox3 morpholinos. 
(A) The alignment of sox3 morpholino with sox2 and sox3 sequence. (B-E) Co-injection of 
2.5ng sox3 morpholinos (MO1 and MO2) alone or together with sox3-GFP at 1-2 cell stage 
and the image were took at 70% epiboly stage. (F-I) C0-injection of 2.5ng sox3 
morpholinos alone or together with sox2-GFP at 1-2 cell stage and the image were took at 
70% epiboly stage. (pictures taken from PhD thesis, Yu-Huan Shih, 2009) 
 
 
Figure 7.3.5 Specific knock-down of sox2 and sox3 have no serious effect on zebrafish. 
Specific sox2 or sox3 morpholinos (0.9ng) were injected at 1 cell stage zebrafish embryos. 
The images were taken at15-16 hpf and 30-33 hpf respectively. Image was taken from 
Okuda et al., 2010. 
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7.4 Summary and perspectives  
The data presented in this thesis indicate that Sox2 functions as a bifunctional 
transcription factor. Through interaction with Groucho, Sox2 acts as a 
transcriptional repressor of GFAP. However, the interaction of Sox2 with 
Groucho is required for regulation of only a small proportion of Sox2 target 
genes in neural stem cells and loss of their interaction has a dramatic effect on 
the function of Sox2 when overexpressed in early zebrafish embryo 
development.  
There are several areas of further research identified in this thesis that could 
help understand the function of Sox2 more detail. First, in order to fully 
analyse the mechanism of Sox2 transcriptional repression function, other 
possible co-repressors, chromatin remodelers and the interaction with 
heterochromatin should be tested. Second, the mechanism by which Sox2 
switches between transcriptional activator and repressor needs to be studied in 
the future.  
As for the function of Sox2 in neural stem cells, the data in this thesis are the 
results of overexpression Sox2 and Sox2 mutant which lose Groucho/Sox2 
interaction motif. Forcing cells to overexpress Sox2 might saturate the factors 
that Sox2 needs for its function or be toxic to the cells. Therefore, it might lead 
to an artificial result that not reflecting the normal function of Sox2. In order to 
understand the full function of endogenous Sox2, the expression array analysis 
of Sox2 knockdown cells is necessary 
From the array data represented in this thesis, it seems that Sox2 transcriptional 
repression function affects the expression of many genes in neural stem cells. 
In order to confirm that those genes are genuine Sox2 repression targets, the 
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further studies of the candidates that selected from array data are needed. The 
expression level and the analysis of Sox2 binding sites in the candidate genes 
could confirm the relationship between Sox2 and the candidate genes.  
Finally, the biological function of Sox2 transcriptional repressor function in 
vivo is needed. In zebrafish, further studies of the role of Sox2 in regulating the 
organizer formation and brain formation are needed to elucidate the 
mechanisms leading to the phenomena presented in chapter 6. On the other 
hand, Sox2 transcriptional activation and repression function affect genes 
which have distinct functions in neural stem cells; activating transcription 
factor, repressing cell cycle relative factors. Further investigations are needed 
to understand the role of these activities in neuronal differentiation and stem 
cell maintenance.  
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